# BugSigDB 2021-10-17, License: Creative Commons Attribution 4.0 International, URL: https://bugsigdb.org
bsdb:1/1/1_adenoma:conventional-adenoma-cases_vs_controls_UP	NA	186817
bsdb:1/1/2_adenoma:conventional-adenoma-cases_vs_controls_DOWN	NA	1117
bsdb:1/2/1_hyperplastic-polyp:hyperplastic-polyp-cases_vs_controls_UP	NA	57037
bsdb:1/2/2_hyperplastic-polyp:hyperplastic-polyp-cases_vs_controls_DOWN	NA	91347
bsdb:1/3/1_sessile-serrated-adenoma:Sessile-serrated-adenoma-cases_vs_controls_DOWN	NA	1236
bsdb:1/4/1_adenoma:Proximal-conventional-adenoma-cases_vs_controls_UP	NA	1853231
bsdb:1/4/2_adenoma:Proximal-conventional-adenoma-cases_vs_controls_DOWN	NA	100883
bsdb:1/5/1_adenoma:Distal-conventional-adenoma-cases_vs_controls_DOWN	NA	508458
bsdb:1/6/1_adenoma:Non-advanced-conventional-adenoma-cases_vs_controls_UP	NA	33024
bsdb:1/7/1_adenoma:advanced-conventional-adenoma-cases_vs_controls_UP	NA	1653
bsdb:1/7/2_adenoma:advanced-conventional-adenoma-cases_vs_controls_DOWN	NA	28211
bsdb:2/1/1_squamous-cell-carcinoma:squamous-cell-carcinoma-tissues_vs_normal-adjacent-tissues_UP	NA	543311
bsdb:2/1/2_squamous-cell-carcinoma:squamous-cell-carcinoma-tissues_vs_normal-adjacent-tissues_DOWN	NA	1654
bsdb:2/2/1_squamous-cell-carcinoma:T3-T4-high-tumor-stages-patients_vs_T0-T2-low-tumor-stages-patients_UP	NA	543311
bsdb:2/2/2_squamous-cell-carcinoma:T3-T4-high-tumor-stages-patients_vs_T0-T2-low-tumor-stages-patients_DOWN	NA	201174
bsdb:2/3/1_squamous-cell-carcinoma:T3-T4-stages-patients_vs_T0-T2-stages-patients_UP	NA	543311
bsdb:2/3/2_squamous-cell-carcinoma:T3-T4-stages-patients_vs_T0-T2-stages-patients_DOWN	NA	201174
bsdb:3/1/1_colorectal-cancer:adenocarcinoma-of-colon-and-rectum-patients_vs_controls_UP	NA	836
bsdb:3/1/2_colorectal-cancer:adenocarcinoma-of-colon-and-rectum-patients_vs_controls_DOWN	NA	186803
bsdb:4/1/1_hepatitis:HCV-stage-4-male-patients_vs_male-healthy-controls_UP	NA	976
bsdb:4/1/2_hepatitis:HCV-stage-4-male-patients_vs_male-healthy-controls_DOWN	NA	256845
bsdb:5/1/1_chronic-obstructive-pulmonary-disease:Chronic-obstructive-pulmonary-disease_vs_controls_UP	NA	84999
bsdb:5/1/2_chronic-obstructive-pulmonary-disease:Chronic-obstructive-pulmonary-disease_vs_controls_DOWN	NA	1663
bsdb:5/2/1_chronic-obstructive-pulmonary-disease:Severe_vs_moderate-Chronic-obstructive-pulmonary-disease_UP	NA	642
bsdb:6/1/1_non-alcoholic-fatty-liver-disease:advanced-fibrosis_vs_mild/moderate-fibrosis_DOWN	NA	39491
bsdb:7/1/1_autism:severely-autistic_vs_non-sibling-control_UP	NA	1224
bsdb:7/1/2_autism:severely-autistic_vs_non-sibling-control_DOWN	NA	1535
bsdb:8/1/1_type-II-diabetes-mellitus:Diabetes-Type-2_vs_Control_UP	NA	28216
bsdb:8/1/2_type-II-diabetes-mellitus:Diabetes-Type-2_vs_Control_DOWN	NA	186801
bsdb:9/1/1_breast-carcinoma:Breast-Cancer_vs_Control_UP	NA	1766
bsdb:9/1/2_breast-carcinoma:Breast-Cancer_vs_Control_DOWN	NA	33917
bsdb:10/1/1_cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Lesion-HIV-patients_vs_Normal-tissue-HIV-patients_UP	NA	437755
bsdb:10/2/1_cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Lesion-HIV-patients_vs_Normal-tissue-HIV-patients_UP	NA	215580
bsdb:11/1/1_cervical-glandular-intraepithelial-neoplasia:HIV-patients-with-lesion-at-12-months_vs_HIV-pateints-with-normal-tissue-at-6-months_DOWN	NA	2702
bsdb:12/1/1_human-papilloma-virus-infection:HPV-persistent_vs_HPV-clearance_UP	NA	387661
bsdb:12/2/1_human-papilloma-virus-infection:HPV-clearance_vs_HPV-negative_UP	NA	2130
bsdb:12/3/1_human-papilloma-virus-infection:HPV-negative_vs_HPV-presistent-and-clearance_UP	NA	47770
bsdb:12/4/1_human-papilloma-virus-infection:HPV-clearance_vs_HPV-presistent-and-negative_UP	NA	39485
bsdb:13/1/1_cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Neoplasis-+2_vs_Cervical-Intraepithelial-Neoplasis--1_UP	NA	827
bsdb:13/1/2_cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Neoplasis-+2_vs_Cervical-Intraepithelial-Neoplasis--1_DOWN	NA	82135
bsdb:13/2/1_cervical-glandular-intraepithelial-neoplasia:HPV-+ve_vs_HPV--ve-among-pateints-with-Cervical-Intraepithelial-Neoplasia-different-severity-status_UP	NA	1261
bsdb:13/2/2_cervical-glandular-intraepithelial-neoplasia:HPV-+ve_vs_HPV--ve-among-pateints-with-Cervical-Intraepithelial-Neoplasia-different-severity-status_DOWN	NA	1584
bsdb:14/1/1_oral-halitosis:Oral-Halitosis_vs_Control_UP	NA	838
bsdb:14/1/2_oral-halitosis:Oral-Halitosis_vs_Control_DOWN	NA	838
bsdb:15/1/1_gestational-diabetes:Gestational-diabetes-mellitus_vs_controls_UP	NA	506
bsdb:15/1/2_gestational-diabetes:Gestational-diabetes-mellitus_vs_controls_DOWN	NA	186822
bsdb:16/1/1_obesity:high-fat-diet_vs_normal-chow-diet_UP	NA	572511
bsdb:16/1/2_obesity:high-fat-diet_vs_normal-chow-diet_DOWN	NA	459786
bsdb:16/2/1_obesity:high-fat-diet-+-melatonin_vs_high-fat-diet_UP	NA	1920251
bsdb:16/2/2_obesity:high-fat-diet-+-melatonin_vs_high-fat-diet_DOWN	NA	152490
bsdb:17/1/1_anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_UP	NA	200643
bsdb:17/1/2_anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	39491
bsdb:17/2/1_anxiety-disorder:treatment-naiive-Generalized-Anxiety-disorder_vs_healthy-controls_UP	NA	32066
bsdb:17/2/2_anxiety-disorder:treatment-naiive-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	39491
bsdb:18/1/1_obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_UP	NA	49118
bsdb:18/1/2_obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_DOWN	NA	1735
bsdb:18/2/1_obesity:Sv129-High-Fat-without-enomithacin_vs_BL6-High-Fat-without-enomithacin_UP	NA	49118
bsdb:18/2/2_obesity:Sv129-High-Fat-without-enomithacin_vs_BL6-High-Fat-without-enomithacin_DOWN	NA	1735
bsdb:18/3/1_obesity:Sv129-High-Fat-with-enomithacin_vs_BL6-High-Fat-with-enomithacin_UP	NA	65842
bsdb:18/3/2_obesity:Sv129-High-Fat-with-enomithacin_vs_BL6-High-Fat-with-enomithacin_DOWN	NA	89152
bsdb:19/1/1_schizophrenia:Schizophrenia_vs_Healthy-controls_UP	NA	872
bsdb:19/1/2_schizophrenia:Schizophrenia_vs_Healthy-controls_DOWN	NA	186803
bsdb:20/1/1_non-alcoholic-fatty-liver-disease:NASH_vs_Non-NASH_UP	NA	816
bsdb:20/1/2_non-alcoholic-fatty-liver-disease:NASH_vs_Non-NASH_DOWN	NA	171552
bsdb:20/2/1_non-alcoholic-fatty-liver-disease:significant-fibrosis-(F>2)_vs_mild-fibrosis-(F-0-1)_UP	NA	816
bsdb:20/2/2_non-alcoholic-fatty-liver-disease:significant-fibrosis-(F>2)_vs_mild-fibrosis-(F-0-1)_DOWN	NA	128827
bsdb:21/1/1_obesity:Cameron-County-Hispanic-Cohort-samples_vs_Human-Microbiome-Project-samples_UP	NA	39948
bsdb:21/1/2_obesity:Cameron-County-Hispanic-Cohort-samples_vs_Human-Microbiome-Project-samples_DOWN	NA	239759
bsdb:22/1/1_parkinson's-disease:Parkinson's_vs_Healthy-controls_UP	NA	100176
bsdb:22/1/2_parkinson's-disease:Parkinson's_vs_Healthy-controls_DOWN	NA	33043
bsdb:23/1/1_alzheimer's-disease:Alzheimer's_vs_Healhty-controls_UP	NA	171550
bsdb:23/1/2_alzheimer's-disease:Alzheimer's_vs_Healhty-controls_DOWN	NA	86331
bsdb:24/1/1_chronic-fatigue-syndrome:Chronic-Fatigue-patients_vs_Healthy-controls_UP	NA	1378
bsdb:24/1/2_chronic-fatigue-syndrome:Chronic-Fatigue-patients_vs_Healthy-controls_DOWN	NA	286
bsdb:25/1/1_psoriasis:Psoriasis-Male_vs_Female_UP	NA	171412
bsdb:25/1/2_psoriasis:Psoriasis-Male_vs_Female_DOWN	NA	1696
bsdb:26/1/1_sex-design:female_vs_male_UP	NA	47678
bsdb:26/1/2_sex-design:female_vs_male_DOWN	NA	310297
bsdb:26/2/1_obesity:BMI->33-female_vs_male_UP	NA	816
bsdb:26/2/2_obesity:BMI->33-female_vs_male_DOWN	NA	310297
bsdb:27/1/1_obesity:foster-mother-wild-type-pre-HFD_vs_foster-mother-fat1-pre-HFD_UP	NA	186802
bsdb:27/1/2_obesity:foster-mother-wild-type-pre-HFD_vs_foster-mother-fat1-pre-HFD_DOWN	NA	1331051
bsdb:27/2/1_obesity:foster-mother-wild-type-post-HFD_vs_foster-mother-fat1-post-HFD_UP	NA	1313211
bsdb:27/2/2_obesity:foster-mother-wild-type-post-HFD_vs_foster-mother-fat1-post-HFD_DOWN	NA	1331051
bsdb:28/1/1_chronic-fatigue-syndrome:CFS-cases_vs_Healthy-controls_UP	NA	100883
bsdb:28/1/2_chronic-fatigue-syndrome:CFS-cases_vs_Healthy-controls_DOWN	NA	40544
bsdb:29/1/1_unipolar-depression:Active-Major-Depressive-Disorder_vs_Healthy-Controls_UP	NA	171550
bsdb:29/1/2_unipolar-depression:Active-Major-Depressive-Disorder_vs_Healthy-Controls_DOWN	NA	620
bsdb:29/2/1_unipolar-depression:Responded-Major-Depressive-Disorder_vs_Healthy-Controls_UP	NA	171551
bsdb:29/2/2_unipolar-depression:Responded-Major-Depressive-Disorder_vs_Healthy-Controls_DOWN	NA	31979
bsdb:30/1/1_chronic-fatigue-syndrome:Norweigan-controls_vs_Belgian-controls_UP	NA	61170
bsdb:30/1/2_chronic-fatigue-syndrome:Norweigan-controls_vs_Belgian-controls_DOWN	NA	375288
bsdb:30/2/1_chronic-fatigue-syndrome:Norweigan-CFS/ME-patients_vs_Norweigan-controls_UP	NA	420345
bsdb:30/2/2_chronic-fatigue-syndrome:Norweigan-CFS/ME-patients_vs_Norweigan-controls_DOWN	NA	84036
bsdb:30/3/1_chronic-fatigue-syndrome:Belgian-CFS/ME-patients_vs_Belgian-controls_UP	NA	420345
bsdb:30/3/2_chronic-fatigue-syndrome:Belgian-CFS/ME-patients_vs_Belgian-controls_DOWN	NA	553372
bsdb:31/1/1_chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_UP	NA	100884
bsdb:31/1/2_chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_DOWN	NA	1971605
bsdb:31/2/1_chronic-fatigue-syndrome:CFS/ME-patients-with-IBS_vs_controls_UP	NA	207244
bsdb:31/2/2_chronic-fatigue-syndrome:CFS/ME-patients-with-IBS_vs_controls_DOWN	NA	40520
bsdb:31/3/1_chronic-fatigue-syndrome:CFS/ME-patients-without-IBS_vs_controls_UP	NA	1506
bsdb:31/3/2_chronic-fatigue-syndrome:CFS/ME-patients-without-IBS_vs_controls_DOWN	NA	189330
bsdb:32/1/1_anorexia-nervosa:Aonerxia-Nervosa-patients_vs_Controls_UP	NA	2173
bsdb:32/1/2_anorexia-nervosa:Aonerxia-Nervosa-patients_vs_Controls_DOWN	NA	1485
bsdb:33/1/1_obesity:obese_vs_controls_UP	NA	40520
bsdb:33/1/2_obesity:obese_vs_controls_DOWN	NA	976
bsdb:34/1/1_bipolar-disorder:Bipolar-disorder_vs_Controls_UP	NA	84998
bsdb:34/1/2_bipolar-disorder:Bipolar-disorder_vs_Controls_DOWN	NA	216851
bsdb:34/2/1_bipolar-disorder:Bipolar-patients-with-high-IL-6_vs_low-IL-6_UP	NA	1301
bsdb:34/3/1_bipolar-disorder:Bipolar-patients-with-high-total-cholesterol_vs_low-total-cholesterol_UP	NA	31979
bsdb:34/4/1_bipolar-disorder:Bipolar-patients-with-high-LDL_vs_low-LDL_DOWN	NA	838
bsdb:34/5/1_bipolar-disorder:Bipolar-patients-with-high-TRP_vs_low-TRP_UP	NA	31979
bsdb:34/6/1_bipolar-disorder:Bipolar-patients-with-high-TBARS-level_vs_low-TBARS-level_UP	NA	1730
bsdb:34/7/1_bipolar-disorder:Bipolar-patients-with-high-MDA-level_vs_low-MDA-level_DOWN	NA	216851
bsdb:34/8/1_bipolar-disorder:Bipolar-patients-with-high-BMI_vs_low-BMI_UP	NA	91061
bsdb:34/9/1_bipolar-disorder:Bipolar-patients-with-metabolic-syndrome_vs_no-metabolic-syndrome_UP	NA	84107
bsdb:34/10/1_bipolar-disorder:Bipolar-patients-with-depressive-syndrome_vs_healthier-bipolar-patients_UP	NA	543
bsdb:34/10/2_bipolar-disorder:Bipolar-patients-with-depressive-syndrome_vs_healthier-bipolar-patients_DOWN	NA	841
bsdb:34/11/1_bipolar-disorder:Bipolar-disorder_vs_Controls_UP	NA	84998
bsdb:34/11/2_bipolar-disorder:Bipolar-disorder_vs_Controls_DOWN	NA	216851
bsdb:35/1/1_sjogren's-syndrome:PSS_vs_Control_UP	NA	1224
bsdb:35/1/2_sjogren's-syndrome:PSS_vs_Control_DOWN	NA	201174
bsdb:36/1/1_obesity:obese-adolescent_vs_control-adult_UP	NA	1747
bsdb:36/1/2_obesity:obese-adolescent_vs_control-adult_DOWN	NA	119852
bsdb:36/2/1_obesity:obese-adult_vs_contorl-adolescent_UP	NA	1301
bsdb:36/2/2_obesity:obese-adult_vs_contorl-adolescent_DOWN	NA	119852
bsdb:36/3/1_obesity:control-adolescent_vs_control-adult_UP	NA	2005519
bsdb:36/3/2_obesity:control-adolescent_vs_control-adult_DOWN	NA	1301
bsdb:36/4/1_obesity:obese-adolescent_vs_obese-adult_UP	NA	1239
bsdb:36/5/1_obesity:obese-adolescent_vs_control-adolescent_UP	NA	1239
bsdb:36/5/2_obesity:obese-adolescent_vs_control-adolescent_DOWN	NA	976
bsdb:36/6/1_obesity:obese-adult_vs_control-adult_UP	NA	1747
bsdb:37/1/1_colorectal-cancer:CRC-patients_vs_Healthy-controls_UP	NA	1737404
bsdb:37/1/2_colorectal-cancer:CRC-patients_vs_Healthy-controls_DOWN	NA	1301
bsdb:38/1/1_body-odor-measurement:teen-head_vs_child-head_UP	NA	1747
bsdb:38/1/2_body-odor-measurement:teen-head_vs_child-head_DOWN	NA	1282
bsdb:38/2/1_body-odor-measurement:teen-neck_vs_child-neck_UP	NA	76773
bsdb:38/2/2_body-odor-measurement:teen-neck_vs_child-neck_DOWN	NA	1290
bsdb:38/3/1_body-odor-measurement:teen-underarm_vs_child-underarm_UP	NA	76773
bsdb:38/3/2_body-odor-measurement:teen-underarm_vs_child-underarm_DOWN	NA	1290
bsdb:39/1/1_body-odor-measurement:youth-underarm-before_vs_after-excercise_UP	NA	1282
bsdb:39/1/2_body-odor-measurement:youth-underarm-before_vs_after-excercise_DOWN	NA	265
bsdb:39/2/1_body-odor-measurement:youth-Neck-before_vs_after-excercise_DOWN	NA	108981
bsdb:39/3/1_body-odor-measurement:Children-underarm-before_vs_after-excercise_DOWN	NA	265
bsdb:39/4/1_body-odor-measurement:Children-Neck-before_vs_after-excercise_UP	NA	1279
bsdb:39/4/2_body-odor-measurement:Children-Neck-before_vs_after-excercise_DOWN	NA	1912216
bsdb:39/5/1_body-odor-measurement:teen-underarm-before_vs_after-excercise_DOWN	NA	265
bsdb:39/6/1_body-odor-measurement:teen-Neck-before_vs_after-excercise_DOWN	NA	469
bsdb:40/1/1_attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_UP	NA	213115
bsdb:40/1/2_attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_DOWN	NA	33042
bsdb:41/1/1_psychosis:FIrst-episode-Psychosis_vs_Controls_UP	NA	1689
bsdb:41/1/2_psychosis:FIrst-episode-Psychosis_vs_Controls_DOWN	NA	115778
bsdb:41/2/1_psychosis:FIrst-episode-Psychosis-(physically-active)_vs_Controls_UP	NA	33958
bsdb:41/2/2_psychosis:FIrst-episode-Psychosis-(physically-active)_vs_Controls_DOWN	NA	31977
bsdb:42/1/1_extrahepatic-cholestasis:cholestasis-infants_vs_healthy-infants_UP	NA	158846
bsdb:42/1/2_extrahepatic-cholestasis:cholestasis-infants_vs_healthy-infants_DOWN	NA	102106
bsdb:43/1/1_behcet's-syndrome:behcet's-disease_vs_controls_UP	NA	1283313
bsdb:43/1/2_behcet's-syndrome:behcet's-disease_vs_controls_DOWN	NA	76123
bsdb:43/2/1_behcet's-syndrome:immunosuppressant-users_vs_non-immunosuppressent-users-among-behcet's-patients_UP	NA	41976
bsdb:43/2/2_behcet's-syndrome:immunosuppressant-users_vs_non-immunosuppressent-users-among-behcet's-patients_DOWN	NA	1969407
bsdb:44/1/1_obesity:pediatric-obese_vs_controls_UP	NA	853
bsdb:44/1/2_obesity:pediatric-obese_vs_controls_DOWN	NA	46506
bsdb:45/1/1_obesity:Rats-fed--HFHS_vs_control-rats_UP	NA	174708
bsdb:46/1/1_obesity:pediatric-obese_vs_controls_DOWN	NA	1853550
bsdb:47/1/1_obesity:low_vs_high-dietary-fiber_UP	NA	1263
bsdb:47/1/2_obesity:low_vs_high-dietary-fiber_DOWN	NA	544448
bsdb:47/2/1_obesity:low_vs_hight-moderate-to-vigrous-physical-activity_UP	NA	91347
bsdb:47/2/2_obesity:low_vs_hight-moderate-to-vigrous-physical-activity_DOWN	NA	186803
bsdb:48/1/1_obesity:obese-adolescent_vs_control-adolescent_UP	NA	838
bsdb:48/1/2_obesity:obese-adolescent_vs_control-adolescent_DOWN	NA	459786
bsdb:48/2/1_obesity:high-BMI-zscore_vs_low-BMI-zscores_UP	NA	838
bsdb:48/2/2_obesity:high-BMI-zscore_vs_low-BMI-zscores_DOWN	NA	239759
bsdb:48/3/1_obesity:high-triglycerides_vs_low-triglycerides_UP	NA	838
bsdb:48/3/2_obesity:high-triglycerides_vs_low-triglycerides_DOWN	NA	816
bsdb:48/4/1_obesity:high-total-cholesterol_vs_low-total-cholesterol_DOWN	NA	816
bsdb:48/5/1_obesity:high-HDL-C_vs_low-HDL-C_UP	NA	816
bsdb:48/6/1_obesity:high-senstive-C-reactive-protein_vs_low-sensetive-C-reactive-protein_UP	NA	838
bsdb:48/6/2_obesity:high-senstive-C-reactive-protein_vs_low-sensetive-C-reactive-protein_DOWN	NA	459786
bsdb:49/1/1_obesity:Obesity-group_vs_controls_UP	NA	186804
bsdb:49/1/2_obesity:Obesity-group_vs_controls_DOWN	NA	40323
bsdb:50/1/1_colorectal-cancer:Colrectal-cancer-patients_vs_healthy-controls_UP	NA	1257
bsdb:50/1/2_colorectal-cancer:Colrectal-cancer-patients_vs_healthy-controls_DOWN	NA	577310
bsdb:51/1/1_colorectal-cancer:Carcinoma-patients_vs_postoperation-patients_UP	NA	1654
bsdb:51/1/2_colorectal-cancer:Carcinoma-patients_vs_postoperation-patients_DOWN	NA	33038
bsdb:51/2/1_colorectal-cancer:NDA(new-dev.-adenoma)_vs_CIT(cleain-intestine)_UP	NA	123375
bsdb:51/2/2_colorectal-cancer:NDA(new-dev.-adenoma)_vs_CIT(cleain-intestine)_DOWN	NA	244127
bsdb:52/1/1_substance-related-disorder:Substance-use-disorder-patients_vs_Healthy-controls_UP	NA	33057
bsdb:52/1/2_substance-related-disorder:Substance-use-disorder-patients_vs_Healthy-controls_DOWN	NA	1300
bsdb:52/2/1_substance-related-disorder:Substance-use-disorder-patients_vs_adjusted-Healthy-controls_UP	NA	838
bsdb:52/2/2_substance-related-disorder:Substance-use-disorder-patients_vs_adjusted-Healthy-controls_DOWN	NA	1407607
bsdb:53/1/1_chronic-fatigue-syndrome:chronic-fatigue-syndrome-patients_vs_healthy-controls_DOWN	NA	57723
bsdb:54/1/1_cesarean-section:meconium_vs_placenta_UP	NA	186817
bsdb:54/1/2_cesarean-section:meconium_vs_placenta_DOWN	NA	543
bsdb:54/2/1_cesarean-section:colostrum_vs_placenta_UP	NA	1300
bsdb:54/2/2_cesarean-section:colostrum_vs_placenta_DOWN	NA	543
bsdb:55/1/1_stimulus-or-stress-design:grid-floor-induced-stress_vs_control_UP	NA	239759
bsdb:56/1/1_type-II-diabetes-mellitus:Healthy-baby-meconium_vs_adult-stool_UP	NA	620
bsdb:56/1/2_type-II-diabetes-mellitus:Healthy-baby-meconium_vs_adult-stool_DOWN	NA	31977
bsdb:56/2/1_gestational-diabetes:Baby-meconium-with-GDM-mothers_vs_Healthy-baby-meconium_DOWN	NA	40323
bsdb:56/3/1_type-II-diabetes-mellitus:Baby-meconium-with-DM-mothers_vs_Healthy-baby-meconium_UP	NA	31977
bsdb:57/1/1_inflammatory-bowel-disease:irritable-bowel-syndrome_vs_control_UP	NA	482
bsdb:57/1/2_inflammatory-bowel-disease:irritable-bowel-syndrome_vs_control_DOWN	NA	286
bsdb:57/2/1_inflammatory-bowel-disease:overweight-irritabe-bowel-syndrome_vs_control_UP	NA	1279
bsdb:57/2/2_inflammatory-bowel-disease:overweight-irritabe-bowel-syndrome_vs_control_DOWN	NA	1279
bsdb:58/1/1_high-fat-diet:newborns-of-maternal-high-fat-diet_vs_nebowrns-of-maternal-control_UP	NA	1350
bsdb:58/1/2_high-fat-diet:newborns-of-maternal-high-fat-diet_vs_nebowrns-of-maternal-control_DOWN	NA	283
bsdb:58/2/1_high-fat-diet:6-months-babies-of-maternal-high-fat-diet_vs_6-months-babies-control_UP	NA	561
bsdb:58/2/2_high-fat-diet:6-months-babies-of-maternal-high-fat-diet_vs_6-months-babies-control_DOWN	NA	816
bsdb:59/1/1_titanium-dioxide-nanoparticles:pregnant-rats-exposed-to-titanium-dioxide-nanoparticles_vs_control-pregnant-rats-at-gestational-day-10_UP	NA	186802
bsdb:59/1/2_titanium-dioxide-nanoparticles:pregnant-rats-exposed-to-titanium-dioxide-nanoparticles_vs_control-pregnant-rats-at-gestational-day-10_DOWN	NA	234266
bsdb:60/1/1_type-II-diabetes-mellitus:Type-2-DM-cases_vs_controls_UP	NA	255204
bsdb:60/1/2_type-II-diabetes-mellitus:Type-2-DM-cases_vs_controls_DOWN	NA	1847
bsdb:60/2/1_type-II-diabetes-mellitus:Type-2-DM-cariers-of-pathogens_vs_carier-of-pathogens-controls_UP	NA	504481
bsdb:60/2/2_type-II-diabetes-mellitus:Type-2-DM-cariers-of-pathogens_vs_carier-of-pathogens-controls_DOWN	NA	816
bsdb:61/1/1_obesity:infants-of-overweight-mothers_vs_infants-of-normal-weight-mother-at-age-1-month_DOWN	NA	838
bsdb:61/2/1_obesity:infants-of-overweight-mothers_vs_infants-of-normal-weight-mother-at-age-6-month_UP	NA	1686
bsdb:61/3/1_obesity:infants-of-excessive-maternal-weight-gain-mothers_vs_infants-of-normal-maternal-weight-gain-mothers-at-age-1-month_DOWN	NA	838
bsdb:61/4/1_obesity:infants-of-excessive-maternal-weight-gain-mothers_vs_infants-of-normal-maternal-weight-gain-mothers-at-age-6-months_UP	NA	1498
bsdb:62/1/1_cesarean-section:C-section-delivery_vs_vaginal-delivery-in-mecomium_DOWN	NA	1596
bsdb:63/1/1_cesarean-section:C-section-delivery_vs_vaginal-delivery-after-7-days-of-delivery_DOWN	NA	1596
bsdb:63/2/1_cesarean-section:C-section-delivery_vs_vaginal-delivery-after-3-months-of-delivery_DOWN	NA	1578
bsdb:63/3/1_cesarean-section:C-section-delivery_vs_vaginal-delivery-after-6-months-of-delivery_DOWN	NA	1598
bsdb:64/1/1_periodontitis:periodnotitis_vs_No-Periodontitis-within-negative-diabetic-background-only_UP	NA	1302
bsdb:64/1/2_periodontitis:periodnotitis_vs_No-Periodontitis-within-negative-diabetic-background-only_DOWN	NA	1924944
bsdb:64/2/1_type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic-within-negative--periodnotitis_UP	NA	80840
bsdb:64/2/2_type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic-within-negative--periodnotitis_DOWN	NA	1018
bsdb:64/3/1_type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic-within-positive--periodnotitis_UP	NA	1019
bsdb:64/4/1_periodontitis:periodnotitis_vs_No-Periodontitis-within-positive-diabetic-background-only_UP	NA	143361
bsdb:64/4/2_periodontitis:periodnotitis_vs_No-Periodontitis-within-positive-diabetic-background-only_DOWN	NA	482
bsdb:64/5/1_periodontitis:periodnotitis_vs_No-Periodontitis-within-both-positive-and-negative-diabetic-background_UP	NA	171552
bsdb:64/5/2_periodontitis:periodnotitis_vs_No-Periodontitis-within-both-positive-and-negative-diabetic-background_DOWN	NA	1655
bsdb:65/1/1_type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic_UP	NA	970
bsdb:65/1/2_type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic_DOWN	NA	157
bsdb:66/1/1_neonatal-jaundice:cesarean-infants-with-jaundice_vs_control_UP	NA	106589
bsdb:66/1/2_neonatal-jaundice:cesarean-infants-with-jaundice_vs_control_DOWN	NA	135625
bsdb:66/2/1_neonatal-jaundice:infants-with-jaundice_vs_control_UP	NA	1502
bsdb:66/2/2_neonatal-jaundice:infants-with-jaundice_vs_control_DOWN	NA	1301
bsdb:67/1/1_autism:autistic_vs_neurotypical_DOWN	NA	976
bsdb:67/2/1_autism:autistic_vs_neurotypical_UP	NA	200643
bsdb:67/2/2_autism:autistic_vs_neurotypical_DOWN	NA	171549
bsdb:67/3/1_autism:constipated-autistic_vs_non-constipated-autistic_UP	NA	1485
bsdb:67/4/1_autism:constipated-neurotypical_vs_non-constipated-neurotypical_DOWN	NA	204475
bsdb:68/1/1_obesity:obese_vs_normal-weight_UP	NA	541000
bsdb:68/1/2_obesity:obese_vs_normal-weight_DOWN	NA	541000
bsdb:68/2/1_obesity:overweight_vs_normal-weight_UP	NA	35832
bsdb:68/2/2_obesity:overweight_vs_normal-weight_DOWN	NA	128827
bsdb:68/3/1_obesity:obese-men_vs_normal-weight-men_UP	NA	1236
bsdb:68/3/2_obesity:obese-men_vs_normal-weight-men_DOWN	NA	1263
bsdb:68/4/1_obesity:overweight-men_vs_normal-weight-men_UP	NA	140625
bsdb:68/4/2_obesity:overweight-men_vs_normal-weight-men_DOWN	NA	649775
bsdb:68/5/1_obesity:obese-women_vs_normal-weight-women_UP	NA	1263
bsdb:68/5/2_obesity:obese-women_vs_normal-weight-women_DOWN	NA	51514
bsdb:68/6/1_obesity:overweight-women_vs_normal-weight-women_UP	NA	543
bsdb:68/6/2_obesity:overweight-women_vs_normal-weight-women_DOWN	NA	31979
bsdb:69/1/1_sex-design:female_vs_male_UP	NA	1263
bsdb:69/2/1_obesity:female-obese_vs_female-normal-weight_DOWN	NA	33024
bsdb:69/3/1_obesity:male-obese_vs_male-normal-weight_UP	NA	848
bsdb:69/4/1_obesity:obese_vs_normal-weight_UP	NA	848
bsdb:70/1/1_obesity:pediatric-obese_vs_pediatric-normal-weight_UP	NA	186803
bsdb:70/1/2_obesity:pediatric-obese_vs_pediatric-normal-weight_DOWN	NA	816
bsdb:70/2/1_obesity:female-pediatric-obese_vs_female-pediatric-normal-weight_UP	NA	28111
bsdb:70/2/2_obesity:female-pediatric-obese_vs_female-pediatric-normal-weight_DOWN	NA	283168
bsdb:70/3/1_obesity:male-pediatric-obese_vs_male-pediatric-normal-weight_UP	NA	28111
bsdb:70/3/2_obesity:male-pediatric-obese_vs_male-pediatric-normal-weight_DOWN	NA	310297
bsdb:71/1/1_cesarean-section:cesarean-premature-birth_vs_vaginally-born-controls_UP	NA	830
bsdb:71/2/1_premature-birth:infants-<33-weeks-gestational-age_vs_>/=33-weeks_UP	NA	201174
bsdb:71/2/2_premature-birth:infants-<33-weeks-gestational-age_vs_>/=33-weeks_DOWN	NA	223927
bsdb:72/1/1_autism:autism_vs_typically-developing-controls_UP	NA	976
bsdb:72/1/2_autism:autism_vs_typically-developing-controls_DOWN	NA	162289
bsdb:73/1/1_obesity:obese_vs_normal-weight_UP	NA	33042
bsdb:73/1/2_obesity:obese_vs_normal-weight_DOWN	NA	128827
bsdb:73/2/1_obesity:obese-+-metabolic-syndrome_vs_normal-weight_UP	NA	33042
bsdb:73/2/2_obesity:obese-+-metabolic-syndrome_vs_normal-weight_DOWN	NA	128827
bsdb:74/1/1_obesity:obese_vs_non-obese_UP	NA	39486
bsdb:74/1/2_obesity:obese_vs_non-obese_DOWN	NA	195950
bsdb:74/2/1_obesity:obese_vs_Nonobese-microbiota-cluster_UP	NA	39488
bsdb:74/2/2_obesity:obese_vs_Nonobese-microbiota-cluster_DOWN	NA	119853
bsdb:74/3/1_obesity:high-BMI_vs_low-BMI_UP	NA	629
bsdb:74/3/2_obesity:high-BMI_vs_low-BMI_DOWN	NA	511
bsdb:74/4/1_obesity:high-C-Reactive-Protein_vs_low-C-Reactive-Protein_UP	NA	29370
bsdb:74/4/2_obesity:high-C-Reactive-Protein_vs_low-C-Reactive-Protein_DOWN	NA	195950
bsdb:75/1/1_smoking-behavior:right-oropharynx-of-smokers_vs_right-oropharynx-of-nonsmokers_UP	NA	482
bsdb:75/1/2_smoking-behavior:right-oropharynx-of-smokers_vs_right-oropharynx-of-nonsmokers_DOWN	NA	541000
bsdb:75/2/1_smoking-behavior:left-oropharynx-of-smokers_vs_left-oropharynx-of-nonsmokers_UP	NA	416916
bsdb:75/2/2_smoking-behavior:left-oropharynx-of-smokers_vs_left-oropharynx-of-nonsmokers_DOWN	NA	34104
bsdb:75/3/1_smoking-behavior:right-nasopharynx-of-smokers_vs_right-nasopharynx-of-nonsmokers_UP	NA	349
bsdb:75/3/2_smoking-behavior:right-nasopharynx-of-smokers_vs_right-nasopharynx-of-nonsmokers_DOWN	NA	52784
bsdb:75/4/1_smoking-behavior:left-nasopharynx-of-smokers_vs_left-nasopharynx-of-nonsmokers_UP	NA	40544
bsdb:75/4/2_smoking-behavior:left-nasopharynx-of-smokers_vs_left-nasopharynx-of-nonsmokers_DOWN	NA	40323
bsdb:76/1/1_type-I-diabetes-mellitus:type-I-diabetes-mellitus-children_vs_controls_UP	NA	904
bsdb:76/1/2_type-I-diabetes-mellitus:type-I-diabetes-mellitus-children_vs_controls_DOWN	NA	1392389
bsdb:77/1/1_bipolar-disorder:atypical-antipsychotic-users_vs_non-users_UP	NA	186803
bsdb:77/1/2_bipolar-disorder:atypical-antipsychotic-users_vs_non-users_DOWN	NA	239934
bsdb:78/1/1_stimulus-or-stress-design:limited-nesting-stress_vs_controls_UP	NA	2316
bsdb:78/1/2_stimulus-or-stress-design:limited-nesting-stress_vs_controls_DOWN	NA	283168
bsdb:79/1/1_obesity:Laparoscopic-sleeve-gastrectomy-baseline_vs_Laparoscopic-sleeve-gastrectomy-after-3-months-and-6-Months-combined_UP	NA	88431
bsdb:79/2/1_obesity:Very-low-calorie-diet-baseline_vs_very-low-calorie-diet-after-3-months-and-6-months_DOWN	NA	100884
bsdb:80/1/1_type-I-diabetes-mellitus:Type-I-diabetic-children-at-onset_vs_controls_UP	NA	816
bsdb:80/1/2_type-I-diabetes-mellitus:Type-I-diabetic-children-at-onset_vs_controls_DOWN	NA	158846
bsdb:81/1/1_obesity:3-Months-after-Roux-en-Y-gastric-bypass-surgery_vs_baseline_UP	NA	1224
bsdb:81/1/2_obesity:3-Months-after-Roux-en-Y-gastric-bypass-surgery_vs_baseline_DOWN	NA	853
bsdb:81/2/1_obesity:one-year-after-Roux-en-Y-gastric-bypass-surgery_vs_baseline_UP	NA	32066
bsdb:82/1/1_obesity:before-surgery_vs_lean-controls_UP	NA	853
bsdb:82/1/2_obesity:before-surgery_vs_lean-controls_DOWN	NA	860
bsdb:83/1/1_obesity:before-surgery_vs_after-surgery_UP	NA	40637
bsdb:83/1/2_obesity:before-surgery_vs_after-surgery_DOWN	NA	5140
bsdb:84/1/1_obesity:after-surgery_vs_lean-controls_UP	NA	621
bsdb:84/1/2_obesity:after-surgery_vs_lean-controls_DOWN	NA	833
bsdb:85/1/1_cesarean-section:two-day-aged-babies-c-section_vs_vaginal-delivery_UP	NA	1266
bsdb:85/2/1_cesarean-section:two-day-aged-babies-c-section_vs_vaginal-delivery_DOWN	NA	816
bsdb:85/3/1_cesarean-section:seven-day-aged-babies-c-section_vs_vaginal-delivery_UP	NA	1266
bsdb:85/4/1_cesarean-section:seven-day-aged-babies-c-section_vs_vaginal-delivery_DOWN	NA	102106
bsdb:86/1/1_cesarean-section:c-section_vs_vaginal-delivery-at-day-3_UP	NA	1578
bsdb:86/2/1_cesarean-section:c-section_vs_vaginal-delivery-at-day-5_UP	NA	1239
bsdb:86/2/2_cesarean-section:c-section_vs_vaginal-delivery-at-day-5_DOWN	NA	976
bsdb:86/3/1_cesarean-section:c-section_vs_vaginal-delivery-at-day-28_DOWN	NA	816
bsdb:86/4/1_cesarean-section:c-section_vs_vaginal-delivery-at-day-150_DOWN	NA	816
bsdb:86/5/1_cesarean-section:c-section_vs_vaginal-delivery-at-day-365_DOWN	NA	976
bsdb:86/6/1_premature-birth:late-preterm-34-36-weeks_vs_full-term-delivery->39-weeks-at-day-3_DOWN	NA	976
bsdb:86/7/1_cesarean-section:overall-time-point-infants-samples-of-c-section_vs_vaginal-delivery_UP	NA	186803
bsdb:86/7/2_cesarean-section:overall-time-point-infants-samples-of-c-section_vs_vaginal-delivery_DOWN	NA	239759
bsdb:87/1/1_type-I-diabetes-mellitus:Type-I-Diabetics_vs_maturity-onset-diabetes-of-the-young-2-(MODY2)-and-healthy-Controls_UP	NA	40544
bsdb:87/1/2_type-I-diabetes-mellitus:Type-I-Diabetics_vs_maturity-onset-diabetes-of-the-young-2-(MODY2)-and-healthy-Controls_DOWN	NA	201174
bsdb:87/2/1_type-I-diabetes-mellitus:Type-I-Diabetics-and-maturity-onset-diabetes-of-the-young-2-(MODY2)_vs_healthy-Controls_DOWN	NA	216851
bsdb:88/1/1_schizophrenia:schizophrenia_vs_non-psychiatric-controls_UP	NA	572511
bsdb:88/1/2_schizophrenia:schizophrenia_vs_non-psychiatric-controls_DOWN	NA	729
bsdb:89/1/1_cesarean-section:C-section-delivery_vs_vaginal-delivery-in-transitional-stools_DOWN	NA	375288
bsdb:90/1/1_cesarean-section:transitional-stool_vs_mecomium-in-vaginal-delivery_UP	NA	209
bsdb:90/1/2_cesarean-section:transitional-stool_vs_mecomium-in-vaginal-delivery_DOWN	NA	80865
bsdb:90/2/1_cesarean-section:transitional-stool_vs_mecomium-in-C-section-delivery_UP	NA	1350
bsdb:90/2/2_cesarean-section:transitional-stool_vs_mecomium-in-C-section-delivery_DOWN	NA	165695
bsdb:91/1/1_cesarean-section:C-section-delivery_vs_vaginal-delivery_UP	NA	39491
bsdb:91/1/2_cesarean-section:C-section-delivery_vs_vaginal-delivery_DOWN	NA	286
bsdb:92/1/1_obesity:obese-without-non-alcoholic-fatty-liver-disease_vs_healthy-controls_UP	NA	201174
bsdb:92/1/2_obesity:obese-without-non-alcoholic-fatty-liver-disease_vs_healthy-controls_DOWN	NA	186801
bsdb:92/2/1_non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease-patients_vs_healthy-controls_UP	NA	1236
bsdb:92/2/2_non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease-patients_vs_healthy-controls_DOWN	NA	28211
bsdb:92/3/1_non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease-patients_vs_obese-without-non-alcoholic-fatty-liver-disease_UP	NA	29547
bsdb:92/3/2_non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease-patients_vs_obese-without-non-alcoholic-fatty-liver-disease_DOWN	NA	1236
bsdb:93/1/1_cesarean-section:C-section-delivery_vs_vaginal-delivery_DOWN	NA	1279
bsdb:93/2/1_cesarean-section:Antimicrobials-use-during-delivery-yes_vs_no_UP	NA	1678
bsdb:93/3/1_cesarean-section:Maternal-consumption-of-probiotics-yes_vs_no_UP	NA	1578
bsdb:93/4/1_cesarean-section:Furry-pets-at-home-yes_vs_no_UP	NA	216851
bsdb:93/4/2_cesarean-section:Furry-pets-at-home-yes_vs_no_DOWN	NA	1239
bsdb:94/1/1_obesity:3-months_vs_baseline-participants_UP	NA	469610
bsdb:94/1/2_obesity:3-months_vs_baseline-participants_DOWN	NA	651822
bsdb:94/2/1_obesity:6-months_vs_3-months-participants_UP	NA	81462
bsdb:94/2/2_obesity:6-months_vs_3-months-participants_DOWN	NA	469610
bsdb:94/3/1_obesity:24-months_vs_6-months-participants_UP	NA	984
bsdb:94/3/2_obesity:24-months_vs_6-months-participants_DOWN	NA	74426
bsdb:95/1/1_obesity:overweight/obese-babies_vs_control-babies-at-the-age-of-3_UP	NA	841
bsdb:95/1/2_obesity:overweight/obese-babies_vs_control-babies-at-the-age-of-3_DOWN	NA	375288
bsdb:96/1/1_obesity:obese_vs_controls_UP	NA	649756
bsdb:96/1/2_obesity:obese_vs_controls_DOWN	NA	290055
bsdb:97/1/1_obesity:obese-patients-prior-to-Sleeve-gastrectomy-SG0_vs_healthy-controls_UP	NA	186804
bsdb:97/2/1_obesity:Roux-en-Y-gastric-bypass-(RYGB)_vs_healthy-controls_UP	NA	906
bsdb:97/3/1_obesity:obese-patients-three-months-after-Sleeve-gastrectomy-SG3_vs_obese-patients-prior-to-Sleeve-gastrectomy-SG0_DOWN	NA	214856
bsdb:97/4/1_obesity:obese-patients-3-moths-after-Roux-en-Y-gastric-bypass-RYGB3_vs_patients-prior-to-Roux-en-Y-gastric-bypass-RYGB0_UP	NA	216851
bsdb:97/4/2_obesity:obese-patients-3-moths-after-Roux-en-Y-gastric-bypass-RYGB3_vs_patients-prior-to-Roux-en-Y-gastric-bypass-RYGB0_DOWN	NA	1308
bsdb:98/1/1_chronic-kidney-disease:CKD_vs_controls_UP	NA	204441
bsdb:98/1/2_chronic-kidney-disease:CKD_vs_controls_DOWN	NA	1506577
bsdb:99/1/1_obesity:obese_vs_controls_UP	NA	39488
bsdb:99/1/2_obesity:obese_vs_controls_DOWN	NA	239759
bsdb:100/1/1_obesity:High-BMI_vs_low-BMI_UP	NA	838
bsdb:100/2/1_obesity:Abdominal-obesity_vs_non-abdominal-obesity_UP	NA	838
bsdb:100/2/2_obesity:Abdominal-obesity_vs_non-abdominal-obesity_DOWN	NA	119852
bsdb:101/1/1_obesity:obese_vs_lean-controls_UP	NA	1578
bsdb:101/1/2_obesity:obese_vs_lean-controls_DOWN	NA	1590
bsdb:102/1/1_type-II-diabetes-mellitus:Women-with-gestational-DM_vs_normoglycemic-controls_UP	NA	1263
bsdb:102/1/2_type-II-diabetes-mellitus:Women-with-gestational-DM_vs_normoglycemic-controls_DOWN	NA	239759
bsdb:103/1/1_unipolar-depression:depressed-female_vs_Healthy-Controls_UP	NA	84107
bsdb:103/1/2_unipolar-depression:depressed-female_vs_Healthy-Controls_DOWN	NA	638847
bsdb:103/2/1_unipolar-depression:depressed-male_vs_Healthy-Controls_UP	NA	128827
bsdb:103/2/2_unipolar-depression:depressed-male_vs_Healthy-Controls_DOWN	NA	638847
bsdb:104/1/1_unipolar-depression:major-depressive-disoreder-(visit-1)_vs_healthy-controls_UP	NA	1301
bsdb:104/1/2_unipolar-depression:major-depressive-disoreder-(visit-1)_vs_healthy-controls_DOWN	NA	976
bsdb:104/2/1_unipolar-depression:major-depressive-disoreder-(visit-2)_vs_healthy-controls_UP	NA	1301
bsdb:104/2/2_unipolar-depression:major-depressive-disoreder-(visit-2)_vs_healthy-controls_DOWN	NA	976
bsdb:104/3/1_unipolar-depression:major-depressive-disoreder-(visit-3)_vs_healthy-controls_UP	NA	186804
bsdb:104/3/2_unipolar-depression:major-depressive-disoreder-(visit-3)_vs_healthy-controls_DOWN	NA	976
bsdb:105/1/1_unipolar-depression:bipolar_vs_healthy-controls_DOWN	NA	216851
bsdb:106/1/1_bipolar-disorder:bipolar_vs_healthy-controls_UP	NA	946234
bsdb:107/1/1_anorexia-nervosa:anorexia_vs_healthy-controls_UP	NA	91061
bsdb:107/1/2_anorexia-nervosa:anorexia_vs_healthy-controls_DOWN	NA	216851
bsdb:107/2/1_anorexia-nervosa:anorexia_vs_healthy-controls_UP	NA	375288
bsdb:108/1/1_anorexia-nervosa:anorexia-nervosa-patients_vs_healthy-controls_DOWN	NA	1590
bsdb:109/1/1_anorexia-nervosa:anorexia-patients-before-weight-gain_vs_HC_UP	NA	207244
bsdb:109/1/2_anorexia-nervosa:anorexia-patients-before-weight-gain_vs_HC_DOWN	NA	841
bsdb:109/2/1_anorexia-nervosa:anorexia-patients-after-weight-gain_vs_HC_UP	NA	1357
bsdb:109/2/2_anorexia-nervosa:anorexia-patients-after-weight-gain_vs_HC_DOWN	NA	816
bsdb:110/1/1_schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	1578
bsdb:111/1/1_attention-deficit-hyperactivity-disorder:ADHD_vs_healthy-control_UP	NA	186807
bsdb:111/1/2_attention-deficit-hyperactivity-disorder:ADHD_vs_healthy-control_DOWN	NA	39948
bsdb:112/1/1_attention-deficit-hyperactivity-disorder:ADHD-males_vs_controls_UP	NA	816
bsdb:112/1/2_attention-deficit-hyperactivity-disorder:ADHD-males_vs_controls_DOWN	NA	375288
bsdb:113/1/1_unipolar-depression:MDD_vs_controls_DOWN	NA	1603
bsdb:114/1/1_unipolar-depression:MDD_vs_controls_UP	NA	1378
bsdb:114/1/2_unipolar-depression:MDD_vs_controls_DOWN	NA	189330
bsdb:115/1/1_unipolar-depression:MDD_vs_controls_UP	NA	1689
bsdb:115/1/2_unipolar-depression:MDD_vs_controls_DOWN	NA	729
bsdb:115/2/1_bipolar-disorder:bipolar_vs_healthy-controls_DOWN	NA	290053
bsdb:116/1/1_type-I-diabetes-mellitus:children-with-type-1-diabetes_vs_healthy-controls_UP	NA	29465
bsdb:116/1/2_type-I-diabetes-mellitus:children-with-type-1-diabetes_vs_healthy-controls_DOWN	NA	1578
bsdb:117/1/1_pneumonia:elderly-pneumonia-patients_vs_elderly-controls_UP	NA	1578
bsdb:117/1/2_pneumonia:elderly-pneumonia-patients_vs_elderly-controls_DOWN	NA	32067
bsdb:117/2/1_pneumonia:adult-pneumonia-patients_vs_adult-controls_UP	NA	1578
bsdb:117/2/2_pneumonia:adult-pneumonia-patients_vs_adult-controls_DOWN	NA	482
bsdb:118/1/1_cesarean-section:cesarean-born_vs_vaginal-born-children_UP	NA	33958
bsdb:118/1/2_cesarean-section:cesarean-born_vs_vaginal-born-children_DOWN	NA	1678
bsdb:118/2/1_cesarean-section:cesarean-born-and-mixed-fed_vs_cesarean-born-and-breastfed_UP	NA	1350
bsdb:118/2/2_cesarean-section:cesarean-born-and-mixed-fed_vs_cesarean-born-and-breastfed_DOWN	NA	171552
bsdb:119/1/1_type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-negative_UP	NA	1678
bsdb:119/1/2_type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-negative_DOWN	NA	47678
bsdb:119/2/1_type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-positive_UP	NA	838
bsdb:119/2/2_type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-positive_DOWN	NA	1678
bsdb:119/3/1_type-II-diabetes-mellitus:Opoid-positive_vs_opoid-negative-among-Metaformin-negative_UP	NA	1678
bsdb:119/3/2_type-II-diabetes-mellitus:Opoid-positive_vs_opoid-negative-among-Metaformin-negative_DOWN	NA	838
bsdb:120/1/1_physical-activity:Activity-Based-Anorexia-group_vs_exercise-group_UP	NA	816
bsdb:120/1/2_physical-activity:Activity-Based-Anorexia-group_vs_exercise-group_DOWN	NA	39491
bsdb:120/2/1_physical-activity:Ad-libitum-group_vs_exercise-group_UP	NA	1485
bsdb:120/2/2_physical-activity:Ad-libitum-group_vs_exercise-group_DOWN	NA	39491
bsdb:121/1/1_gingivitis:gingivitis_vs_healthy-controls_UP	NA	241556
bsdb:121/1/2_gingivitis:gingivitis_vs_healthy-controls_DOWN	NA	1016
bsdb:122/1/1_breast-carcinoma:tumor-tissue_vs_normal-tissue_UP	NA	407
bsdb:122/1/2_breast-carcinoma:tumor-tissue_vs_normal-tissue_DOWN	NA	257758
bsdb:123/1/1_diet:high-fat-diet_vs_low-fat-diet_UP	NA	102106
bsdb:123/1/2_diet:high-fat-diet_vs_low-fat-diet_DOWN	NA	588605
bsdb:124/1/1_diet:body-builders-(high-protein)_vs_distance-runners-(high-carb)_UP	NA	550
bsdb:124/1/2_diet:body-builders-(high-protein)_vs_distance-runners-(high-carb)_DOWN	NA	1357
bsdb:124/2/1_diet:body-builders-(high-protein)_vs_control_UP	NA	1432051
bsdb:124/2/2_diet:body-builders-(high-protein)_vs_control_DOWN	NA	1243
bsdb:124/3/1_diet:distance-runners-(high-carb)_vs_control_UP	NA	40544
bsdb:124/3/2_diet:distance-runners-(high-carb)_vs_control_DOWN	NA	1243
bsdb:125/1/1_squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_noncancer-individuals_UP	NA	1016
bsdb:125/1/2_squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_noncancer-individuals_DOWN	NA	724
bsdb:126/1/1_oral-leukoplakia:Oral-leukoplakia_vs_healthy-controls_UP	NA	1386
bsdb:126/1/2_oral-leukoplakia:Oral-leukoplakia_vs_healthy-controls_DOWN	NA	46123
bsdb:126/2/1_squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_healthy-controls_UP	NA	1386
bsdb:126/2/2_squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_healthy-controls_DOWN	NA	46123
bsdb:126/3/1_oral-leukoplakia:Oral-leukoplakia_vs_Oral-Squamous-Cell-Cancer-patients_UP	NA	1301
bsdb:126/3/2_oral-leukoplakia:Oral-leukoplakia_vs_Oral-Squamous-Cell-Cancer-patients_DOWN	NA	1386
bsdb:127/1/1_alcohol-drinking:alcohol-overconsumers_vs_controls_UP	NA	61170
bsdb:127/1/2_alcohol-drinking:alcohol-overconsumers_vs_controls_DOWN	NA	216851
bsdb:127/2/1_alcohol-drinking:alcohol-overconsumers_vs_controls_UP	NA	2037
bsdb:127/2/2_alcohol-drinking:alcohol-overconsumers_vs_controls_DOWN	NA	186801
bsdb:128/1/1_gastric-cancer:gastric-cancer_vs_intestinal-metaplasia_UP	NA	1301
bsdb:128/1/2_gastric-cancer:gastric-cancer_vs_intestinal-metaplasia_DOWN	NA	235572
bsdb:128/2/1_gastric-cancer:gastric-cancer_vs_atrophic-gastric_UP	NA	437755
bsdb:128/2/2_gastric-cancer:gastric-cancer_vs_atrophic-gastric_DOWN	NA	235572
bsdb:128/3/1_gastric-cancer:gastric-cancer_vs_superficial-gastric_UP	NA	437755
bsdb:128/3/2_gastric-cancer:gastric-cancer_vs_superficial-gastric_DOWN	NA	235572
bsdb:129/1/1_multiple-sclerosis:multiple-sclerosis_vs_healthy-controls_UP	NA	286
bsdb:129/1/2_multiple-sclerosis:multiple-sclerosis_vs_healthy-controls_DOWN	NA	724
bsdb:130/1/1_diet:high-Southern-European-Atlantic-Diet_vs_low-Southern-European-Atlantic-Diet_UP	NA	1678
bsdb:130/2/1_diet:intermediate-Southern-European-Atlantic-Diet_vs_low-Southern-European-Atlantic-Diet_UP	NA	1678
bsdb:130/3/1_diet:>-30-years-participants_vs_<20-years-participants_UP	NA	1224
bsdb:130/4/1_diet:20-30-years-participants_vs_>20-years-participants_UP	NA	1224
bsdb:130/5/1_diet:>-30-years-participants_vs_20-30-years-participants_UP	NA	1578
bsdb:130/6/1_diet:BMI->25_vs_BMI-<-20_UP	NA	976
bsdb:130/6/2_diet:BMI->25_vs_BMI-<-20_DOWN	NA	1678
bsdb:130/7/1_diet:BMI-20-25_vs_BMI-<20_DOWN	NA	1678
bsdb:130/8/1_diet:BMI->25_vs_BMI-20-25_UP	NA	201174
bsdb:131/1/1_diet:Time-7-days_vs_Time-0-days-controls_DOWN	NA	171551
bsdb:131/2/1_diet:Time-7-days_vs_Time-0-days-Cara-Cara_UP	NA	1737406
bsdb:131/2/2_diet:Time-7-days_vs_Time-0-days-Cara-Cara_DOWN	NA	283168
bsdb:131/3/1_diet:Time-7-days_vs_Time-0-days-Bahia_UP	NA	31977
bsdb:131/4/1_diet:Cara-Cara_vs_controls-at-time-7_UP	NA	574697
bsdb:131/4/2_diet:Cara-Cara_vs_controls-at-time-7_DOWN	NA	990719
bsdb:131/5/1_diet:Bahia_vs_controls-at-time-7_UP	NA	244127
bsdb:131/6/1_diet:Cara-Cara_vs_Bahia-at-time-7_UP	NA	1263076
bsdb:132/1/1_diet:Meat_vs_mushroom_UP	NA	189330
bsdb:132/1/2_diet:Meat_vs_mushroom_DOWN	NA	40544
bsdb:133/1/1_diet:Equol-NON-producer-("unhealthier"-diet)_vs_Equol-producer-("healhtier"-diet)_UP	NA	1224
bsdb:133/2/1_diet:Equol-NON-producer-("unhealthier"-diet)_vs_Equol-producer-("healhtier"-diet)_DOWN	NA	1239
bsdb:134/1/1_diet:6-months-after-Average-Danish-Diet_vs_before-Average-Danish-Diet_UP	NA	872
bsdb:134/2/1_diet:6-months-after--New-Nordic-Diet_vs_before--New-Nordic-Diet_UP	NA	872
bsdb:134/2/2_diet:6-months-after--New-Nordic-Diet_vs_before--New-Nordic-Diet_DOWN	NA	2173
bsdb:135/1/1_diet:High-animal-protein_vs_low-animal-protein_UP	NA	816
bsdb:135/1/2_diet:High-animal-protein_vs_low-animal-protein_DOWN	NA	171552
bsdb:135/2/1_diet:Low-fiber_vs_high-fiber_UP	NA	201174
bsdb:135/2/2_diet:Low-fiber_vs_high-fiber_DOWN	NA	201174
bsdb:136/1/1_diet:Low-vegetable,-fruit,-grains,_vs_high-vegetable,-fruit,-grain_UP	NA	33958
bsdb:136/1/2_diet:Low-vegetable,-fruit,-grains,_vs_high-vegetable,-fruit,-grain_DOWN	NA	203557
bsdb:136/2/1_diet:two-weeks-after-a-dietry-intervention_vs_before-dietary-intervention_UP	NA	572511
bsdb:136/2/2_diet:two-weeks-after-a-dietry-intervention_vs_before-dietary-intervention_DOWN	NA	39492
bsdb:137/1/1_colorectal-cancer:CRC_vs_controls_UP	NA	848
bsdb:137/1/2_colorectal-cancer:CRC_vs_controls_DOWN	NA	841
bsdb:138/1/1_lung-cancer:lung-cancer_vs_controls_UP	NA	90964
bsdb:138/1/2_lung-cancer:lung-cancer_vs_controls_DOWN	NA	1257
bsdb:139/1/1_squamous-cell-carcinoma:HNSCC_vs_controls_UP	NA	201174
bsdb:139/1/2_squamous-cell-carcinoma:HNSCC_vs_controls_DOWN	NA	28216
bsdb:139/2/1_squamous-cell-carcinoma:Larynx-cancer-cases_vs_controls_DOWN	NA	206351
bsdb:139/3/1_squamous-cell-carcinoma:Pharynx-cancer-cases_vs_controls_DOWN	NA	32257
bsdb:139/4/1_squamous-cell-carcinoma:Oral-cavity-cancer-cases_vs_controls_UP	NA	1654
bsdb:139/4/2_squamous-cell-carcinoma:Oral-cavity-cancer-cases_vs_controls_DOWN	NA	490
bsdb:140/1/1_multiple-sclerosis:multiple-sclerosis_vs_controls_UP	NA	28890
bsdb:140/1/2_multiple-sclerosis:multiple-sclerosis_vs_controls_DOWN	NA	574697
bsdb:140/2/1_multiple-sclerosis:multiple-sclerosis_vs_controls_UP	NA	28890
bsdb:140/2/2_multiple-sclerosis:multiple-sclerosis_vs_controls_DOWN	NA	574697
bsdb:140/3/1_multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_UP	NA	239934
bsdb:140/3/2_multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_DOWN	NA	40544
bsdb:140/4/1_multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_UP	NA	239934
bsdb:140/4/2_multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_DOWN	NA	40544
bsdb:140/5/1_multiple-sclerosis:treated-multiple-sclerosis_vs_untreated_UP	NA	40544
bsdb:140/5/2_multiple-sclerosis:treated-multiple-sclerosis_vs_untreated_DOWN	NA	1266
bsdb:140/6/1_multiple-sclerosis:treated-multiple-sclerosis_vs_untreated_UP	NA	838
bsdb:140/6/2_multiple-sclerosis:treated-multiple-sclerosis_vs_untreated_DOWN	NA	1266
bsdb:141/1/1_preterm-premature-rupture-of-the-membranes:PPROM_vs_controls_UP	NA	1300
bsdb:141/1/2_preterm-premature-rupture-of-the-membranes:PPROM_vs_controls_DOWN	NA	1239
bsdb:142/1/1_squamous-cell-carcinoma:HNSCC_vs_Controls_UP	NA	29465
bsdb:142/1/2_squamous-cell-carcinoma:HNSCC_vs_Controls_DOWN	NA	32067
bsdb:142/2/1_squamous-cell-carcinoma:HPV-+_vs_HPV--_UP	NA	1013
bsdb:142/2/2_squamous-cell-carcinoma:HPV-+_vs_HPV--_DOWN	NA	32067
bsdb:142/3/1_squamous-cell-carcinoma:chemothrapy-radiation-and-surgery_vs_surgery_UP	NA	1578
bsdb:142/4/1_squamous-cell-carcinoma:chemothrapy-radiation-and-surgery_vs_surgery_DOWN	NA	32067
bsdb:143/1/1_inflammatory-bowel-disease:Crohn's-disease_vs_Ulcerative-colitis_UP	NA	1224
bsdb:143/2/1_inflammatory-bowel-disease:Crohn's-disease_vs_Ulcerative-colitis_DOWN	NA	1239
bsdb:144/1/1_air-pollution:moderately-polluted-region-(B)_vs_lightly-poluuted-region-(A)_UP	NA	1654
bsdb:144/1/2_air-pollution:moderately-polluted-region-(B)_vs_lightly-poluuted-region-(A)_DOWN	NA	475
bsdb:144/2/1_air-pollution:heavily-polluted-region-(C)_vs_lightly-poluuted-region-(A)_UP	NA	186803
bsdb:144/2/2_air-pollution:heavily-polluted-region-(C)_vs_lightly-poluuted-region-(A)_DOWN	NA	194
bsdb:144/3/1_air-pollution:heavily-polluted-region-(C)_vs_moderately-poluuted-region-(B)_UP	NA	72274
bsdb:144/3/2_air-pollution:heavily-polluted-region-(C)_vs_moderately-poluuted-region-(B)_DOWN	NA	482
bsdb:145/1/1_oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_UP	NA	1018
bsdb:145/1/2_oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_DOWN	NA	467210
bsdb:146/1/1_oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_UP	NA	203691
bsdb:146/1/2_oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_DOWN	NA	1239
bsdb:147/1/1_squamous-cell-carcinoma:laryngeal-squamous-cell-carcinoma-(LSCC)_vs_controls_UP	NA	186804
bsdb:147/1/2_squamous-cell-carcinoma:laryngeal-squamous-cell-carcinoma-(LSCC)_vs_controls_DOWN	NA	32207
bsdb:147/2/1_squamous-cell-carcinoma:Site-1-(upper-portion-of-throat-near-the-epiglottis)_vs_Site-2-(site-below-the-epiglottis-in-the-throat)_UP	NA	95818
bsdb:147/2/2_squamous-cell-carcinoma:Site-1-(upper-portion-of-throat-near-the-epiglottis)_vs_Site-2-(site-below-the-epiglottis-in-the-throat)_DOWN	NA	186804
bsdb:148/1/1_polycystic-ovary-syndrome:NIR-PCOS_vs_HC_UP	NA	28050
bsdb:148/1/2_polycystic-ovary-syndrome:NIR-PCOS_vs_HC_DOWN	NA	838
bsdb:148/2/1_polycystic-ovary-syndrome:IR-PCOS_vs_HC_UP	NA	815
bsdb:148/2/2_polycystic-ovary-syndrome:IR-PCOS_vs_HC_DOWN	NA	838
bsdb:148/3/1_polycystic-ovary-syndrome:NIR-PCOS_vs_IR-PCOS_UP	NA	816
bsdb:148/3/2_polycystic-ovary-syndrome:NIR-PCOS_vs_IR-PCOS_DOWN	NA	186801
bsdb:149/1/1_obesity:Obese_vs_controls_UP	NA	158846
bsdb:149/1/2_obesity:Obese_vs_controls_DOWN	NA	815
bsdb:150/1/1_head-and-neck-carcinoma:Throat-cancer_vs_Healthy-controls_UP	NA	766
bsdb:150/1/2_head-and-neck-carcinoma:Throat-cancer_vs_Healthy-controls_DOWN	NA	31977
bsdb:150/2/1_head-and-neck-carcinoma:Cancer_vs_Vocal-cord-polyp_UP	NA	351
bsdb:150/2/2_head-and-neck-carcinoma:Cancer_vs_Vocal-cord-polyp_DOWN	NA	213115
bsdb:151/1/1_breast-cancer:Postmenopausal-breast-cancer-patients_vs_controls_UP	NA	24
bsdb:151/1/2_breast-cancer:Postmenopausal-breast-cancer-patients_vs_controls_DOWN	NA	1633
bsdb:152/1/1_cervical-cancer:cervical-cancer_vs_healthy-controls_UP	NA	189330
bsdb:152/1/2_cervical-cancer:cervical-cancer_vs_healthy-controls_DOWN	NA	33024
bsdb:152/2/1_cervical-cancer:cervical-cancer_vs_healthy-controls_UP	NA	46506
bsdb:152/2/2_cervical-cancer:cervical-cancer_vs_healthy-controls_DOWN	NA	909932
bsdb:153/1/1_prostate-cancer:prostate-cancer_vs_controls_UP	NA	547
bsdb:153/1/2_prostate-cancer:prostate-cancer_vs_controls_DOWN	NA	44249
bsdb:154/1/1_colorectal-cancer:colorectal-cancer_vs_healthy-controls_UP	NA	59732
bsdb:154/1/2_colorectal-cancer:colorectal-cancer_vs_healthy-controls_DOWN	NA	613
bsdb:155/1/1_esophageal-cancer:Esophageal-Adenocarcinoma-(EAC)_vs_controls_UP	NA	970
bsdb:155/1/2_esophageal-cancer:Esophageal-Adenocarcinoma-(EAC)_vs_controls_DOWN	NA	724
bsdb:155/2/1_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_UP	NA	69710
bsdb:155/2/2_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_DOWN	NA	732
bsdb:156/1/1_gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_UP	NA	375288
bsdb:156/1/2_gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	1506553
bsdb:156/2/1_gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_UP	NA	990719
bsdb:156/2/2_gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	1506553
bsdb:157/1/1_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Dysplasia_UP	NA	1578
bsdb:157/1/2_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Dysplasia_DOWN	NA	963
bsdb:157/2/1_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_UP	NA	816
bsdb:157/2/2_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_DOWN	NA	2717
bsdb:158/1/1_lung-cancer:lung-cancer_vs_healthy-volunteers_UP	NA	33024
bsdb:158/1/2_lung-cancer:lung-cancer_vs_healthy-volunteers_DOWN	NA	620
bsdb:158/2/1_lung-cancer:lung-cancer_vs_healthy-volunteers_UP	NA	203492
bsdb:158/2/2_lung-cancer:lung-cancer_vs_healthy-volunteers_DOWN	NA	620
bsdb:159/1/1_gingival-disease:1-month-after-the-placement-of-the-brackets_vs_before_UP	NA	1016
bsdb:159/2/1_gingival-disease:3-months-after-the-placement-of-the-brackets_vs_before_UP	NA	1016
bsdb:159/2/2_gingival-disease:3-months-after-the-placement-of-the-brackets_vs_before_DOWN	NA	1077464
bsdb:160/1/1_head-and-neck-carcinoma:OCC-&-OPC_vs_High-risk-individuals_DOWN	NA	47670
bsdb:160/2/1_head-and-neck-carcinoma:OCC-&-OPC_vs_Normal-Healthy-Controls_UP	NA	265975
bsdb:160/2/2_head-and-neck-carcinoma:OCC-&-OPC_vs_Normal-Healthy-Controls_DOWN	NA	1016
bsdb:161/1/1_lung-cancer:NSCLC_vs_healthy-controls_UP	NA	29465
bsdb:161/1/2_lung-cancer:NSCLC_vs_healthy-controls_DOWN	NA	836
bsdb:161/2/1_lung-cancer:NSCLC_vs_healthy-controls_UP	NA	47670
bsdb:161/2/2_lung-cancer:NSCLC_vs_healthy-controls_DOWN	NA	171549
bsdb:162/1/1_lung-cancer:lung-cancer-group_vs_healthy-control_DOWN	NA	186803
bsdb:162/2/1_lung-cancer:CEA-group_vs_others_UP	NA	1300
bsdb:162/3/1_lung-cancer:NSE-group_vs_others_UP	NA	203557
bsdb:162/4/1_lung-cancer:CYF-group_vs_healthy-controls_UP	NA	31977
bsdb:163/1/1_squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_UP	NA	970
bsdb:163/1/2_squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_DOWN	NA	171552
bsdb:163/2/1_squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_UP	NA	83763
bsdb:163/2/2_squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_DOWN	NA	1236
bsdb:164/1/1_gastric-cancer:gastric-cancer_vs_controls_UP	NA	201174
bsdb:164/1/2_gastric-cancer:gastric-cancer_vs_controls_DOWN	NA	1224
bsdb:165/1/1_chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_UP	NA	201174
bsdb:165/1/2_chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_DOWN	NA	48461
bsdb:166/1/1_chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_UP	NA	84111
bsdb:166/1/2_chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_DOWN	NA	1239
bsdb:167/1/1_squamous-cell-carcinoma:Stage-4_vs_healthy-controls_UP	NA	1872471
bsdb:167/1/2_squamous-cell-carcinoma:Stage-4_vs_healthy-controls_DOWN	NA	46124
bsdb:167/2/1_squamous-cell-carcinoma:Stage-1_vs_healthy-controls_UP	NA	205
bsdb:167/2/2_squamous-cell-carcinoma:Stage-1_vs_healthy-controls_DOWN	NA	28037
bsdb:167/3/1_squamous-cell-carcinoma:Stage-2-&-3_vs_healthy-controls_UP	NA	1730
bsdb:167/3/2_squamous-cell-carcinoma:Stage-2-&-3_vs_healthy-controls_DOWN	NA	28037
bsdb:168/1/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_healthy-controls_UP	NA	1224
bsdb:168/1/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_healthy-controls_DOWN	NA	543311
bsdb:168/2/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_chronic-hepatitis-B-white-tongue-coating-patients_UP	NA	363464
bsdb:168/2/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_chronic-hepatitis-B-white-tongue-coating-patients_DOWN	NA	976
bsdb:168/3/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-white-tongue-coating-patients_vs_healthy-controls_UP	NA	836
bsdb:168/3/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-white-tongue-coating-patients_vs_healthy-controls_DOWN	NA	1654
bsdb:169/1/1_gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_UP	NA	187326
bsdb:169/1/2_gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	142586
bsdb:169/2/1_gastric-cancer:white-thick-tongue-coating-GC-patient_vs_other-coatings_UP	NA	439703
bsdb:169/2/2_gastric-cancer:white-thick-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	1624
bsdb:169/3/1_gastric-cancer:yellow-thick-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	729
bsdb:170/1/1_lung-cancer:cancerous-site_vs_controls_UP	NA	85007
bsdb:170/1/2_lung-cancer:cancerous-site_vs_controls_DOWN	NA	1279
bsdb:170/2/1_lung-cancer:paired-contralateral-non-cancerous-site_vs_controls_UP	NA	970
bsdb:170/2/2_lung-cancer:paired-contralateral-non-cancerous-site_vs_controls_DOWN	NA	72274
bsdb:170/3/1_lung-cancer:cancerous-site_vs_paired-contralateral-non-cancerous-site_UP	NA	95818
bsdb:170/4/1_lung-cancer:cacerous-site-with-no-antibiotics_vs_control-groups-with-no-antibiotics_UP	NA	1016
bsdb:170/4/2_lung-cancer:cacerous-site-with-no-antibiotics_vs_control-groups-with-no-antibiotics_DOWN	NA	468
bsdb:171/1/1_digestive-system-cancer:digestive-track-cancers_vs_controls_UP	NA	848
bsdb:171/1/2_digestive-system-cancer:digestive-track-cancers_vs_controls_DOWN	NA	32207
bsdb:171/2/1_tongue-neoplasm:tongue/pharylgeal-cancer_vs_controls_UP	NA	1305
bsdb:171/2/2_tongue-neoplasm:tongue/pharylgeal-cancer_vs_controls_DOWN	NA	28132
bsdb:171/3/1_esophageal-cancer:esophageal-cancer_vs_controls_UP	NA	482
bsdb:171/3/2_esophageal-cancer:esophageal-cancer_vs_controls_DOWN	NA	28132
bsdb:171/4/1_colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	237576
bsdb:171/4/2_colorectal-cancer:colorectal-cancer_vs_controls_DOWN	NA	28132
bsdb:171/5/1_gastric-cancer:gastric-cancer_vs_controls_UP	NA	837
bsdb:171/5/2_gastric-cancer:gastric-cancer_vs_controls_DOWN	NA	1924944
bsdb:172/1/1_cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_UP	NA	86331
bsdb:172/1/2_cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_DOWN	NA	976
bsdb:172/2/1_cannabis-use:marijuana-usage-group_vs_controls-(oral-pharynx)_UP	NA	541000
bsdb:172/2/2_cannabis-use:marijuana-usage-group_vs_controls-(oral-pharynx)_DOWN	NA	186826
bsdb:172/3/1_cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_UP	NA	32207
bsdb:172/3/2_cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_DOWN	NA	59735
bsdb:173/1/1_pancreatic-carcinoma:pancreatic-cancer_vs_healthy-controls_UP	NA	416916
bsdb:173/1/2_pancreatic-carcinoma:pancreatic-cancer_vs_healthy-controls_DOWN	NA	204475
bsdb:173/2/1_pancreatic-carcinoma:pancreatic-head-cancer-with-obstruction_vs_without-cancer_UP	NA	117563
bsdb:173/2/2_pancreatic-carcinoma:pancreatic-head-cancer-with-obstruction_vs_without-cancer_DOWN	NA	118966
bsdb:174/1/1_gastric-cancer:cacerous-tissue_vs_paired-adjacent-non-cacerous-tissue_UP	NA	1239
bsdb:174/1/2_gastric-cancer:cacerous-tissue_vs_paired-adjacent-non-cacerous-tissue_DOWN	NA	135614
bsdb:175/1/1_pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_UP	NA	1283313
bsdb:175/1/2_pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_DOWN	NA	32067
bsdb:175/2/1_pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_DOWN	NA	32066
bsdb:175/3/1_pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_DOWN	NA	32067
bsdb:176/1/1_leukemia:survivors-of-acute-lymphoblastic-leukemia_vs_controls_UP	NA	1654
bsdb:176/1/2_leukemia:survivors-of-acute-lymphoblastic-leukemia_vs_controls_DOWN	NA	194924
bsdb:177/1/1_colorectal-cancer:mucosa_vs_control_UP	NA	544448
bsdb:177/1/2_colorectal-cancer:mucosa_vs_control_DOWN	NA	1301
bsdb:177/2/1_colorectal-cancer:tumor_vs_control_UP	NA	1257
bsdb:177/3/1_colorectal-cancer:fecal_vs_control_UP	NA	1257
bsdb:177/3/2_colorectal-cancer:fecal_vs_control_DOWN	NA	841
bsdb:178/1/1_gastric-cancer:gastric-cancer-peritumor-group_vs_normal_UP	NA	1762
bsdb:178/1/2_gastric-cancer:gastric-cancer-peritumor-group_vs_normal_DOWN	NA	118969
bsdb:178/2/1_gastric-cancer:gastric-cancer-tumor-group_vs_peritumor_UP	NA	572511
bsdb:178/2/2_gastric-cancer:gastric-cancer-tumor-group_vs_peritumor_DOWN	NA	1224
bsdb:178/3/1_gastric-cancer:gastric-cancer-tumor-group_vs_normal_UP	NA	31977
bsdb:178/3/2_gastric-cancer:gastric-cancer-tumor-group_vs_normal_DOWN	NA	1279
bsdb:179/1/1_esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_UP	NA	2717
bsdb:179/1/2_esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_DOWN	NA	836
bsdb:179/2/1_esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_UP	NA	1654
bsdb:179/2/2_esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_DOWN	NA	836
bsdb:180/1/1_gastric-carcinoma:gastric-carcinoma_vs_chronic-gastritis_UP	NA	1236
bsdb:180/1/2_gastric-carcinoma:gastric-carcinoma_vs_chronic-gastritis_DOWN	NA	32066
bsdb:181/1/1_pancreatic-carcinoma:pancreatic-cancer_vs_controls_UP	NA	1283313
bsdb:181/1/2_pancreatic-carcinoma:pancreatic-cancer_vs_controls_DOWN	NA	32067
bsdb:182/1/1_acetaldehyde:high-acetaldehyde-concentration-group_vs_low-acetaldehyde-concentration-group_UP	NA	484
bsdb:182/1/2_acetaldehyde:high-acetaldehyde-concentration-group_vs_low-acetaldehyde-concentration-group_DOWN	NA	470565
bsdb:183/1/1_crohn-disease:crohn-disease-ASCA-positive-patients_vs_crohn-disease-ASCA-negative-patients_UP	NA	33039
bsdb:183/1/2_crohn-disease:crohn-disease-ASCA-positive-patients_vs_crohn-disease-ASCA-negative-patients_DOWN	NA	853
bsdb:184/1/1_prostate-cancer:prostate-cancer-patients_vs_controls_UP	NA	816
bsdb:184/2/1_prostate-cancer:prostate-cancer-patients_vs_controls_DOWN	NA	216851
bsdb:185/1/1_gastric-cancer:gastric-cancer_vs_controls_UP	NA	91347
bsdb:185/1/2_gastric-cancer:gastric-cancer_vs_controls_DOWN	NA	171549
bsdb:185/2/1_gastric-cancer:gastric-cancer_vs_healthy-gastric-cancer_UP	NA	570
bsdb:185/2/2_gastric-cancer:gastric-cancer_vs_healthy-gastric-cancer_DOWN	NA	171552
bsdb:186/1/1_prostate-cancer:prostrate-cancer_vs_non-prostrate-cancer_UP	NA	547
bsdb:186/1/2_prostate-cancer:prostrate-cancer_vs_non-prostrate-cancer_DOWN	NA	44249
bsdb:187/1/1_medroxyprogesterone-acetate:naive-(baseline-visit)_vs_depot-mdroxyprogesterone-Acetate-vaginal-microbiome-(visit-2)-among-black-participants_UP	NA	838
bsdb:187/2/1_medroxyprogesterone-acetate:white-naiive-vaginal-microbiome_vs_black-naive-vaginal-microbiome-(the-baseline-visit-)_UP	NA	150022
bsdb:187/2/2_medroxyprogesterone-acetate:white-naiive-vaginal-microbiome_vs_black-naive-vaginal-microbiome-(the-baseline-visit-)_DOWN	NA	177971
bsdb:187/3/1_medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone_vs_black-participants-after-using-depot-medroxyprogesterone--(the-second-visit-)_UP	NA	1578
bsdb:187/3/2_medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone_vs_black-participants-after-using-depot-medroxyprogesterone--(the-second-visit-)_DOWN	NA	1378
bsdb:187/4/1_medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone_vs_black-participants-after-using-depot-medroxyprogesterone--(the-third-visit-)_UP	NA	150022
bsdb:187/4/2_medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone_vs_black-participants-after-using-depot-medroxyprogesterone--(the-third-visit-)_DOWN	NA	1375
bsdb:188/1/1_cervical-cerclage:Vaginal-microbiome-of-symptomatic-women-prior-ro-cerclage_vs_Vaginal-microbiome-of-asymptomatic-women-prior-to-cerclage_UP	NA	2701
bsdb:188/1/2_cervical-cerclage:Vaginal-microbiome-of-symptomatic-women-prior-ro-cerclage_vs_Vaginal-microbiome-of-asymptomatic-women-prior-to-cerclage_DOWN	NA	47770
bsdb:189/1/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_UP	NA	158846
bsdb:189/1/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_DOWN	NA	543
bsdb:190/1/1_breast-milk-measurement:one-month-age-infants-exposed-to-high-chemical-breast-milk_vs_one-month-age-infants-exposed-to-low-chemical-breast-milk_UP	NA	13623
bsdb:190/1/2_breast-milk-measurement:one-month-age-infants-exposed-to-high-chemical-breast-milk_vs_one-month-age-infants-exposed-to-low-chemical-breast-milk_DOWN	NA	29465
bsdb:191/1/1_equol:equol-producers_vs_equol-non-producers_UP	NA	572010
bsdb:192/1/1_NA:diarrhea-predominant-irritable-bowel-syndrome_vs_healthy-controls_UP	NA	543
bsdb:192/1/2_NA:diarrhea-predominant-irritable-bowel-syndrome_vs_healthy-controls_DOWN	NA	216851
bsdb:192/2/1_NA:diarrhea-predominant-irritable-bowel-syndrome_vs_healthy-controls_UP	NA	253238
bsdb:193/1/1_gastric-cancer:gastric-cancer_vs_chronic-gastritis-and-intestinal-metaplasia_UP	NA	1300
bsdb:193/1/2_gastric-cancer:gastric-cancer_vs_chronic-gastritis-and-intestinal-metaplasia_DOWN	NA	72293
bsdb:193/2/1_gastric-cancer:H.-pylori-postive_vs_H.-pylori-negative_DOWN	NA	119060
bsdb:194/1/1_ovarian-cancer:ovarian-cancer_vs_normal-tissue_UP	NA	1364
bsdb:194/1/2_ovarian-cancer:ovarian-cancer_vs_normal-tissue_DOWN	NA	330920
bsdb:195/1/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_healthy-controls_UP	NA	186801
bsdb:195/1/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_healthy-controls_DOWN	NA	1016
bsdb:195/2/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_liver-cirrhosis_UP	NA	203692
bsdb:195/2/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_liver-cirrhosis_DOWN	NA	482
bsdb:196/1/1_Henoch-Schoenlein-purpura:Henoch-Schnlein-Purpura_vs_controls_UP	NA	375288
bsdb:196/1/2_Henoch-Schoenlein-purpura:Henoch-Schnlein-Purpura_vs_controls_DOWN	NA	39491
bsdb:197/1/1_asthma:severe-asthma_vs_non-asthma_UP	NA	1263
bsdb:197/1/2_asthma:severe-asthma_vs_non-asthma_DOWN	NA	237557
bsdb:198/1/1_Henoch-Schoenlein-purpura:Henoch-Schnlein-Purpura_vs_controls_UP	NA	171549
bsdb:198/1/2_Henoch-Schoenlein-purpura:Henoch-Schnlein-Purpura_vs_controls_DOWN	NA	1224
bsdb:199/1/1_ovarian-cancer:ovarian-cancer_vs_controls_UP	NA	768668
bsdb:199/1/2_ovarian-cancer:ovarian-cancer_vs_controls_DOWN	NA	2251
bsdb:200/1/1_endometrial-cancer:post_vs_pre_UP	NA	1448937
bsdb:200/1/2_endometrial-cancer:post_vs_pre_DOWN	NA	184869
bsdb:200/2/1_endometrial-cancer:endometrial-cancer_vs_benign_UP	NA	1578
bsdb:200/2/2_endometrial-cancer:endometrial-cancer_vs_benign_DOWN	NA	28263
bsdb:201/1/1_leukemia:induction_vs_repeat-therapy_UP	NA	459786
bsdb:201/1/2_leukemia:induction_vs_repeat-therapy_DOWN	NA	1350
bsdb:202/1/1_autism:children-with-autism-mental-regression-AMR_vs_children-with-autism-non-mental-regression-ANMR_UP	NA	1350
bsdb:202/2/1_autism:children-with-autism-non-mental-regression-ANMR_vs_healthy-control_UP	NA	208479
bsdb:202/3/1_autism:children-with-autism-mental-regression-AMR_vs_healthy-control_UP	NA	208479
bsdb:202/4/1_autism:children-with-autism-spectrum-disordorders-ASD_vs_healthy-controls_UP	NA	186824
bsdb:202/4/2_autism:children-with-autism-spectrum-disordorders-ASD_vs_healthy-controls_DOWN	NA	186803
bsdb:203/1/1_syncope:children-with-vasovagal-syncope_vs_healthy-children_UP	NA	541000
bsdb:204/1/1_premature-birth:mothers-whose-newborns-were-delivered-at-<34-gestational-week_vs_mothers-whose-newborns-were-delivered-at-37-getastional-weeks_DOWN	NA	1678
bsdb:205/1/1_human-papilloma-virus-infection:HPV-positive_vs_HPV-negative_UP	NA	2702
bsdb:206/1/1_gastric-cancer:patients-diagnosed-with-gastric-cancer_vs_patients-diagnosed-with-gastritis_UP	NA	1318
bsdb:207/1/1_vulvovaginitis:BV_vs_NC_UP	NA	836
bsdb:207/1/2_vulvovaginitis:BV_vs_NC_DOWN	NA	1578
bsdb:207/2/1_vulvovaginitis:BV.VVC_vs_NC_UP	NA	838
bsdb:208/1/1_food-allergy:infants-with-food-allergies_vs_healthy-controls_UP	NA	85025
bsdb:208/1/2_food-allergy:infants-with-food-allergies_vs_healthy-controls_DOWN	NA	468
bsdb:208/1/3_food-allergy:infants-with-food-allergies_vs_healthy-controls_UP	NA	32066
bsdb:208/1/4_food-allergy:infants-with-food-allergies_vs_healthy-controls_DOWN	NA	74201
bsdb:208/1/5_food-allergy:infants-with-food-allergies_vs_healthy-controls_UP	NA	946234
bsdb:208/1/6_food-allergy:infants-with-food-allergies_vs_healthy-controls_DOWN	NA	186804
bsdb:208/2/1_food-allergy:infants-with-food-allergies_vs_healthy-controls_UP	NA	89373
bsdb:208/2/2_food-allergy:infants-with-food-allergies_vs_healthy-controls_DOWN	NA	283
bsdb:208/3/1_food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_UP	NA	186801
bsdb:208/3/2_food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_DOWN	NA	85025
bsdb:208/4/1_food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_UP	NA	1485
bsdb:208/4/2_food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_DOWN	NA	816
bsdb:209/1/1_cesarean-section:c-section-delivery_vs_vaginal-delivery_UP	NA	357
bsdb:209/1/2_cesarean-section:c-section-delivery_vs_vaginal-delivery_DOWN	NA	1301
bsdb:210/1/1_food-allergy:children-with-food-sensitization_vs_healthy-controls_UP	NA	216572
bsdb:210/1/2_food-allergy:children-with-food-sensitization_vs_healthy-controls_DOWN	NA	29465
bsdb:210/2/1_food-allergy:children-with-food-sensitization_vs_healthy-controls_UP	NA	216572
bsdb:210/2/2_food-allergy:children-with-food-sensitization_vs_healthy-controls_DOWN	NA	29465
bsdb:211/1/1_diet:low-fiber-(Q1-and-Q2)_vs_high-fiber-(Q3-and-Q4)_UP	NA	1654
bsdb:212/1/1_diet:low-fiber-(Q1-and-Q2)_vs_high-fiber-(Q3-and-Q4)_UP	NA	283168
bsdb:212/1/2_diet:low-fiber-(Q1-and-Q2)_vs_high-fiber-(Q3-and-Q4)_DOWN	NA	NA
bsdb:213/1/1_diet:low-fiber-(Q1-and-Q2)_vs_high-fiber-(Q3-and-Q4)_UP	NA	31971
bsdb:213/1/2_diet:low-fiber-(Q1-and-Q2)_vs_high-fiber-(Q3-and-Q4)_DOWN	NA	NA
bsdb:213/2/1_diet:low-fiber-from-FRUITS/VEGETABLES-(Q1-and-Q2)_vs_high-fiber-from-FRUITS/VEGETABLES-(Q3-and-Q4)_UP	NA	820
bsdb:213/3/1_diet:low-fiber-from-BEANS-(Q1-and-Q2)_vs_high-fiber-from-BEANS-(Q3-and-Q4)_UP	NA	31971
bsdb:213/3/2_diet:low-fiber-from-BEANS-(Q1-and-Q2)_vs_high-fiber-from-BEANS-(Q3-and-Q4)_DOWN	NA	853
bsdb:214/1/1_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_UP	NA	171549
bsdb:214/1/2_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_DOWN	NA	1239
bsdb:214/1/3_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_UP	NA	171549
bsdb:214/1/4_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_DOWN	NA	1239
bsdb:214/1/5_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_UP	NA	171549
bsdb:214/1/6_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_DOWN	NA	1239
bsdb:214/1/7_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_UP	NA	590
bsdb:214/1/8_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_DOWN	NA	1239
bsdb:214/1/9_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_UP	NA	171549
bsdb:214/1/10_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_DOWN	NA	1239
bsdb:214/1/11_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_UP	NA	171549
bsdb:214/1/12_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_DOWN	NA	1239
bsdb:215/1/1_eczema:infant-with-eczema_vs_healthy-control_UP	NA	29465
bsdb:215/1/2_eczema:infant-with-eczema_vs_healthy-control_DOWN	NA	31977
bsdb:216/1/1_cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1502
bsdb:217/1/1_eczema:child-with-eczema_vs_healthy-control_UP	NA	29343
bsdb:217/1/2_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	976
bsdb:217/2/1_age:infant-at-18-months_vs_infant-at-6-months_UP	NA	NA
bsdb:217/2/2_age:infant-at-18-months_vs_infant-at-6-months_DOWN	NA	91061
bsdb:217/3/1_age:infant-at-18-months_vs_infant-at-6-months_UP	NA	31969
bsdb:217/3/2_age:infant-at-18-months_vs_infant-at-6-months_DOWN	NA	1590
bsdb:218/1/1_hepatocellular-carcinoma:non-HBV-non-HCV-related-HCC_vs_healthy-control_UP	NA	244127
bsdb:218/1/2_hepatocellular-carcinoma:non-HBV-non-HCV-related-HCC_vs_healthy-control_DOWN	NA	186803
bsdb:218/2/1_hepatocellular-carcinoma:HBV-related-HCC_vs_healthy-control_UP	NA	244127
bsdb:218/3/1_hepatocellular-carcinoma:non-HBV-non-HCV_vs_HBV-related-HCC_UP	NA	1283313
bsdb:219/1/1_diet:lower-fiber-(cracker)_vs_higher-fiber-(almonds)---interaction-by-time_UP	NA	817
bsdb:219/2/1_diet:week-8_vs_baseline_UP	NA	31969
bsdb:219/2/2_diet:week-8_vs_baseline_DOWN	NA	2005473
bsdb:219/3/1_diet:lower-fiber-(cracker)_vs_higher-fiber-(almonds)_DOWN	NA	40544
bsdb:220/1/1_age:older-age-European-women_vs_younger-age_UP	NA	1224
bsdb:220/1/2_age:older-age-European-women_vs_younger-age_DOWN	NA	85009
bsdb:221/1/1_NA:urinary-tract-infection_vs_healthy-controls_UP	NA	536633
bsdb:221/1/2_NA:urinary-tract-infection_vs_healthy-controls_DOWN	NA	1537
bsdb:222/1/1_gastric-cancer:high-gastric-cancer-risk_vs_low-gastric-cancer-risk-patients_UP	NA	1926307
bsdb:222/1/2_gastric-cancer:high-gastric-cancer-risk_vs_low-gastric-cancer-risk-patients_DOWN	NA	1310087
bsdb:223/1/1_HIV-infection:HIV-infected-patients_vs_healthy-controls_UP	NA	91347
bsdb:223/1/2_HIV-infection:HIV-infected-patients_vs_healthy-controls_DOWN	NA	33024
bsdb:223/2/1_HIV-infection:HIV-infected-homosexual-patients_vs_healthy-controls_UP	NA	1547
bsdb:223/2/2_HIV-infection:HIV-infected-homosexual-patients_vs_healthy-controls_DOWN	NA	33024
bsdb:223/3/1_HIV-infection:Intravenous-drug-abuse-HIV-patients_vs_healthy-controls_UP	NA	33038
bsdb:223/4/1_HIV-infection:homosexual_vs_hetersexual_DOWN	NA	375288
bsdb:223/5/1_HIV-infection:HAART_vs_healty-control_UP	NA	817
bsdb:223/5/2_HIV-infection:HAART_vs_healty-control_DOWN	NA	33024
bsdb:223/6/1_HIV-infection:HAART-untreated_vs_healthy-control_UP	NA	1578
bsdb:224/1/1_diet:barley-(WGB)_vs_baseline_UP	NA	39491
bsdb:224/1/2_diet:barley-(WGB)_vs_baseline_DOWN	NA	283168
bsdb:224/2/1_diet:brown-rice-(BR)_vs_baseline_UP	NA	1239
bsdb:224/2/2_diet:brown-rice-(BR)_vs_baseline_DOWN	NA	976
bsdb:224/3/1_diet:brown-rice-+-barley-(BR-+-WGB)_vs_baseline_UP	NA	1239
bsdb:224/3/2_diet:brown-rice-+-barley-(BR-+-WGB)_vs_baseline_DOWN	NA	816
bsdb:225/1/1_atopic-eczema:infant-with-atopic-eczema_vs_healthy-infant_UP	NA	186804
bsdb:225/1/2_atopic-eczema:infant-with-atopic-eczema_vs_healthy-infant_DOWN	NA	1224
bsdb:226/1/1_HIV-infection:HIV-1-infected_vs_healthy-control_UP	NA	1239
bsdb:226/1/2_HIV-infection:HIV-1-infected_vs_healthy-control_DOWN	NA	816
bsdb:226/2/1_HIV-infection:HIV-1-treated_vs_untreated_UP	NA	1239
bsdb:226/2/2_HIV-infection:HIV-1-treated_vs_untreated_DOWN	NA	283168
bsdb:227/1/1_atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_UP	NA	201174
bsdb:227/1/2_atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_UP	NA	239934
bsdb:227/2/1_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_UP	NA	1301
bsdb:227/2/2_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_DOWN	NA	1485
bsdb:227/3/1_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_UP	NA	1301
bsdb:227/3/2_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_DOWN	NA	239934
bsdb:227/4/1_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_UP	NA	100883
bsdb:227/4/2_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_DOWN	NA	100883
bsdb:227/5/1_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_UP	NA	1239
bsdb:227/5/2_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_DOWN	NA	160674
bsdb:227/6/1_atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_UP	NA	1760
bsdb:227/6/2_atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_DOWN	NA	85006
bsdb:228/1/1_diet:day-3-of-PECTIN-spike-in_vs_day-6-of-PECTIN-spike-in_DOWN	NA	853
bsdb:228/2/1_diet:day-3-of-INULIN-spike-in_vs_day-6-of-INULIN-spike-in_DOWN	NA	853
bsdb:229/1/1_diet:early_vs_late-pectin-incubation-time_UP	NA	816
bsdb:229/1/2_diet:early_vs_late-pectin-incubation-time_DOWN	NA	171549
bsdb:230/1/1_food-allergy:infant-with-food-allergy_vs_non-allergy_DOWN	NA	29465
bsdb:230/1/2_food-allergy:infant-with-food-allergy_vs_non-allergy_UP	NA	1485
bsdb:231/1/1_diet:cellulose_vs_renatta-canada-apple---at-10-hr_UP	NA	186802
bsdb:231/2/1_diet:cellulose_vs_golden-delicious-apple---at-10-hr_UP	NA	186802
bsdb:231/3/1_diet:cellulose_vs_pink-lady-apple---at-10-hr_UP	NA	186802
bsdb:232/1/1_HIV-infection:HIV-infected-cART-negative_vs_HC_UP	NA	848
bsdb:232/1/2_HIV-infection:HIV-infected-cART-negative_vs_HC_DOWN	NA	239759
bsdb:233/1/1_HIV-infection:HIV-infected_vs_uninfected_UP	NA	468
bsdb:233/1/2_HIV-infection:HIV-infected_vs_uninfected_DOWN	NA	171550
bsdb:234/1/1_atopic-eczema:adult-with-atopic-dermatitis_vs_healthy-control_UP	NA	1280
bsdb:234/1/2_atopic-eczema:adult-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	1747
bsdb:234/2/1_psoriasis:adult-with-psoriasis_vs_healthy-control_UP	NA	1872515
bsdb:234/2/2_psoriasis:adult-with-psoriasis_vs_healthy-control_DOWN	NA	1909303
bsdb:235/1/1_food-allergy:child-with-food-allergy_vs_healthy-control_UP	NA	1971605
bsdb:235/1/2_food-allergy:child-with-food-allergy_vs_healthy-control_DOWN	NA	1955243
bsdb:235/2/1_food-allergy:child-with-food-allergy_vs_healthy-sibling_UP	NA	NA
bsdb:235/2/2_food-allergy:child-with-food-allergy_vs_healthy-sibling_DOWN	NA	1872444
bsdb:235/3/1_food-allergy:healthy-sibling_vs_healthy-control_UP	NA	1872444
bsdb:235/3/2_food-allergy:healthy-sibling_vs_healthy-control_DOWN	NA	1955243
bsdb:235/4/1_age:7-18-years_vs_<7-years_UP	NA	976
bsdb:235/4/2_age:7-18-years_vs_<7-years_DOWN	NA	186804
bsdb:236/1/1_diet:before-walnut-diet_vs_after-walnut-diet_UP	NA	572511
bsdb:236/1/2_diet:before-walnut-diet_vs_after-walnut-diet_DOWN	NA	1678
bsdb:236/2/1_diet:carbohydrate-replacement-(with-walnuts)_vs_replace-both_DOWN	NA	816
bsdb:236/3/1_diet:replace-both_vs_fat-replacement-(with-walnuts)_UP	NA	816
bsdb:237/1/1_chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_healthy-controls_UP	NA	46255
bsdb:237/1/2_chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_healthy-controls_DOWN	NA	213484
bsdb:237/2/1_chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_no-cirrhosis_UP	NA	1253
bsdb:237/3/1_chronic-hepatitis-C-virus-infection:hepatitis-C-patients_vs_healthy-controls_DOWN	NA	35829
bsdb:238/1/1_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	1301
bsdb:238/1/2_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	620
bsdb:238/2/1_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	437755
bsdb:238/2/2_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	239759
bsdb:238/3/1_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	437755
bsdb:238/3/2_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	239759
bsdb:239/1/1_egg-allergy:infant-with-egg-allergy_vs_healthy-control_UP	NA	1357
bsdb:239/1/2_egg-allergy:infant-with-egg-allergy_vs_healthy-control_DOWN	NA	1243
bsdb:239/2/1_egg-allergy:infant-with-egg-sensitization_vs_healthy-control_UP	NA	841
bsdb:240/1/1_food-allergy:infant-with-food-sensitization_vs_healthy-control_UP	NA	543
bsdb:240/2/1_food-allergy:infant-with-food-sensitization_vs_healthy-control_UP	NA	543
bsdb:240/2/2_food-allergy:infant-with-food-sensitization_vs_healthy-control_DOWN	NA	815
bsdb:241/1/1_iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_UP	NA	137838
bsdb:241/1/2_iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	39948
bsdb:242/1/1_iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_UP	NA	1578
bsdb:242/1/2_iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	2717
bsdb:242/2/1_iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_UP	NA	57493
bsdb:242/2/2_iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	1760
bsdb:242/3/1_iron-deficiency-anemia:iron-deficiency-anemia-severe_vs_iron-deficiency-anemia-moderate_UP	NA	72274
bsdb:242/3/2_iron-deficiency-anemia:iron-deficiency-anemia-severe_vs_iron-deficiency-anemia-moderate_DOWN	NA	481
bsdb:243/1/1_gastric-cancer:current-H.pyloriI-infection_vs_non-current-H.pylori-infection_UP	NA	1378
bsdb:243/1/2_gastric-cancer:current-H.pyloriI-infection_vs_non-current-H.pylori-infection_DOWN	NA	1833
bsdb:243/2/1_gastric-cancer:current-H.pyloriI-infection_vs_past-H.pylori-infection_UP	NA	165179
bsdb:243/3/1_gastric-cancer:past-H.pylori-infection_vs_H.pylori-negative_DOWN	NA	820
bsdb:243/4/1_gastric-cancer:gastritis_vs_normal_UP	NA	562
bsdb:243/4/2_gastric-cancer:gastritis_vs_normal_DOWN	NA	171549
bsdb:243/5/1_gastric-cancer:metaplasia_vs_normal_UP	NA	191303
bsdb:243/5/2_gastric-cancer:metaplasia_vs_normal_DOWN	NA	171549
bsdb:243/6/1_gastric-cancer:metaplasia_vs_gastritis_UP	NA	543
bsdb:243/6/2_gastric-cancer:metaplasia_vs_gastritis_DOWN	NA	NA
bsdb:244/1/1_age:18-62-years_vs_2-12-years_UP	NA	1282
bsdb:244/1/2_age:18-62-years_vs_2-12-years_DOWN	NA	1306
bsdb:244/1/3_age:18-62-years_vs_2-12-years_UP	NA	165779
bsdb:244/1/4_age:18-62-years_vs_2-12-years_DOWN	NA	724
bsdb:244/2/1_atopic-eczema:lesional-skin_vs_non-lesional-skin_UP	NA	1279
bsdb:244/2/2_atopic-eczema:lesional-skin_vs_non-lesional-skin_DOWN	NA	848
bsdb:244/3/1_age:13-62-years_vs_2-12-years_UP	NA	1578
bsdb:244/3/2_age:13-62-years_vs_2-12-years_DOWN	NA	724
bsdb:244/3/3_age:13-62-years_vs_2-12-years_UP	NA	1578
bsdb:244/3/4_age:13-62-years_vs_2-12-years_DOWN	NA	724
bsdb:244/4/1_age:18-62-years_vs_2-12-years_UP	NA	147802
bsdb:244/5/1_atopic-eczema:lesional-skin_vs_non-lesional-skin_UP	NA	1280
bsdb:244/6/1_atopic-eczema:lesional-skin_vs_non-lesional-skin_UP	NA	1280
bsdb:244/7/1_age:18-62-years_vs_2-12-years_UP	NA	147802
bsdb:244/7/2_age:18-62-years_vs_2-12-years_DOWN	NA	45634
bsdb:244/7/3_age:18-62-years_vs_2-12-years_UP	NA	147802
bsdb:244/7/4_age:18-62-years_vs_2-12-years_DOWN	NA	45634
bsdb:245/1/1_kidney-stone:kidney-stone-group_vs_healthy-control_UP	NA	561
bsdb:245/1/2_kidney-stone:kidney-stone-group_vs_healthy-control_DOWN	NA	547
bsdb:245/2/1_kidney-stone:kidney-stone-group_vs_healthy-control_UP	NA	526525
bsdb:245/2/2_kidney-stone:kidney-stone-group_vs_healthy-control_DOWN	NA	35832
bsdb:246/1/1_asthma:maternal-asthma_vs_no-asthma_UP	NA	158846
bsdb:246/1/2_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	158851
bsdb:246/2/1_asthma:maternal-asthma_vs_no-asthma_UP	NA	171549
bsdb:246/2/2_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	906
bsdb:246/3/1_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	1578
bsdb:246/4/1_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	1578
bsdb:246/5/1_asthma:maternal-asthma_vs_no-asthma_UP	NA	189330
bsdb:246/5/2_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	543
bsdb:246/6/1_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	543
bsdb:246/7/1_asthma:maternal-asthma_vs_no-asthma_UP	NA	239934
bsdb:246/7/2_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	1654
bsdb:247/1/1_diet:placebo_vs_prebiotic-(inulin-type-fructan)_UP	NA	186803
bsdb:247/1/2_diet:placebo_vs_prebiotic-(inulin-type-fructan)_DOWN	NA	1678
bsdb:247/2/1_diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-low-dietary-fiber_DOWN	NA	1678
bsdb:247/3/1_diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-high-dietary-fiber_UP	NA	189330
bsdb:247/3/2_diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-high-dietary-fiber_DOWN	NA	1678
bsdb:247/4/1_diet:low-dietary-fiber_vs_high-dietary-fiber_DOWN	NA	216851
bsdb:248/1/1_human-papilloma-virus-infection:high-risk-hpv_vs_low-risk-hpv_UP	NA	32066
bsdb:248/1/2_human-papilloma-virus-infection:high-risk-hpv_vs_low-risk-hpv_DOWN	NA	69277
bsdb:248/2/1_human-papilloma-virus-infection:HPV_vs_no-HPV_UP	NA	2701
bsdb:248/2/2_human-papilloma-virus-infection:HPV_vs_no-HPV_DOWN	NA	204458
bsdb:249/1/1_hepatitis,-alcoholic:alcoholics_vs_NAC_UP	NA	374
bsdb:249/1/2_hepatitis,-alcoholic:alcoholics_vs_NAC_DOWN	NA	642
bsdb:249/2/1_hepatitis,-alcoholic:HDC_vs_NAC_UP	NA	469
bsdb:249/2/2_hepatitis,-alcoholic:HDC_vs_NAC_DOWN	NA	351
bsdb:249/3/1_hepatitis,-alcoholic:MAH_vs_NAC_UP	NA	469
bsdb:249/3/2_hepatitis,-alcoholic:MAH_vs_NAC_DOWN	NA	351
bsdb:249/4/1_hepatitis,-alcoholic:SAH_vs_NAC_UP	NA	1651
bsdb:249/4/2_hepatitis,-alcoholic:SAH_vs_NAC_DOWN	NA	89373
bsdb:250/1/1_severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-engraftment_vs_baseline_UP	NA	28129
bsdb:250/2/1_severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-engraftment_vs_baseline_DOWN	NA	425941
bsdb:250/3/1_severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-100-days-after-the-transplant_vs_engraftment_UP	NA	84135
bsdb:250/4/1_severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-100-days-after-the-transplant_vs_engraftment_DOWN	NA	43675
bsdb:251/1/1_milk-allergic-reaction:cows-milk-allergy_vs_healthy-control_UP	NA	375288
bsdb:251/1/2_milk-allergic-reaction:cows-milk-allergy_vs_healthy-control_DOWN	NA	590
bsdb:252/1/1_pemphigus-vulgaris:pemphigus-vulgaris_vs_healthy-control_UP	NA	1300
bsdb:252/1/2_pemphigus-vulgaris:pemphigus-vulgaris_vs_healthy-control_DOWN	NA	80840
bsdb:253/1/1_asthma:asthma_vs_healthy-control_UP	NA	838
bsdb:253/1/2_asthma:asthma_vs_healthy-control_DOWN	NA	724
bsdb:253/2/1_asthma:asthma-remission_vs_healthy-control_UP	NA	543311
bsdb:253/2/2_asthma:asthma-remission_vs_healthy-control_DOWN	NA	724
bsdb:254/1/1_kidney-stone:kidney-stone-patient_vs_healthy-control_UP	NA	239759
bsdb:254/1/2_kidney-stone:kidney-stone-patient_vs_healthy-control_DOWN	NA	162289
bsdb:255/1/1_human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_UP	NA	90964
bsdb:255/1/2_human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_DOWN	NA	150022
bsdb:255/2/1_human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_UP	NA	2085
bsdb:255/2/2_human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_DOWN	NA	150022
bsdb:255/3/1_HIV-infection:HIV+_vs_HIV-_UP	NA	31953
bsdb:255/3/2_HIV-infection:HIV+_vs_HIV-_DOWN	NA	1678
bsdb:256/1/1_gastric-cancer:peritumoral-tissues_vs_normal-tissues_UP	NA	239935
bsdb:256/1/2_gastric-cancer:peritumoral-tissues_vs_normal-tissues_DOWN	NA	1396
bsdb:256/2/1_gastric-cancer:tumoral-tissues_vs_peritumoral-tissues_UP	NA	1396
bsdb:256/2/2_gastric-cancer:tumoral-tissues_vs_peritumoral-tissues_DOWN	NA	210
bsdb:256/3/1_gastric-cancer:tumoral-tissues_vs_normal-tissues_UP	NA	239935
bsdb:256/3/2_gastric-cancer:tumoral-tissues_vs_normal-tissues_DOWN	NA	820
bsdb:256/4/1_gastric-cancer:early-stage-tumor_vs_early-stage-normal_UP	NA	1328
bsdb:256/4/2_gastric-cancer:early-stage-tumor_vs_early-stage-normal_DOWN	NA	172044
bsdb:256/5/1_gastric-cancer:early-stage-peritumor_vs_early-stage-normal_DOWN	NA	172044
bsdb:256/6/1_gastric-cancer:late-stage-tumor_vs_late-stage-normal_UP	NA	1328
bsdb:256/7/1_gastric-cancer:late-stage-tumor_vs_late-stage-normal_DOWN	NA	172044
bsdb:256/8/1_gastric-cancer:late-stage-peritumor_vs_late-stage-normal_DOWN	NA	165179
bsdb:256/9/1_gastric-cancer:normal-HP+_vs_normal-HP-_UP	NA	1224
bsdb:256/9/2_gastric-cancer:normal-HP+_vs_normal-HP-_DOWN	NA	135622
bsdb:256/10/1_gastric-cancer:peritumor-HP+_vs_peritumor-HP-_UP	NA	29547
bsdb:256/10/2_gastric-cancer:peritumor-HP+_vs_peritumor-HP-_DOWN	NA	375288
bsdb:256/11/1_gastric-cancer:tumor-HP+_vs_tumor-HP-_UP	NA	29547
bsdb:256/11/2_gastric-cancer:tumor-HP+_vs_tumor-HP-_DOWN	NA	1224
bsdb:257/1/1_colorectal-cancer:colorectal-cancer_vs_healthy-control_UP	NA	239934
bsdb:257/1/2_colorectal-cancer:colorectal-cancer_vs_healthy-control_DOWN	NA	41294
bsdb:258/1/1_colorectal-cancer:carcinoma_vs_healthy-control_UP	NA	543
bsdb:258/1/2_colorectal-cancer:carcinoma_vs_healthy-control_DOWN	NA	186802
bsdb:259/1/1_atopic-eczema:emollient-use_vs_no-emollient-use_UP	NA	1304
bsdb:259/2/1_atopic-eczema:emollient-use_vs_no-emollient-use_UP	NA	1304
bsdb:259/2/2_atopic-eczema:emollient-use_vs_no-emollient-use_UP	NA	1304
bsdb:260/1/1_food-allergy:allergic_vs_nonallergic_UP	NA	91347
bsdb:260/1/2_food-allergy:allergic_vs_nonallergic_DOWN	NA	816
bsdb:261/1/1_chronic-pancreatitis:chronic-pancreatitis_vs_autoimmune-pancreatitis-type-1_UP	NA	460384
bsdb:262/1/1_atopic-asthma:nasal-brush_vs_bronchial-brush-specimen-type_UP	NA	475
bsdb:262/1/2_atopic-asthma:nasal-brush_vs_bronchial-brush-specimen-type_DOWN	NA	32067
bsdb:262/2/1_atopic-asthma:oral-wash_vs_bronchial-brush-specimen-type_UP	NA	32067
bsdb:262/2/2_atopic-asthma:oral-wash_vs_bronchial-brush-specimen-type_DOWN	NA	1279
bsdb:262/3/1_atopic-asthma:induced-sputum_vs_nasal-brush-specimen-type_UP	NA	32067
bsdb:262/3/2_atopic-asthma:induced-sputum_vs_nasal-brush-specimen-type_DOWN	NA	475
bsdb:262/4/1_atopic-asthma:oral-wash_vs_nasal-brush-specimen-type_UP	NA	32067
bsdb:262/4/2_atopic-asthma:oral-wash_vs_nasal-brush-specimen-type_DOWN	NA	475
bsdb:262/5/1_atopic-asthma:oral-wash_vs_induced-sputum-specimen-type_UP	NA	1654
bsdb:262/5/2_atopic-asthma:oral-wash_vs_induced-sputum-specimen-type_DOWN	NA	1279
bsdb:262/6/1_atopic-asthma:induced-sputum_vs_bronchial-brush-specimen-type_UP	NA	32067
bsdb:262/7/1_atopic-asthma:atopic-asthma_vs_healthy-control_UP	NA	724
bsdb:262/7/2_atopic-asthma:atopic-asthma_vs_healthy-control_DOWN	NA	1301
bsdb:263/1/1_crohn-disease:chron's-disease_vs_healthy-controls_UP	NA	1301
bsdb:263/1/2_crohn-disease:chron's-disease_vs_healthy-controls_DOWN	NA	191303
bsdb:263/2/1_ulcerative-colitis:ulcerative-colitis_vs_healthy-controls_UP	NA	1301
bsdb:263/2/2_ulcerative-colitis:ulcerative-colitis_vs_healthy-controls_DOWN	NA	44748
bsdb:263/3/1_multiple-sclerosis:multiple-sceloris_vs_healthy-controls_UP	NA	191303
bsdb:263/3/2_multiple-sclerosis:multiple-sceloris_vs_healthy-controls_DOWN	NA	292632
bsdb:263/4/1_rheumatoid-arthritis:arthiritis_vs_healthy-controls_UP	NA	1301
bsdb:263/4/2_rheumatoid-arthritis:arthiritis_vs_healthy-controls_DOWN	NA	292632
bsdb:264/1/1_human-papilloma-virus-infection:HPV+/HIV-_vs_HPV-/HIV-_UP	NA	203491
bsdb:264/1/2_human-papilloma-virus-infection:HPV+/HIV-_vs_HPV-/HIV-_DOWN	NA	135614
bsdb:265/1/1_human-papilloma-virus-infection:two-months_vs_at-birth_UP	NA	43675
bsdb:265/1/2_human-papilloma-virus-infection:two-months_vs_at-birth_DOWN	NA	1737406
bsdb:265/2/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	2129
bsdb:265/2/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	29465
bsdb:265/3/1_human-papilloma-virus-infection:HPV+_vs_HPV--at-two-months_DOWN	NA	39778
bsdb:266/1/1_diet:healthy-vegetarian_vs_healthy-non-vegetarian_UP	NA	570
bsdb:266/1/2_diet:healthy-vegetarian_vs_healthy-non-vegetarian_DOWN	NA	239934
bsdb:267/1/1_atopic-asthma:atopic-asthma_vs_healthy-control_UP	NA	147802
bsdb:267/1/2_atopic-asthma:atopic-asthma_vs_healthy-control_DOWN	NA	57037
bsdb:267/2/1_atopic-asthma:atopic-no-asthma_vs_healthy-control_UP	NA	727
bsdb:267/2/2_atopic-asthma:atopic-no-asthma_vs_healthy-control_DOWN	NA	57037
bsdb:267/3/1_atopic-asthma:atopic-asthma_vs_atopic-no-asthma_UP	NA	28131
bsdb:267/3/2_atopic-asthma:atopic-asthma_vs_atopic-no-asthma_DOWN	NA	57037
bsdb:267/4/1_atopic-asthma:inhaled-corticosteroid-responder_vs_nonresponder_UP	NA	1300
bsdb:267/4/2_atopic-asthma:inhaled-corticosteroid-responder_vs_nonresponder_DOWN	NA	351
bsdb:267/5/1_atopic-asthma:post-inhaled-corticosteroid-treatment_vs_baseline_UP	NA	2092
bsdb:267/5/2_atopic-asthma:post-inhaled-corticosteroid-treatment_vs_baseline_DOWN	NA	39948
bsdb:267/6/1_atopic-asthma:post-placebo-treatment_vs_baseline_UP	NA	2092
bsdb:267/6/2_atopic-asthma:post-placebo-treatment_vs_baseline_DOWN	NA	186804
bsdb:267/7/1_atopic-asthma:atopic-asthma_vs_healthy-control_UP	NA	203691
bsdb:267/7/2_atopic-asthma:atopic-asthma_vs_healthy-control_DOWN	NA	1239
bsdb:267/8/1_atopic-asthma:atopic-no-asthma_vs_healthy-control_UP	NA	1224
bsdb:267/8/2_atopic-asthma:atopic-no-asthma_vs_healthy-control_DOWN	NA	203691
bsdb:267/9/1_atopic-asthma:atopic-asthma_vs_atopic-no-asthma_UP	NA	32066
bsdb:267/9/2_atopic-asthma:atopic-asthma_vs_atopic-no-asthma_DOWN	NA	203691
bsdb:268/1/1_cervical-glandular-intraepithelial-neoplasia:before_vs_after-loop-electrosurgical-excision-procedure_UP	NA	102106
bsdb:268/1/2_cervical-glandular-intraepithelial-neoplasia:before_vs_after-loop-electrosurgical-excision-procedure_DOWN	NA	91061
bsdb:269/1/1_leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_UP	NA	817
bsdb:269/1/2_leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_DOWN	NA	836
bsdb:269/1/3_leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_UP	NA	1678
bsdb:269/1/4_leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_DOWN	NA	1716
bsdb:270/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	286
bsdb:270/1/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	222991
bsdb:270/2/1_human-papilloma-virus-infection:HPV+-(persistance)_vs_HPV+-(clearance)_UP	NA	216851
bsdb:270/2/2_human-papilloma-virus-infection:HPV+-(persistance)_vs_HPV+-(clearance)_DOWN	NA	NA
bsdb:271/1/1_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease--(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	44748
bsdb:271/1/2_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease--(positivity)-with-Allogenic-Stem-Cell-Transplant_DOWN	NA	1335
bsdb:271/2/1_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease--(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	1730
bsdb:271/2/2_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease--(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	216851
bsdb:271/3/1_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease--(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	853
bsdb:271/4/1_acute-lymphoblastic-leukemia:males_vs_female_UP	NA	853
bsdb:271/5/1_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease--(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	39488
bsdb:271/6/1_acute-lymphoblastic-leukemia:Age-less-than-65-years-old_vs_Age-greater-than-65-years-old_UP	NA	39488
bsdb:272/1/1_pneumonia:S.pneumoniae-positive_vs_negative_UP	NA	1301
bsdb:272/1/2_pneumonia:S.pneumoniae-positive_vs_negative_DOWN	NA	1279
bsdb:273/1/1_acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_UP	NA	853
bsdb:273/1/2_acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_DOWN	NA	853
bsdb:273/2/1_acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_DOWN	NA	293
bsdb:273/2/2_acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_DOWN	NA	358
bsdb:274/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	838
bsdb:274/1/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1596
bsdb:274/2/1_cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_UP	NA	82135
bsdb:274/2/2_cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_DOWN	NA	47770
bsdb:274/3/1_cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_UP	NA	177971
bsdb:274/3/2_cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_DOWN	NA	1596
bsdb:274/4/1_cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_UP	NA	40543
bsdb:274/4/2_cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_DOWN	NA	47770
bsdb:274/5/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	906
bsdb:274/5/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1678
bsdb:274/6/1_cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_UP	NA	1596
bsdb:274/6/2_cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_DOWN	NA	47770
bsdb:274/7/1_cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_UP	NA	177971
bsdb:274/7/2_cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_DOWN	NA	59505
bsdb:274/8/1_cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_DOWN	NA	28125
bsdb:274/9/1_NA:normal-pH_vs_abnormal-pH_UP	NA	1311
bsdb:274/9/2_NA:normal-pH_vs_abnormal-pH_DOWN	NA	1596
bsdb:274/10/1_human-papilloma-virus-infection:Hispanic_vs_non-Hispanic_UP	NA	1328
bsdb:274/10/2_human-papilloma-virus-infection:Hispanic_vs_non-Hispanic_DOWN	NA	1596
bsdb:275/1/1_acute-lymphoblastic-leukemia:ALL-patient_vs_healthy-sibling-control_UP	NA	816
bsdb:275/1/2_acute-lymphoblastic-leukemia:ALL-patient_vs_healthy-sibling-control_DOWN	NA	816
bsdb:276/1/1_multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_UP	NA	74201
bsdb:276/1/2_multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_DOWN	NA	544448
bsdb:276/2/1_multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_UP	NA	28141
bsdb:276/2/2_multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_DOWN	NA	904
bsdb:276/3/1_multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_DOWN	NA	1472649
bsdb:276/4/1_multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-relatives-control_UP	NA	287
bsdb:277/1/1_crohn-disease:crohn's-disease_vs_healthy-control_DOWN	NA	830
bsdb:278/1/1_non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease_vs_healthy-control_UP	NA	33958
bsdb:278/1/2_non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease_vs_healthy-control_DOWN	NA	1239
bsdb:279/1/1_acute-myeloid-leukemia:High-Intensity-Chemotherapy_vs_Low-Intensity-Chemotherapy_UP	NA	NA
bsdb:279/1/2_acute-myeloid-leukemia:High-Intensity-Chemotherapy_vs_Low-Intensity-Chemotherapy_DOWN	NA	NA
bsdb:279/2/1_acute-myeloid-leukemia:bacterial-infections_vs_No-bacterial-infections_UP	NA	NA
bsdb:279/2/2_acute-myeloid-leukemia:bacterial-infections_vs_No-bacterial-infections_DOWN	NA	NA
bsdb:279/2/3_acute-myeloid-leukemia:bacterial-infections_vs_No-bacterial-infections_UP	NA	NA
bsdb:279/2/4_acute-myeloid-leukemia:bacterial-infections_vs_No-bacterial-infections_DOWN	NA	NA
bsdb:280/1/1_cervical-glandular-intraepithelial-neoplasia:high-grade-squamus-intraepithelial-lesion_vs_low-grade-squamus-intraepithelial-lesion_UP	NA	1129771
bsdb:280/1/2_cervical-glandular-intraepithelial-neoplasia:high-grade-squamus-intraepithelial-lesion_vs_low-grade-squamus-intraepithelial-lesion_DOWN	NA	181675
bsdb:281/1/1_acute-lymphoblastic-leukemia:Fecal-bacterial-composition-in-small-intestines-of-leukemia-mice_vs_Fecal-bacterial-composition-in-small-intestines-of-control-mice_UP	NA	572511
bsdb:281/1/2_acute-lymphoblastic-leukemia:Fecal-bacterial-composition-in-small-intestines-of-leukemia-mice_vs_Fecal-bacterial-composition-in-small-intestines-of-control-mice_DOWN	NA	572511
bsdb:282/1/1_graft-versus-host-disease:Grades-II-IV-(acute-graft-host-disease)_vs_Grades-0-I-(non-acute-graft-host-disease)_UP	NA	1224
bsdb:282/1/2_graft-versus-host-disease:Grades-II-IV-(acute-graft-host-disease)_vs_Grades-0-I-(non-acute-graft-host-disease)_DOWN	NA	572511
bsdb:282/2/1_graft-versus-host-disease:intensified-conditioning_vs_standard-conditioning_DOWN	NA	541000
bsdb:282/3/1_graft-versus-host-disease:b-lactum-antibiotics_vs_no-b-lactum-antibiotics_DOWN	NA	186803
bsdb:282/4/1_graft-versus-host-disease:vancomycin-antibiotics_vs_no-vancomycin-antibiotics_UP	NA	543
bsdb:283/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	1633
bsdb:283/1/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	47770
bsdb:284/1/1_chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_UP	NA	59735
bsdb:284/1/2_chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_DOWN	NA	836
bsdb:284/2/1_chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_UP	NA	200
bsdb:284/3/1_chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_DOWN	NA	192066
bsdb:284/4/1_chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_UP	NA	1309
bsdb:285/1/1_multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_UP	NA	33024
bsdb:285/1/2_multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_DOWN	NA	1261
bsdb:285/2/1_multiple-sclerosis:IMD-exposure-multiple-sclerosis-cases_vs_IMD-naive-cases_UP	NA	201174
bsdb:285/2/2_multiple-sclerosis:IMD-exposure-multiple-sclerosis-cases_vs_IMD-naive-cases_DOWN	NA	1117
bsdb:285/3/1_multiple-sclerosis:IMD-naive-cases-multiple-sclerosis_vs_healthy-controls_UP	NA	33038
bsdb:285/3/2_multiple-sclerosis:IMD-naive-cases-multiple-sclerosis_vs_healthy-controls_DOWN	NA	189330
bsdb:286/1/1_graves-ophthalmopathy:graves-orbitopathy_vs_Healthy-controls_UP	NA	976
bsdb:286/1/2_graves-ophthalmopathy:graves-orbitopathy_vs_Healthy-controls_DOWN	NA	1263
bsdb:286/2/1_graves-ophthalmopathy:graves-orbitopathy_vs_healthy-controls_UP	NA	171552
bsdb:286/2/2_graves-ophthalmopathy:graves-orbitopathy_vs_healthy-controls_DOWN	NA	186803
bsdb:287/1/1_human-papilloma-virus-infection:Visit-1-HPV-(progression)_vs_HPV-(clearance)_UP	NA	1660
bsdb:287/1/2_human-papilloma-virus-infection:Visit-1-HPV-(progression)_vs_HPV-(clearance)_DOWN	NA	147802
bsdb:287/2/1_human-papilloma-virus-infection:Visit-2-HPV-(progression)_vs_HPV-(clearance)_UP	NA	33043
bsdb:287/2/2_human-papilloma-virus-infection:Visit-2-HPV-(progression)_vs_HPV-(clearance)_DOWN	NA	544581
bsdb:288/1/1_phenylketonuria:phenylketonuric-with-Phe-restricted-diet_vs_mild-hyperphenylalaninemic-with-unrestricted-diet_DOWN	NA	1578
bsdb:289/1/1_health-trait:suboptimal-health-status_vs_healthy-controls_UP	NA	841
bsdb:289/1/2_health-trait:suboptimal-health-status_vs_healthy-controls_DOWN	NA	40544
bsdb:290/1/1_oral-mucositis:ulcerative-oral-mucositis_vs_no-ulcerative-oral-mucositis_UP	NA	838
bsdb:290/1/2_oral-mucositis:ulcerative-oral-mucositis_vs_no-ulcerative-oral-mucositis_DOWN	NA	1654
bsdb:290/2/1_oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_UP	NA	1926307
bsdb:290/2/2_oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_DOWN	NA	230143
bsdb:290/3/1_oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_UP	NA	84135
bsdb:290/3/2_oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_DOWN	NA	1351
bsdb:290/4/1_oral-mucositis:0.1%-or-higher-fungi-load_vs_low-or-no-fungi-load_UP	NA	1578
bsdb:290/4/2_oral-mucositis:0.1%-or-higher-fungi-load_vs_low-or-no-fungi-load_DOWN	NA	1301
bsdb:291/1/1_graves-disease:graves-disease_vs_healthy-controls_UP	NA	582
bsdb:291/1/2_graves-disease:graves-disease_vs_healthy-controls_DOWN	NA	1872444
bsdb:292/1/1_graft-versus-host-disease:allogeneic-hematopoietic-stem-cell-transplant_vs_community-dwelling_UP	NA	316
bsdb:292/1/2_graft-versus-host-disease:allogeneic-hematopoietic-stem-cell-transplant_vs_community-dwelling_DOWN	NA	1164882
bsdb:293/1/1_human-papilloma-virus-infection:Baseline-HPV+_vs_Baseline-HPV-_UP	NA	2129
bsdb:293/1/2_human-papilloma-virus-infection:Baseline-HPV+_vs_Baseline-HPV-_DOWN	NA	848
bsdb:293/2/1_human-papilloma-virus-infection:new-acquisition-of-HPV-within-a-year_vs_no-new-acquisition-of-HPV-within-a-year_DOWN	NA	1654
bsdb:293/3/1_human-papilloma-virus-infection:without-any-HPV-type-cleared_vs_with-at-least-one-HPV-type-cleared-in-a-year_DOWN	NA	204455
bsdb:293/4/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	134821
bsdb:293/4/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	287
bsdb:293/5/1_human-papilloma-virus-infection:new-acquisition-of-HPV-within-a-year_vs_no-new-acquisition-of-HPV-within-a-year_UP	NA	218538
bsdb:293/6/1_human-papilloma-virus-infection:without-any-HPV-type-cleared_vs_with-any-HPV-type-cleared-in-a-year_UP	NA	1763509
bsdb:293/7/1_human-papilloma-virus-infection:at-least-one-HPV-type-persisted_vs_no-HPV-type-persisted_UP	NA	1297424
bsdb:293/7/2_human-papilloma-virus-infection:at-least-one-HPV-type-persisted_vs_no-HPV-type-persisted_DOWN	NA	1584
bsdb:294/1/1_acute-lymphoblastic-leukemia:post-induction-therapy_vs_baseline_UP	NA	33958
bsdb:294/1/2_acute-lymphoblastic-leukemia:post-induction-therapy_vs_baseline_DOWN	NA	74201
bsdb:294/2/1_acute-lymphoblastic-leukemia:post-consolidation-therapy_vs_baseline_UP	NA	33958
bsdb:294/2/2_acute-lymphoblastic-leukemia:post-consolidation-therapy_vs_baseline_DOWN	NA	201174
bsdb:294/3/1_acute-lymphoblastic-leukemia:post-re-induction-therapy_vs_baseline_UP	NA	33958
bsdb:294/3/2_acute-lymphoblastic-leukemia:post-re-induction-therapy_vs_baseline_DOWN	NA	74201
bsdb:294/4/1_acute-lymphoblastic-leukemia:febrile-neutropenia_vs_non-febrile-neutropenia_UP	NA	1224
bsdb:295/1/1_human-papilloma-virus-infection:low-risk-HPV_vs_negative-control_UP	NA	544448
bsdb:295/1/2_human-papilloma-virus-infection:low-risk-HPV_vs_negative-control_DOWN	NA	1033997
bsdb:296/1/1_multiple-myeloma:multiple-myeloma_vs_health-control_UP	NA	351091
bsdb:296/1/2_multiple-myeloma:multiple-myeloma_vs_health-control_DOWN	NA	856
bsdb:296/2/1_multiple-myeloma:multiple-myeloma_vs_health-control_UP	NA	1313
bsdb:296/2/2_multiple-myeloma:multiple-myeloma_vs_health-control_DOWN	NA	84030
bsdb:297/1/1_human-papilloma-virus-infection:non-pregnant-high-risk-HPV_vs_non-pregnant-no-HPV_UP	NA	1386
bsdb:297/1/2_human-papilloma-virus-infection:non-pregnant-high-risk-HPV_vs_non-pregnant-no-HPV_DOWN	NA	186826
bsdb:297/2/1_human-papilloma-virus-infection:pregnant-high-risk-HPV_vs_pregnant-no-HPV_UP	NA	12916
bsdb:297/2/2_human-papilloma-virus-infection:pregnant-high-risk-HPV_vs_pregnant-no-HPV_DOWN	NA	1301
bsdb:298/1/1_acute-myeloid-leukemia:stool_vs_oral_UP	NA	292632
bsdb:298/1/2_acute-myeloid-leukemia:stool_vs_oral_DOWN	NA	1301
bsdb:298/2/1_acute-myeloid-leukemia:infection_vs_no-infection_UP	NA	1301
bsdb:298/3/1_acute-myeloid-leukemia:infection_vs_no-infection_UP	NA	1301
bsdb:299/1/1_acute-lymphoblastic-leukemia:induction-chemotherapy_vs_no-induction-chemotherapy_UP	NA	35783
bsdb:299/1/2_acute-lymphoblastic-leukemia:induction-chemotherapy_vs_no-induction-chemotherapy_DOWN	NA	NA
bsdb:300/1/1_graft-versus-host-disease:acute-graft--versus--host-disease_vs_non--graft--versus--host-disease_UP	NA	43675
bsdb:300/1/2_graft-versus-host-disease:acute-graft--versus--host-disease_vs_non--graft--versus--host-disease_DOWN	NA	47678
bsdb:301/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	168808
bsdb:301/1/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	NA
bsdb:301/2/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	203491
bsdb:301/3/1_human-papilloma-virus-infection:HR-HPV+_vs_HPV-_UP	NA	203491
bsdb:301/3/2_human-papilloma-virus-infection:HR-HPV+_vs_HPV-_DOWN	NA	186826
bsdb:302/1/1_asthma:exacerbated-asthma_vs_healthy-control_UP	NA	1224
bsdb:302/2/1_asthma:non-exacerbated-asthma_vs_healthy-control_UP	NA	1224
bsdb:302/3/1_asthma:exacerbated-asthma_vs_non-exacerbated-asthma_UP	NA	2701
bsdb:302/3/2_asthma:exacerbated-asthma_vs_non-exacerbated-asthma_DOWN	NA	39948
bsdb:302/4/1_asthma:asthma_vs_healthy-control_UP	NA	208968
bsdb:302/5/1_asthma:asthma_vs_healthy-control_UP	NA	2702
bsdb:303/1/1_non-hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_UP	NA	1350
bsdb:303/1/2_non-hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_DOWN	NA	102106
bsdb:304/1/1_antimicrobial-agent:oral-intake-of-vancomycin-(directed-against-Gram-positive-bacteria)_vs_or-placebo-(microcrystalline-cellulose)_UP	NA	29343
bsdb:305/1/1_female-reproductive-organ-cancer:cancer_vs_healthy_UP	NA	32066
bsdb:305/1/2_female-reproductive-organ-cancer:cancer_vs_healthy_DOWN	NA	1224
bsdb:306/1/1_graft-versus-host-disease:post--allogeneic-hematopoietic-stem-cell-transplant_vs_pre--allogeneic-hematopoietic-stem-cell-transplant_UP	NA	303
bsdb:306/1/2_graft-versus-host-disease:post--allogeneic-hematopoietic-stem-cell-transplant_vs_pre--allogeneic-hematopoietic-stem-cell-transplant_DOWN	NA	303
bsdb:307/1/1_antimicrobial-agent:moxifloxacin-treated-group-(MXF)_vs_Negative-control-group-(CLT)_UP	NA	572511
bsdb:307/1/2_antimicrobial-agent:moxifloxacin-treated-group-(MXF)_vs_Negative-control-group-(CLT)_DOWN	NA	1318
bsdb:307/2/1_antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_moxifloxacin-treated-group-(MXF)_UP	NA	1288121
bsdb:307/2/2_antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_moxifloxacin-treated-group-(MXF)_DOWN	NA	572511
bsdb:307/3/1_antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_Negative-control-group-(CLT)_UP	NA	186803
bsdb:307/3/2_antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_Negative-control-group-(CLT)_DOWN	NA	292800
bsdb:308/1/1_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	171549
bsdb:308/1/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	186827
bsdb:308/2/1_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	NA
bsdb:308/2/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	191303
bsdb:308/3/1_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	NA
bsdb:308/3/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	119852
bsdb:308/4/1_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	171549
bsdb:308/4/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	1578
bsdb:308/5/1_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	375288
bsdb:308/5/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	1485
bsdb:308/6/1_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	1578
bsdb:308/6/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	171550
bsdb:309/1/1_cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_UP	NA	28111
bsdb:309/1/2_cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_DOWN	NA	186802
bsdb:309/2/1_cervical-glandular-intraepithelial-neoplasia:>38.8%-8-OHdG-positive-cervical-cells_vs_<=38.8%-8-OHdG-positive-cervical-cells_UP	NA	20
bsdb:309/2/2_cervical-glandular-intraepithelial-neoplasia:>38.8%-8-OHdG-positive-cervical-cells_vs_<=38.8%-8-OHdG-positive-cervical-cells_DOWN	NA	31979
bsdb:309/3/1_cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_UP	NA	1598
bsdb:309/3/2_cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_DOWN	NA	239935
bsdb:310/1/1_non-hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_UP	NA	561
bsdb:310/1/2_non-hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_DOWN	NA	1678
bsdb:311/1/1_graft-versus-host-disease:post--engraftment_vs_pre--engraftment_DOWN	NA	119852
bsdb:311/2/1_graft-versus-host-disease:post--engraftment_vs_pre--engraftment_DOWN	NA	119852
bsdb:312/1/1_antimicrobial-agent:Infants-born-by-mothers-positive-to-GBS-and-received-IAP_vs_infants-born-by-mothers-negative-to-GBS_DOWN	NA	815
bsdb:312/2/1_antimicrobial-agent:Infants-born-by-mothers-positive-to-GBS-and-received-IAP_vs_infants-born-by-mothers-negative-to-GBS_DOWN	NA	1678
bsdb:313/1/1_non-hodgkins-lymphoma:bloodstream-infection_vs_non-bloodstream-infection_UP	NA	29465
bsdb:313/1/2_non-hodgkins-lymphoma:bloodstream-infection_vs_non-bloodstream-infection_DOWN	NA	574697
bsdb:314/1/1_cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	1760
bsdb:314/1/2_cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_DOWN	NA	1239
bsdb:314/2/1_cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	2702
bsdb:314/3/1_cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	386414
bsdb:314/4/1_cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	87541
bsdb:315/1/1_antimicrobial-agent:Infants-to-mothers-received-IAP_vs_Infants-to-mothers-didn't-receive-IAP_UP	NA	171550
bsdb:315/1/2_antimicrobial-agent:Infants-to-mothers-received-IAP_vs_Infants-to-mothers-didn't-receive-IAP_DOWN	NA	201174
bsdb:315/2/1_antimicrobial-agent:Breast-fed-Infants-to-mothers-received-IAP_vs_breast-fed-Infants-to-mothers-didn't-receive-IAP_UP	NA	74201
bsdb:315/2/2_antimicrobial-agent:Breast-fed-Infants-to-mothers-received-IAP_vs_breast-fed-Infants-to-mothers-didn't-receive-IAP_DOWN	NA	976
bsdb:315/3/1_antimicrobial-agent:Formula-fed-Infants-to-mothers-received-IAP_vs_Formula-fed-Infants-to-mothers-didn't-receive-IAP_UP	NA	976
bsdb:315/3/2_antimicrobial-agent:Formula-fed-Infants-to-mothers-received-IAP_vs_Formula-fed-Infants-to-mothers-didn't-receive-IAP_DOWN	NA	201174
bsdb:316/1/1_premature-birth:2-day-old-Pre-term_vs_2-day-old-Full-term-infants(born-after-uncomplicated-pregnancy)_UP	NA	33958
bsdb:316/1/2_premature-birth:2-day-old-Pre-term_vs_2-day-old-Full-term-infants(born-after-uncomplicated-pregnancy)_DOWN	NA	171551
bsdb:316/2/1_premature-birth:10-day-old-Pre-term_vs_10-day-old-Full-term-infants(born-after-uncomplicated-pregnancy)_UP	NA	1236
bsdb:316/2/2_premature-birth:10-day-old-Pre-term_vs_10-day-old-Full-term-infants(born-after-uncomplicated-pregnancy)_DOWN	NA	31977
bsdb:316/3/1_premature-birth:30-day-old-Pre-term_vs_30-day-old-Full-term-infants(born-after-uncomplicated-pregnancy)_UP	NA	1236
bsdb:316/3/2_premature-birth:30-day-old-Pre-term_vs_30-day-old-Full-term-infants(born-after-uncomplicated-pregnancy)_DOWN	NA	31977
bsdb:316/4/1_premature-birth:90-day-old-Pre-term_vs_90-day-old-Full-term-infants(born-after-uncomplicated-pregnancy)_UP	NA	1236
bsdb:316/4/2_premature-birth:90-day-old-Pre-term_vs_90-day-old-Full-term-infants(born-after-uncomplicated-pregnancy)_DOWN	NA	31977
bsdb:316/5/1_antimicrobial-agent:2-day-old-pre-tem-neonates-exposed-to-antibiotics-(IAP)_vs_2-day-old-full-term-neonates-not-exposed-to-antibiotics-(IAP/postnatal)_DOWN	NA	81850
bsdb:316/6/1_antimicrobial-agent:10-day-old-pre-tem-neonates-exposed-to-antibiotics-(IAP)_vs_10-day-old-full-term-neonates-not-exposed-to-antibiotics-(IAP/postnatal)_DOWN	NA	31957
bsdb:316/7/1_antimicrobial-agent:30-day-old-pre-tem-neonates-exposed-to-antibiotics-(IAP)_vs_30-day-old-full-term-neonates-not-exposed-to-antibiotics-(IAP/postnatal)_DOWN	NA	91061
bsdb:316/8/1_antimicrobial-agent:90-day-old-pre-tem-neonates-exposed-to-antibiotics-(IAP)_vs_90-day-old-full-term-neonates-not-exposed-to-antibiotics-(IAP/postnatal)_DOWN	NA	541000
bsdb:316/9/1_antimicrobial-agent:30-day-old-pre-tem-neonates-exposed-to-antibiotics-(IAP)_vs_30-day-old-full-term-neonates-not-exposed-to-antibiotics-(IAP/postnatal)_UP	NA	543
bsdb:316/9/2_antimicrobial-agent:30-day-old-pre-tem-neonates-exposed-to-antibiotics-(IAP)_vs_30-day-old-full-term-neonates-not-exposed-to-antibiotics-(IAP/postnatal)_DOWN	NA	186826
bsdb:316/10/1_antimicrobial-agent:30-day-old-pre-tem-neonates-exposed-to-antibiotics-(IAP/postnatal)_vs_30-day-old-pre-term-neonates-not-exposed-to-antibiotics-(IAP/postnatal)_DOWN	NA	543
bsdb:316/11/1_antimicrobial-agent:90-day-old-pre-tem-neonates-exposed-to-antibiotics-(IAP/postnatal)_vs_90-day-old-pre-term-neonates-not-exposed-to-antibiotics-(IAP/postnatal)_DOWN	NA	31953
bsdb:317/1/1_antimicrobial-agent:infants-delivered-to-mothers-with_vs_without-prenatal-antibiotics-usages_UP	NA	543
bsdb:317/2/1_antimicrobial-agent:infants-delivered-to-mothers-with_vs_without-peripartum-antibiotics-usages_UP	NA	1301
bsdb:317/2/2_antimicrobial-agent:infants-delivered-to-mothers-with_vs_without-peripartum-antibiotics-usages_DOWN	NA	1350
bsdb:318/1/1_graft-versus-host-disease:acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_UP	NA	1239
bsdb:318/2/1_graft-versus-host-disease:acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_UP	NA	1730
bsdb:319/1/1_air-pollution:mice-exposed-to-filtered-air-(FA)_vs_mice-exposed-to-PM-2.5-(CAP)_UP	NA	2085
bsdb:319/1/2_air-pollution:mice-exposed-to-filtered-air-(FA)_vs_mice-exposed-to-PM-2.5-(CAP)_DOWN	NA	29547
bsdb:320/1/1_antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(6-weeks)-to-mothers-unexposed-to--intrapartum-antibiotic_UP	NA	39778
bsdb:320/1/2_antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(6-weeks)-to-mothers-unexposed-to--intrapartum-antibiotic_DOWN	NA	1263
bsdb:320/2/1_antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(1-year)-to-mothers-unexposed-to--intrapartum-antibiotic_UP	NA	39778
bsdb:320/2/2_antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(1-year)-to-mothers-unexposed-to--intrapartum-antibiotic_DOWN	NA	841
bsdb:320/3/1_antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to--antibiotics-(amoxicillin,-penicillin-or-ampicillin)_vs_infants-(6-weeks)-to-mothers-unexposed-to--antibiotic_DOWN	NA	1678
bsdb:320/4/1_antimicrobial-agent:infants(1-year)-to-mothers-exposed-to--antibiotics-(amoxicillin,-penicillin-or-ampicillin)_vs_infants-(1-year)-to-mothers-unexposed-to--antibiotic_UP	NA	33038
bsdb:320/4/2_antimicrobial-agent:infants(1-year)-to-mothers-exposed-to--antibiotics-(amoxicillin,-penicillin-or-ampicillin)_vs_infants-(1-year)-to-mothers-unexposed-to--antibiotic_DOWN	NA	1301
bsdb:320/5/1_antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-multi-class-antibiotics_vs_infants-(6-weeks)-to-mothers-unexposed-to--antibiotic_UP	NA	39778
bsdb:321/1/1_antimicrobial-agent:10-d-old-7-10-day-treatment-infants_vs_10-d-old-2-day-treatment-infants_DOWN	NA	816
bsdb:322/1/1_oral-mucositis:newly-diagnosis-maligancies_vs_reference_UP	NA	203697
bsdb:322/1/2_oral-mucositis:newly-diagnosis-maligancies_vs_reference_DOWN	NA	713
bsdb:322/2/1_oral-mucositis:oral-mucositis_vs_no-oral-mucositis_UP	NA	146
bsdb:322/3/1_oral-mucositis:during-chemotherapy_vs_at-malignancy-diagnosis_UP	NA	1279
bsdb:322/3/2_oral-mucositis:during-chemotherapy_vs_at-malignancy-diagnosis_DOWN	NA	203697
bsdb:322/4/1_oral-mucositis:during-chemotherapy_vs_at-malignancy-diagnosis_UP	NA	338
bsdb:322/5/1_oral-mucositis:mucositis-lesions_vs_all-samples_UP	NA	128827
bsdb:322/5/2_oral-mucositis:mucositis-lesions_vs_all-samples_DOWN	NA	2093
bsdb:323/1/1_necrotizing-enterocolitis:NEC_vs_non-NEC_UP	NA	1279
bsdb:323/2/1_necrotizing-enterocolitis:NEC_vs_non-NEC_DOWN	NA	1716
bsdb:323/3/1_necrotizing-enterocolitis:NEC_vs_non-NEC_UP	NA	1279
bsdb:324/1/1_thyroid-carcinoma:thyroid-carcinoma_vs_healthy-control_UP	NA	1239
bsdb:324/1/2_thyroid-carcinoma:thyroid-carcinoma_vs_healthy-control_DOWN	NA	33038
bsdb:325/1/1_psoriasis:psoriasis_vs_healthy-controls_UP	NA	102106
bsdb:325/1/2_psoriasis:psoriasis_vs_healthy-controls_DOWN	NA	577309
bsdb:326/1/1_NA:Responders_vs_Non-Responders_UP	NA	838
bsdb:326/1/2_NA:Responders_vs_Non-Responders_DOWN	NA	823
bsdb:326/2/1_NA:Progressive--Free--Survival-more-than-30-days_vs_Progressive--Free--Survival-more-less-than-30-days_UP	NA	41978
bsdb:326/2/2_NA:Progressive--Free--Survival-more-than-30-days_vs_Progressive--Free--Survival-more-less-than-30-days_DOWN	NA	128827
bsdb:326/3/1_NA:Responders_vs_Non-Responders_DOWN	NA	169292
bsdb:327/1/1_antimicrobial-agent:infants-received-short-term(<3days)-antibiotic-treatment_vs_control(no-treatment)_UP	NA	1578
bsdb:327/1/2_antimicrobial-agent:infants-received-short-term(<3days)-antibiotic-treatment_vs_control(no-treatment)_DOWN	NA	1301
bsdb:327/2/1_antimicrobial-agent:infants-received-long-term(>5days)-antibiotic-treatment_vs_control(no-treatment)_UP	NA	1350
bsdb:327/2/2_antimicrobial-agent:infants-received-long-term(>5days)-antibiotic-treatment_vs_control(no-treatment)_DOWN	NA	1301
bsdb:328/1/1_psoriatic-arthritis:psoriatic-arthiritis_vs_healthy-controls_DOWN	NA	33042
bsdb:328/2/1_psoriatic-arthritis:skin-psoriasis_vs_healthy-controls_DOWN	NA	976
bsdb:328/3/1_psoriatic-arthritis:psoriatic-arthiritis_vs_skin-psoriasis_UP	NA	976
bsdb:328/3/2_psoriatic-arthritis:psoriatic-arthiritis_vs_skin-psoriasis_DOWN	NA	74201
bsdb:329/1/1_antimicrobial-agent:Postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_UP	NA	1578
bsdb:329/1/2_antimicrobial-agent:Postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/2/1_antimicrobial-agent:IAP-group-(4-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/3/1_antimicrobial-agent:IAP-group-(6-month-old-infant)_vs_control-group_UP	NA	1485
bsdb:329/4/1_antimicrobial-agent:IAP+postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_UP	NA	1578
bsdb:329/4/2_antimicrobial-agent:IAP+postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/5/1_antimicrobial-agent:IAP+postnatal-antibiotic-group-(4-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/6/1_antimicrobial-agent:IAP+postnatal-antibiotic-group-(6-month-old-infant)_vs_control-group_UP	NA	1485
bsdb:330/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	147802
bsdb:330/2/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	147802
bsdb:330/2/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1257
bsdb:330/3/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	150022
bsdb:330/3/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	724
bsdb:331/1/1_hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_UP	NA	42322
bsdb:331/1/2_hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_DOWN	NA	508458
bsdb:332/1/1_hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_UP	NA	1265
bsdb:332/1/2_hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_DOWN	NA	1596
bsdb:333/1/1_antimicrobial-agent:infants-with-(Abx)_vs_without-(non-Abx)-use-of-maternal-antimicrobial-agents-at-delivery_DOWN	NA	1678
bsdb:334/1/1_antimicrobial-agent:infants(14-d-old)-exposed-to-prenatal-antibiotic-therapy-(PAT-group)_vs_prenatal-antibiotic-free-group-(PAF-group)_UP	NA	200644
bsdb:334/1/2_antimicrobial-agent:infants(14-d-old)-exposed-to-prenatal-antibiotic-therapy-(PAT-group)_vs_prenatal-antibiotic-free-group-(PAF-group)_DOWN	NA	1678
bsdb:334/2/1_antimicrobial-agent:infants-exposed-to-antibiotic->7day-(H-group)_vs_infants-exposed-to-antibiotic-<=7day-(L-group)_UP	NA	28216
bsdb:334/2/2_antimicrobial-agent:infants-exposed-to-antibiotic->7day-(H-group)_vs_infants-exposed-to-antibiotic-<=7day-(L-group)_DOWN	NA	31953
bsdb:335/1/1_air-pollution:wild-type-mice-fed-mouse-chow-with-PM10_vs_healthy-mice_UP	NA	74201
bsdb:335/2/1_air-pollution:IL-10/--mice-fed-mouse-chow-with-PM10_vs_healthy-mice_UP	NA	544448
bsdb:335/2/2_air-pollution:IL-10/--mice-fed-mouse-chow-with-PM10_vs_healthy-mice_DOWN	NA	976
bsdb:336/1/1_antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(PM-group_3d-sample)_vs_Antibiotic-free-group-(AF-group_3d-sample)_UP	NA	1578
bsdb:336/1/2_antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(PM-group_3d-sample)_vs_Antibiotic-free-group-(AF-group_3d-sample)_DOWN	NA	1485
bsdb:336/2/1_antimicrobial-agent:piperacillin-tazobactam-group-(PT-group_3d-sample)_vs_Antibiotic-free-group-(AF-group_3d-sample)_UP	NA	201174
bsdb:336/3/1_antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(PM-group_7d-sample)_vs_Antibiotic-free-group-(AF-group_7d-sample)_UP	NA	816
bsdb:336/4/1_antimicrobial-agent:piperacillin-tazobactam-group-(PT-group_7d-sample)_vs_Antibiotic-free-group-(AF-group_7d-sample)_UP	NA	1350
bsdb:336/4/2_antimicrobial-agent:piperacillin-tazobactam-group-(PT-group_7d-sample)_vs_Antibiotic-free-group-(AF-group_7d-sample)_DOWN	NA	570
bsdb:337/1/1_antimicrobial-agent:3-month-old-infants-either-exposed_vs_not-exposed-to-antibiotics-during-the-second-trimester_UP	NA	1407607
bsdb:337/2/1_antimicrobial-agent:3-month-old-infants-exposed_vs_not-exposed-to-antibiotics-during-the-second-trimester_DOWN	NA	227943
bsdb:337/3/1_antimicrobial-agent:12-month-old-infants-either-exposed_vs_not-exposed-to-antibiotics-during-the-second-trimester_UP	NA	186803
bsdb:337/3/2_antimicrobial-agent:12-month-old-infants-either-exposed_vs_not-exposed-to-antibiotics-during-the-second-trimester_DOWN	NA	1506553
bsdb:338/1/1_obesity:obese_vs_normal-weight_UP	NA	724
bsdb:338/1/2_obesity:obese_vs_normal-weight_DOWN	NA	39948
bsdb:338/2/1_obesity:obese_vs_normal-weight_UP	NA	33038
bsdb:338/2/2_obesity:obese_vs_normal-weight_DOWN	NA	544448
bsdb:339/1/1_air-pollution:mice-exposed-to-UFP_vs_vehicle-control_UP	NA	74201
bsdb:339/1/2_air-pollution:mice-exposed-to-UFP_vs_vehicle-control_DOWN	NA	201174
bsdb:340/1/1_obesity:obese/overweight_vs_non-overweight/non-obese-children_UP	NA	189330
bsdb:340/1/2_obesity:obese/overweight_vs_non-overweight/non-obese-children_DOWN	NA	375288
bsdb:340/2/1_obesity:obese/overweight_vs_non-overweight/non-obese-children_UP	NA	189330
bsdb:340/2/2_obesity:obese/overweight_vs_non-overweight/non-obese-children_DOWN	NA	186804
bsdb:340/3/1_obesity:obese/overweight_vs_non-overweight/non-obese-children_UP	NA	1301
bsdb:340/3/2_obesity:obese/overweight_vs_non-overweight/non-obese-children_DOWN	NA	186804
bsdb:341/1/1_nicotine-dependence:patients-with-FD,-ID,or-CD-who-currently-smoked_vs_never-smoked_UP	NA	29465
bsdb:341/2/1_nicotine-dependence:patients-with-FD,-ID,or-CD-who-currently-smokes_vs_never-smoked_DOWN	NA	838
bsdb:342/1/1_asthma:Children-who-experienced-exacerbtion_vs_children-who-did-not-experience-more-than-one-exacerbation_DOWN	NA	724
bsdb:342/2/1_asthma:Children-with-any-rhinovirus-infection_vs_children-with-no-rhinovirus-infection_UP	NA	1301
bsdb:342/2/2_asthma:Children-with-any-rhinovirus-infection_vs_children-with-no-rhinovirus-infection_DOWN	NA	1279
bsdb:342/3/1_asthma:Children-with-rhinovirus-A-(RV-A)_vs_children-RV-_UP	NA	1301
bsdb:342/3/2_asthma:Children-with-rhinovirus-A-(RV-A)_vs_children-RV-_DOWN	NA	1279
bsdb:342/4/1_asthma:Younger-children_vs_older-children_DOWN	NA	475
bsdb:342/5/1_asthma:Children-who-experienced-exacerbation_vs_children-who-did-not-experience-more-than-one-exacerbation_UP	NA	475
bsdb:342/5/2_asthma:Children-who-experienced-exacerbation_vs_children-who-did-not-experience-more-than-one-exacerbation_DOWN	NA	1279
bsdb:342/6/1_asthma:Viral-illnesses_vs_no-viral-illnesses_UP	NA	475
bsdb:342/6/2_asthma:Viral-illnesses_vs_no-viral-illnesses_DOWN	NA	1279
bsdb:342/7/1_asthma:Children-with-any-rhinovirus-infection_vs_children-with-no-rhinovirus-infection_UP	NA	1301
bsdb:342/7/2_asthma:Children-with-any-rhinovirus-infection_vs_children-with-no-rhinovirus-infection_DOWN	NA	1279
bsdb:342/8/1_asthma:Children-with-rhinovirus-A-infection_vs_children-rhinovirus-negative_UP	NA	1301
bsdb:342/8/2_asthma:Children-with-rhinovirus-A-infection_vs_children-rhinovirus-negative_DOWN	NA	1279
bsdb:342/9/1_asthma:Children-with-rhinovirus-C-infection_vs_children-rhinovirus-neagtive_UP	NA	1301
bsdb:342/9/2_asthma:Children-with-rhinovirus-C-infection_vs_children-rhinovirus-neagtive_DOWN	NA	1279
bsdb:342/10/1_asthma:Respiratory-illness_vs_no-respiratory-illness_UP	NA	1301
bsdb:342/10/2_asthma:Respiratory-illness_vs_no-respiratory-illness_DOWN	NA	1279
bsdb:343/1/1_leukemia:Antileukemic_vs_Allogeneic-Hematopoeitic-Stem-Cell-Transplant_UP	NA	375288
bsdb:343/1/2_leukemia:Antileukemic_vs_Allogeneic-Hematopoeitic-Stem-Cell-Transplant_DOWN	NA	816
bsdb:344/1/1_air-pollution:mice-exposed-to-Pm-2.5-suspension_vs_mice-exposed-suspension-from-extracts-of-blank-filter_UP	NA	213115
bsdb:344/1/2_air-pollution:mice-exposed-to-Pm-2.5-suspension_vs_mice-exposed-suspension-from-extracts-of-blank-filter_DOWN	NA	283168
bsdb:345/1/1_obesity:obese_vs_normal_UP	NA	158846
bsdb:345/1/2_obesity:obese_vs_normal_DOWN	NA	815
bsdb:346/1/1_unipolar-depression:severe-depression_vs_mild-depression_UP	NA	292800
bsdb:346/1/2_unipolar-depression:severe-depression_vs_mild-depression_DOWN	NA	847
bsdb:346/2/1_unipolar-depression:moderate-depression_vs_mild-depression_UP	NA	1512
bsdb:346/3/1_anxiety-disorder:severe-anxiety_vs_mild-anxiety_UP	NA	1328
bsdb:346/3/2_anxiety-disorder:severe-anxiety_vs_mild-anxiety_DOWN	NA	116085
bsdb:346/4/1_anxiety-disorder:moderate-anxiety_vs_mild-anxiety_UP	NA	1358
bsdb:347/1/1_obesity:obese_vs_control_UP	NA	847
bsdb:347/1/2_obesity:obese_vs_control_DOWN	NA	341220
bsdb:348/1/1_obesity:obese_vs_lean_UP	NA	1591
bsdb:348/1/2_obesity:obese_vs_lean_DOWN	NA	41200
bsdb:348/2/1_obesity:overweight_vs_lean_UP	NA	1591
bsdb:348/2/2_obesity:overweight_vs_lean_DOWN	NA	41200
bsdb:348/3/1_obesity:obese_vs_lean_UP	NA	817
bsdb:348/3/2_obesity:obese_vs_lean_DOWN	NA	41200
bsdb:348/4/1_obesity:overweight_vs_lean_UP	NA	1591
bsdb:349/1/1_cervical-glandular-intraepithelial-neoplasia:LEEP-group-before-prcocedure_vs_normal_UP	NA	134821
bsdb:349/2/1_cervical-glandular-intraepithelial-neoplasia:LEEP-group-before-prcocedure_vs_normal_UP	NA	134821
bsdb:349/3/1_cervical-glandular-intraepithelial-neoplasia:LEEP-group-before-prcocedure_vs_normal_UP	NA	134821
bsdb:349/4/1_cervical-glandular-intraepithelial-neoplasia:LEEP-group-before-prcocedure_vs_normal_UP	NA	134821
bsdb:349/5/1_cervical-glandular-intraepithelial-neoplasia:LEEP-group-6-months-prcocedure_vs_normal_UP	NA	134821
bsdb:349/6/1_cervical-glandular-intraepithelial-neoplasia:LEEP-group-12-months-prcocedure_vs_normal_UP	NA	134821
bsdb:350/1/1_obesity:obese_vs_normal-weight_UP	NA	853
bsdb:350/1/2_obesity:obese_vs_normal-weight_DOWN	NA	33024
bsdb:350/2/1_obesity:obesity-with-metabolic-syndrome_vs_normal-weight_UP	NA	1224
bsdb:350/2/2_obesity:obesity-with-metabolic-syndrome_vs_normal-weight_DOWN	NA	200643
bsdb:351/1/1_obesity:overweight/obesity_vs_normal_UP	NA	1578
bsdb:351/1/2_obesity:overweight/obesity_vs_normal_DOWN	NA	1678
bsdb:352/1/1_NA:Low-Grade-Squamous-Intraepithelial-Lesion_vs_Atypical-Squamous-Cells-of-Undetermined-Significance_DOWN	NA	1799696
bsdb:352/2/1_NA:High-risk-HPV_vs_Low-risk-HPV_UP	NA	55193
bsdb:352/2/2_NA:High-risk-HPV_vs_Low-risk-HPV_DOWN	NA	1799696
bsdb:352/3/1_NA:Low-Grade-Squamous-Intraepithelial-Lesion_vs_Atypical-Squamous-Cells-of-Undetermined-Significance_DOWN	NA	1799696
bsdb:352/4/1_NA:High-risk-HPV_vs_Low-risk-HPV_UP	NA	55193
bsdb:352/4/2_NA:High-risk-HPV_vs_Low-risk-HPV_DOWN	NA	1799696
bsdb:353/1/1_obesity:obese_vs_non-obese_UP	NA	853
bsdb:354/1/1_obesity:overweight/obese_vs_control-(BMI-at-normal-range)_UP	NA	543
bsdb:354/1/2_obesity:overweight/obese_vs_control-(BMI-at-normal-range)_DOWN	NA	872
bsdb:355/1/1_obesity:obese-(obese/overweight/morbidly-obese)_vs_control-(lean/normal-weight)_UP	NA	1591
bsdb:355/1/2_obesity:obese-(obese/overweight/morbidly-obese)_vs_control-(lean/normal-weight)_DOWN	NA	821
bsdb:356/1/1_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-3_UP	NA	171550
bsdb:356/1/2_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-3_DOWN	NA	1940338
bsdb:356/2/1_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-10_UP	NA	85010
bsdb:356/3/1_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-21_UP	NA	1385
bsdb:356/3/2_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-21_DOWN	NA	244127
bsdb:356/4/1_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-35_UP	NA	2062
bsdb:356/5/1_air-pollution:ICR-female-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-10_UP	NA	NA
bsdb:356/5/2_air-pollution:ICR-female-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-10_DOWN	NA	171552
bsdb:356/6/1_air-pollution:ICR-female-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-21_UP	NA	194924
bsdb:356/6/2_air-pollution:ICR-female-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-21_DOWN	NA	1578
bsdb:356/7/1_air-pollution:ICR-female-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-35_UP	NA	541000
bsdb:356/7/2_air-pollution:ICR-female-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-35_DOWN	NA	186804
bsdb:357/1/1_air-pollution:post-smog-swabs_vs_pre-smog-swabs_UP	NA	838
bsdb:357/1/2_air-pollution:post-smog-swabs_vs_pre-smog-swabs_DOWN	NA	32067
bsdb:358/1/1_NA:CIN2/3-CC_vs_Healthy-controls_UP	NA	286638
bsdb:359/1/1_smoking-behavior:current-smoker_vs_former-smoker_UP	NA	84998
bsdb:359/1/2_smoking-behavior:current-smoker_vs_former-smoker_DOWN	NA	117743
bsdb:359/1/3_smoking-behavior:current-smoker_vs_former-smoker_UP	NA	1301
bsdb:359/1/4_smoking-behavior:current-smoker_vs_former-smoker_DOWN	NA	970
bsdb:360/1/1_air-pollution:mice-exposed-to-MVE_vs_mice-exposed-to-Filtered-Air_UP	NA	1485
bsdb:360/1/2_air-pollution:mice-exposed-to-MVE_vs_mice-exposed-to-Filtered-Air_DOWN	NA	1578
bsdb:360/2/1_air-pollution:mice-exposed-to-WS_vs_mice-exposed-to-Filtered-Air_UP	NA	NA
bsdb:360/2/2_air-pollution:mice-exposed-to-WS_vs_mice-exposed-to-Filtered-Air_DOWN	NA	1578
bsdb:361/1/1_air-pollution:male-mice-exposed-to-cigarette-smoke_vs_control_UP	NA	204441
bsdb:361/1/2_air-pollution:male-mice-exposed-to-cigarette-smoke_vs_control_DOWN	NA	2005473
bsdb:361/2/1_air-pollution:female-mice-exposed-to-cigarette-smoke_vs_control_UP	NA	816
bsdb:361/2/2_air-pollution:female-mice-exposed-to-cigarette-smoke_vs_control_DOWN	NA	283168
bsdb:361/3/1_air-pollution:ovariectomized-female-mice-exposed-to-cigarette-smoke_vs_control_UP	NA	830
bsdb:361/3/2_air-pollution:ovariectomized-female-mice-exposed-to-cigarette-smoke_vs_control_DOWN	NA	NA
bsdb:361/4/1_air-pollution:mice-exposed-to-smoke_vs_control_UP	NA	459786
bsdb:361/4/2_air-pollution:mice-exposed-to-smoke_vs_control_DOWN	NA	239759
bsdb:362/1/1_obesity:obese_vs_normal-weight-children_UP	NA	33958
bsdb:362/1/2_obesity:obese_vs_normal-weight-children_DOWN	NA	171552
bsdb:363/1/1_smoking-behavior:current-smokers_vs_never-smokers_UP	NA	2093
bsdb:363/1/2_smoking-behavior:current-smokers_vs_never-smokers_DOWN	NA	1378
bsdb:364/1/1_smoking-behavior:smoker_vs_non-smoker_UP	NA	39777
bsdb:365/1/1_diet:mice-exposed-to-American-Diet_vs_mice-fed-control-rodent-diet._UP	NA	1263
bsdb:365/1/2_diet:mice-exposed-to-American-Diet_vs_mice-fed-control-rodent-diet._DOWN	NA	816
bsdb:366/1/1_non-alcoholic-fatty-liver-disease:nonalcoholic-fatty-liver-disease_vs_healthy-controls_UP	NA	189330
bsdb:366/1/2_non-alcoholic-fatty-liver-disease:nonalcoholic-fatty-liver-disease_vs_healthy-controls_DOWN	NA	459786
bsdb:367/1/1_obesity:obese_vs_normal-weight_UP	NA	2049040
bsdb:367/1/2_obesity:obese_vs_normal-weight_DOWN	NA	119852
bsdb:367/2/1_obesity:overweight_vs_normal-weight_UP	NA	2049040
bsdb:367/2/2_obesity:overweight_vs_normal-weight_DOWN	NA	119852
bsdb:368/1/1_smoking-behavior:shammah-users_vs_non-shammah-users_UP	NA	495
bsdb:368/1/2_smoking-behavior:shammah-users_vs_non-shammah-users_DOWN	NA	47
bsdb:369/1/1_obesity:obese_vs_normal-weight_UP	NA	841
bsdb:369/1/2_obesity:obese_vs_normal-weight_DOWN	NA	119852
bsdb:369/2/1_obesity:after-onset-of-obesity_vs_before-onset-of-obesity_UP	NA	40544
bsdb:369/2/2_obesity:after-onset-of-obesity_vs_before-onset-of-obesity_DOWN	NA	1263
bsdb:370/1/1_air-pollution:farmworker-exposure_vs_non-farmworker-exposure_DOWN	NA	1301
bsdb:371/1/1_obesity:obese_vs_lean_UP	NA	1591
bsdb:371/2/1_obesity:obese_vs_lean_DOWN	NA	2173
bsdb:371/3/1_obesity:obese_vs_lean_DOWN	NA	562
bsdb:371/4/1_obesity:obese_vs_lean_UP	NA	1598
bsdb:372/1/1_air-pollution:Diesel-exhaust-particle-(DEP)-exposed-mice_vs_mice-exposed-to-FRA_UP	NA	1578
bsdb:372/1/2_air-pollution:Diesel-exhaust-particle-(DEP)-exposed-mice_vs_mice-exposed-to-FRA_DOWN	NA	186801
bsdb:373/1/1_obesity:overweight_vs_normal-weight-children_UP	NA	1681
bsdb:373/1/2_obesity:overweight_vs_normal-weight-children_DOWN	NA	239935
bsdb:373/2/1_obesity:overweight_vs_normal-weight-adult_UP	NA	1680
bsdb:373/2/2_obesity:overweight_vs_normal-weight-adult_DOWN	NA	88431
bsdb:374/1/1_cervical-glandular-intraepithelial-neoplasia:cervical-intraepithelial-neoplasia-cases_vs_normal-control_UP	NA	953
bsdb:374/1/2_cervical-glandular-intraepithelial-neoplasia:cervical-intraepithelial-neoplasia-cases_vs_normal-control_DOWN	NA	497
bsdb:374/2/1_cervical-cancer:cervical-cancer-cancer_vs_normal-control_UP	NA	953
bsdb:374/2/2_cervical-cancer:cervical-cancer-cancer_vs_normal-control_DOWN	NA	1263978
bsdb:375/1/1_obesity:obese_vs_normal-weight_UP	NA	NA
bsdb:375/1/2_obesity:obese_vs_normal-weight_DOWN	NA	562
bsdb:376/1/1_antimicrobial-agent:patients-that-took-amoxiclav_vs_before-antibiotic-exposure_UP	NA	976
bsdb:376/1/2_antimicrobial-agent:patients-that-took-amoxiclav_vs_before-antibiotic-exposure_DOWN	NA	1239
bsdb:376/2/1_antimicrobial-agent:patients-that-took-levofloxacin/Metronidazole_vs_before-antibiotic-exposure_UP	NA	310297
bsdb:376/2/2_antimicrobial-agent:patients-that-took-levofloxacin/Metronidazole_vs_before-antibiotic-exposure_DOWN	NA	1239
bsdb:376/3/1_antimicrobial-agent:patients-that-took-Piperacilin/Tazobactam_vs_before-antibiotic-exposure_UP	NA	816
bsdb:376/3/2_antimicrobial-agent:patients-that-took-Piperacilin/Tazobactam_vs_before-antibiotic-exposure_DOWN	NA	1239
bsdb:376/4/1_antimicrobial-agent:patients-that-took-Ceftriaxone/Azithromycin_vs_before-antibiotic-exposure_UP	NA	976
bsdb:376/4/2_antimicrobial-agent:patients-that-took-Ceftriaxone/Azithromycin_vs_before-antibiotic-exposure_DOWN	NA	1239
bsdb:376/5/1_antimicrobial-agent:patients-that-took-Ciprofloxacin_vs_before-antibiotic-exposure_UP	NA	976
bsdb:376/5/2_antimicrobial-agent:patients-that-took-Ciprofloxacin_vs_before-antibiotic-exposure_DOWN	NA	1239
bsdb:377/1/1_smoking-behavior:never-smoker_vs_E-cigarette-smoker_UP	NA	2049038
bsdb:377/1/2_smoking-behavior:never-smoker_vs_E-cigarette-smoker_DOWN	NA	39778
bsdb:377/2/1_smoking-behavior:never-smoker_vs_cigarette-smoker_UP	NA	192066
bsdb:377/2/2_smoking-behavior:never-smoker_vs_cigarette-smoker_DOWN	NA	31977
bsdb:377/3/1_smoking-behavior:E-cigarette-smoker_vs_cigarette-smoker_UP	NA	2049038
bsdb:377/3/2_smoking-behavior:E-cigarette-smoker_vs_cigarette-smoker_DOWN	NA	1318
bsdb:378/1/1_graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_UP	NA	1357
bsdb:378/1/2_graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_DOWN	NA	1508657
bsdb:378/2/1_graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_UP	NA	40323
bsdb:378/2/2_graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_DOWN	NA	1505663
bsdb:379/1/1_obesity:non-obese_vs_obese_UP	NA	227945
bsdb:379/2/1_obesity:obese_vs_non-obese_UP	NA	29317
bsdb:379/2/2_obesity:obese_vs_non-obese_UP	NA	156454
bsdb:380/1/1_response-to-allogeneic-hematopoietic-stem-cell-transplant:patients-preallogenic-hematopoietic-cell-transplant_vs_patients-post-allogenic-hematopoietic-cell-transplant/pre-Fecal-Microbiota-Transplant_UP	NA	186802
bsdb:380/2/1_response-to-allogeneic-hematopoietic-stem-cell-transplant:post-allogenic-hematopoietic-cell-transplant/-pre-Fecal-microbiota-transplant_vs_post-fecal-mircobiota-day-180_DOWN	NA	186802
bsdb:380/3/1_response-to-allogeneic-hematopoietic-stem-cell-transplant:post-allogenic-hematopoietic-cell-transplant/-pre-Fecal-microbiota-transplant_vs_post-fecal-mircobiota-day-7_DOWN	NA	186802
bsdb:380/4/1_response-to-allogeneic-hematopoietic-stem-cell-transplant:post-allogenic-hematopoietic-cell-transplant/-pre-Fecal-microbiota-transplant_vs_post-fecal-mircobiota-day-30_DOWN	NA	186802
bsdb:381/1/1_response-to-allogeneic-hematopoietic-stem-cell-transplant:hematopoietic-stem-cell-transplant-recipients_vs_healthy-volunteers_UP	NA	1350
bsdb:381/1/2_response-to-allogeneic-hematopoietic-stem-cell-transplant:hematopoietic-stem-cell-transplant-recipients_vs_healthy-volunteers_DOWN	NA	292632
bsdb:381/2/1_response-to-allogeneic-hematopoietic-stem-cell-transplant:high-fecal-butyrate-levels_vs_low-fecal-butyrate-levels_UP	NA	1505663
bsdb:381/2/2_response-to-allogeneic-hematopoietic-stem-cell-transplant:high-fecal-butyrate-levels_vs_low-fecal-butyrate-levels_DOWN	NA	91061
bsdb:382/1/1_chlamydia-trachomatis-infectious-disease:patient-with-chlamydia-infection_vs_healthy-control_UP	NA	87541
bsdb:382/1/2_chlamydia-trachomatis-infectious-disease:patient-with-chlamydia-infection_vs_healthy-control_DOWN	NA	91061
bsdb:382/2/1_NA:patient-with-chlamydia-infection_vs_HPV-positive-women_UP	NA	813
bsdb:382/2/2_NA:patient-with-chlamydia-infection_vs_HPV-positive-women_DOWN	NA	1239
bsdb:383/1/1_food-allergy:child-with-food-sensitization_vs_no-food-sensitization_DOWN	NA	1485
bsdb:383/2/1_food-allergy:child-with-food-allergy_vs_no-food-allergy_DOWN	NA	189330
bsdb:384/1/1_schizophrenia:FSCZ_vs_healthy-controls_UP	NA	29465
bsdb:384/1/2_schizophrenia:FSCZ_vs_healthy-controls_DOWN	NA	83763
bsdb:384/2/1_schizophrenia:TSCZ_vs_healthy-controls_UP	NA	29465
bsdb:384/2/2_schizophrenia:TSCZ_vs_healthy-controls_DOWN	NA	712
bsdb:384/3/1_schizophrenia:TSCZ_vs_FSCZ_UP	NA	1301
bsdb:384/3/2_schizophrenia:TSCZ_vs_FSCZ_DOWN	NA	29465
bsdb:385/1/1_gastric-adenocarcinoma:gastric-adenocarcinoma-(GC)_vs_superficial-gastritis-(SG)_UP	NA	1283313
bsdb:385/1/2_gastric-adenocarcinoma:gastric-adenocarcinoma-(GC)_vs_superficial-gastritis-(SG)_DOWN	NA	1318
bsdb:386/1/1_pulmonary-tuberculosis:Tuberculosis-(TB)-patients_vs_healthy-controls_UP	NA	208479
bsdb:386/1/2_pulmonary-tuberculosis:Tuberculosis-(TB)-patients_vs_healthy-controls_DOWN	NA	46228
bsdb:387/1/1_antimicrobial-agent:Before-ciprofloxacin-exposure_vs_after-antibiotic-exposure_UP	NA	816
bsdb:387/1/2_antimicrobial-agent:Before-ciprofloxacin-exposure_vs_after-antibiotic-exposure_DOWN	NA	128827
bsdb:387/2/1_antimicrobial-agent:Before-clindamycin-exposure_vs_after-antibiotic-exposure_DOWN	NA	186802
bsdb:388/1/1_oral-squamous-cell-carcinoma:cancerous--lesions_vs_paracancerous-tissues_UP	NA	848
bsdb:388/1/2_oral-squamous-cell-carcinoma:cancerous--lesions_vs_paracancerous-tissues_DOWN	NA	41275
bsdb:389/1/1_schizophrenia:schizophrenia_vs_healthy-controls_UP	NA	1301
bsdb:389/1/2_schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	838
bsdb:389/2/1_schizophrenia:schizophrenia_vs_healthy-controls_UP	NA	215579
bsdb:389/2/2_schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	838
bsdb:390/1/1_schizophrenia:acute-schizphrenia_vs_healthy-controls_UP	NA	35832
bsdb:390/1/2_schizophrenia:acute-schizphrenia_vs_healthy-controls_DOWN	NA	1774107
bsdb:390/2/1_schizophrenia:scizophrenia-during-remission_vs_healthy-controls_UP	NA	191303
bsdb:390/2/2_schizophrenia:scizophrenia-during-remission_vs_healthy-controls_DOWN	NA	1432051
bsdb:390/3/1_schizophrenia:acute-schizphrenia_vs_symptomatic-remission_DOWN	NA	186804
bsdb:391/1/1_neuromyelitis-optica:neuromyelitis-optica-spectrum-disorder_vs_healthy-controls_UP	NA	1300
bsdb:391/1/2_neuromyelitis-optica:neuromyelitis-optica-spectrum-disorder_vs_healthy-controls_DOWN	NA	186801
bsdb:392/1/1_milk-allergic-reaction:non-IgE-mediated-cow's-milk-allergy_vs_healthy-controls_UP	NA	239759
bsdb:392/2/1_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-at-diagnosis_DOWN	NA	816
bsdb:392/3/1_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF+LGG_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-at-diagnosis_DOWN	NA	1883
bsdb:392/4/1_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF+LGG_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF_UP	NA	1578
bsdb:392/4/2_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF+LGG_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF_DOWN	NA	39948
bsdb:393/1/1_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-tolerant-to-cow's-milk-protein_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-non-tolerant-to-cow's-milk-protein_UP	NA	1678
bsdb:393/2/1_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy_vs_healthy-control_UP	NA	84107
bsdb:393/2/2_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy_vs_healthy-control_DOWN	NA	816
bsdb:394/1/1_asthma:child-with-asthma-at-age-6_vs_healthy-control_UP	NA	838
bsdb:395/1/1_end-stage-renal-disease:peritoneal-dialysis_vs_healthy-controls_DOWN	NA	1239
bsdb:395/2/1_end-stage-renal-disease:hemodialysis_vs_healthy-controls_UP	NA	201174
bsdb:395/3/1_end-stage-renal-disease:hemodialysis_vs_peritoneal-dialysis_DOWN	NA	1224
bsdb:396/1/1_atopic-eczema:atopic-dermatitis_vs_healthy-control_UP	NA	91061
bsdb:396/1/2_atopic-eczema:atopic-dermatitis_vs_healthy-control_DOWN	NA	1760
bsdb:396/1/3_atopic-eczema:atopic-dermatitis_vs_healthy-control_UP	NA	1279
bsdb:396/1/4_atopic-eczema:atopic-dermatitis_vs_healthy-control_DOWN	NA	106589
bsdb:396/2/1_atopic-eczema:atopic-dermatitis-after-treatment-with-TCS-+-Bleach_vs_baseline_UP	NA	838
bsdb:396/2/2_atopic-eczema:atopic-dermatitis-after-treatment-with-TCS-+-Bleach_vs_baseline_DOWN	NA	1279
bsdb:396/3/1_atopic-eczema:atopic-dermatitis-after-treatment-with-TCS_vs_baseline_UP	NA	838
bsdb:396/3/2_atopic-eczema:atopic-dermatitis-after-treatment-with-TCS_vs_baseline_DOWN	NA	1279
bsdb:397/1/1_atopic-eczema:severe-atopic-dermatitis_vs_healthy-control_UP	NA	172044
bsdb:397/1/2_atopic-eczema:severe-atopic-dermatitis_vs_healthy-control_DOWN	NA	425941
bsdb:398/1/1_atopic-eczema:atopic-dermatitis_vs_healthy-control_DOWN	NA	1279
bsdb:399/1/1_age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_UP	NA	29465
bsdb:399/1/2_age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_DOWN	NA	1016
bsdb:399/2/1_age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_UP	NA	620
bsdb:399/2/2_age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_DOWN	NA	186803
bsdb:400/1/1_asthma:asthma_vs_healthy-control_UP	NA	1730
bsdb:400/1/2_asthma:asthma_vs_healthy-control_DOWN	NA	1239
bsdb:400/2/1_allergic-rhinitis:allergic-rhinitis_vs_healthy-control_UP	NA	447020
bsdb:400/2/2_allergic-rhinitis:allergic-rhinitis_vs_healthy-control_DOWN	NA	1239
bsdb:401/1/1_asthma:asthma_vs_healthy-control_UP	NA	970
bsdb:401/1/2_asthma:asthma_vs_healthy-control_DOWN	NA	543311
bsdb:401/2/1_allergic-rhinitis:allergic-rhinitis_vs_healthy-control_UP	NA	1224
bsdb:401/2/2_allergic-rhinitis:allergic-rhinitis_vs_healthy-control_DOWN	NA	437755
bsdb:402/1/1_atopic-eczema:IgE-associated-eczema_vs_healthy-control_DOWN	NA	541000
bsdb:402/2/1_atopic-eczema:Mothers-whose-infants-developed-IgE-associated-eczema_vs_mothers-whose-infants-remained-non-allergic_UP	NA	1301
bsdb:402/3/1_cesarean-section:caesarean-delivered-infant_vs_vaginally-delivered-infant_UP	NA	1224
bsdb:402/3/2_cesarean-section:caesarean-delivered-infant_vs_vaginally-delivered-infant_DOWN	NA	976
bsdb:403/1/1_eczema:child-with-eczema_vs_healthy-control_UP	NA	551
bsdb:403/1/2_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	547
bsdb:403/2/1_eczema:child-with-eczema_vs_healthy-control_UP	NA	186801
bsdb:403/2/2_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1224
bsdb:403/3/1_eczema:child-with-eczema_vs_healthy-control_UP	NA	551
bsdb:403/3/2_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	28050
bsdb:403/4/1_eczema:child-with-eczema_vs_healthy-control_UP	NA	817
bsdb:403/4/2_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1681
bsdb:403/5/1_eczema:child-with-eczema_vs_healthy-control_UP	NA	551
bsdb:403/5/2_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	194
bsdb:403/6/1_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	547
bsdb:403/7/1_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	547
bsdb:403/8/1_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	201174
bsdb:403/9/1_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	35832
bsdb:403/10/1_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1224
bsdb:404/1/1_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_UP	NA	239759
bsdb:404/1/2_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	543
bsdb:404/2/1_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_UP	NA	1263
bsdb:404/2/2_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	100883
bsdb:404/3/1_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_UP	NA	186804
bsdb:404/3/2_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	61170
bsdb:405/1/1_asthma:child-with-asthma-at-5-years-old_vs_no-asthma-at-5-years-old_UP	NA	29465
bsdb:405/1/2_asthma:child-with-asthma-at-5-years-old_vs_no-asthma-at-5-years-old_DOWN	NA	946234
bsdb:405/2/1_asthma:child-with-asthma-at-5-years-old-among-mothers-with-asthma_vs_no-asthma-at-5-years-old_UP	NA	29465
bsdb:405/2/2_asthma:child-with-asthma-at-5-years-old-among-mothers-with-asthma_vs_no-asthma-at-5-years-old_DOWN	NA	39948
bsdb:406/1/1_lung-cancer:non-smoking-female-lung-cancer-patients_vs_healthy-controls_UP	NA	75682
bsdb:406/1/2_lung-cancer:non-smoking-female-lung-cancer-patients_vs_healthy-controls_DOWN	NA	469
bsdb:407/1/1_peptic-esophagitis:reflux-esophagus-patients_vs_healthy-controls_UP	NA	976
bsdb:407/1/2_peptic-esophagitis:reflux-esophagus-patients_vs_healthy-controls_DOWN	NA	843
bsdb:408/1/1_asthma:asthma-at-3-months_vs_healthy-controls_UP	NA	31979
bsdb:408/1/2_asthma:asthma-at-3-months_vs_healthy-controls_DOWN	NA	186802
bsdb:408/2/1_asthma:asthma-at-1-year_vs_healthy-controls_UP	NA	32207
bsdb:409/1/1_milk-allergic-reaction:IgE-mediated-cow's-milk-allergy_vs_healthy-controls_UP	NA	216851
bsdb:409/1/2_milk-allergic-reaction:IgE-mediated-cow's-milk-allergy_vs_healthy-controls_DOWN	NA	561
bsdb:410/1/1_HIV-infection:ART-treated-HIV-infected-MSM_vs_HIV-uninfected-MSM_UP	NA	194
bsdb:410/1/2_HIV-infection:ART-treated-HIV-infected-MSM_vs_HIV-uninfected-MSM_DOWN	NA	838
bsdb:410/2/1_NA:MSM-with-gonorrhea_vs_MSM-with-no-gonorrhea_UP	NA	838
bsdb:411/1/1_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_UP	NA	52225
bsdb:411/1/2_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_DOWN	NA	620
bsdb:411/2/1_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_UP	NA	1301
bsdb:412/1/1_NA:HIV-positive-MA-users_vs_HIV-positive-non-MA-users_UP	NA	34104
bsdb:412/2/1_methamphetamine-dependence:Methamphetamine-users_vs_non-users_UP	NA	86331
bsdb:412/2/2_methamphetamine-dependence:Methamphetamine-users_vs_non-users_DOWN	NA	1283313
bsdb:412/3/1_methamphetamine-dependence:MSM-who-tested-positive-on-MA-urine-drug-screening_vs_MSM-who-did-not-test-positive-on-MA-urine-drug-screening_UP	NA	165779
bsdb:412/3/2_methamphetamine-dependence:MSM-who-tested-positive-on-MA-urine-drug-screening_vs_MSM-who-did-not-test-positive-on-MA-urine-drug-screening_DOWN	NA	83770
bsdb:412/4/1_NA:HIV-positive-men-who-have-sex-with-men-who-tested-positive-in-a-methamphetamine-drug-screening_vs_HIV-positive-men-who-have-sex-with-men-who-did-not-test-positive-in-a-methamphetamine-drug-screening_UP	NA	34104
bsdb:412/4/2_NA:HIV-positive-men-who-have-sex-with-men-who-tested-positive-in-a-methamphetamine-drug-screening_vs_HIV-positive-men-who-have-sex-with-men-who-did-not-test-positive-in-a-methamphetamine-drug-screening_DOWN	NA	846
bsdb:412/5/1_NA:HIV-negative-MSM-who-tested-positive-in-a-MA-drug-screening_vs_HIV-negative-MSM-who-did-not-test-positive-in-a-MA-drug-screening_UP	NA	1485
bsdb:412/5/2_NA:HIV-negative-MSM-who-tested-positive-in-a-MA-drug-screening_vs_HIV-negative-MSM-who-did-not-test-positive-in-a-MA-drug-screening_DOWN	NA	168808
bsdb:413/1/1_obsessive-compulsive-disorder:OCD_vs_healthy-controls_DOWN	NA	207244
bsdb:414/1/1_epilepsy:before-keto-diet_vs_after-keto-diet_UP	NA	39948
bsdb:414/1/2_epilepsy:before-keto-diet_vs_after-keto-diet_DOWN	NA	1224
bsdb:415/1/1_HIV-infection:HIV-positive-women-who-have-been-taking-ART-for-more-than-1-year_vs_Age-matched-HIV-uninfected-women_UP	NA	437755
bsdb:415/2/1_NA:HIV-positive-women-with-oral-candidiasis_vs_Age-matched-HIV-uninfected-womenn_UP	NA	186803
bsdb:415/3/1_age:HIV-uninfected-women-who-are-50-years-of-age-or-older_vs_HIV-uninfected-women-who-are-less-than-35-years-of-age_UP	NA	437755
bsdb:416/1/1_NA:continue-cotrimoxazole-prophylaxis_vs_stop-cotrimoxazole-prophylaxis_UP	NA	28118
bsdb:416/1/2_NA:continue-cotrimoxazole-prophylaxis_vs_stop-cotrimoxazole-prophylaxis_DOWN	NA	1318
bsdb:416/1/3_NA:continue-cotrimoxazole-prophylaxis_vs_stop-cotrimoxazole-prophylaxis_UP	NA	166486
bsdb:416/1/4_NA:continue-cotrimoxazole-prophylaxis_vs_stop-cotrimoxazole-prophylaxis_DOWN	NA	1343
bsdb:417/1/1_NA:Women-with-diabetes_vs_Women-without-diabetes_DOWN	NA	165779
bsdb:418/1/1_HIV-infection:immunological-non-responders-assigned-to-treatment-for-12-weeks_vs_baseline_UP	NA	872
bsdb:418/1/2_HIV-infection:immunological-non-responders-assigned-to-treatment-for-12-weeks_vs_baseline_DOWN	NA	135858
bsdb:418/2/1_HIV-infection:immunological-responders-assigned-to-treatment-for-12-weeks_vs_baseline_UP	NA	872
bsdb:418/2/2_HIV-infection:immunological-responders-assigned-to-treatment-for-12-weeks_vs_baseline_DOWN	NA	135858
bsdb:419/1/1_HIV-infection:combination-antiretroviral-therapy-treated-individuals-after-taking-LGG-probiotic-for-8-weeks_vs_baseline_UP	NA	186803
bsdb:419/1/2_HIV-infection:combination-antiretroviral-therapy-treated-individuals-after-taking-LGG-probiotic-for-8-weeks_vs_baseline_DOWN	NA	128827
bsdb:419/2/1_HIV-infection:combination-antiretroviral-therapy-naive-individuals-after-taking-LGG-probiotic-for-8-weeks_vs_baseline_UP	NA	128827
bsdb:419/2/2_HIV-infection:combination-antiretroviral-therapy-naive-individuals-after-taking-LGG-probiotic-for-8-weeks_vs_baseline_DOWN	NA	128827
bsdb:419/3/1_HIV-infection:individuals-with-decreased-F-2-fluoro-2-deoxy-D-glucose-(F-FDG)-uptake-on-positron-emission-tomography-(PET)/magnetic-resonance-imaging-(MRI)_vs_individuals-with-no-change-in-uptake_DOWN	NA	543
bsdb:420/1/1_HIV-infection:HIV-infected-on-antiretroviral-therapy-allocated-to-probiotic-intervention_vs_baseline_UP	NA	1239
bsdb:420/1/2_HIV-infection:HIV-infected-on-antiretroviral-therapy-allocated-to-probiotic-intervention_vs_baseline_DOWN	NA	976
bsdb:420/2/1_HIV-infection:HIV-infected-on-antiretroviral-therapy-allocated-to-probiotic-intervention_vs_nonprobiotic-intervention_UP	NA	1578
bsdb:421/1/1_HIV-infection:Vertically-HIV-infected-children_vs_uninfected-siblings-or-children-born-to-HIV-infected-mothers_UP	NA	100883
bsdb:421/2/1_HIV-infection:Vertically-HIV-infected-children_vs_uninfected-siblings-or-children-born-to-HIV-infected-mothers_DOWN	NA	1357
bsdb:422/1/1_HIV-infection:Perinatally-HIV-infected-children_vs_uninfected-age-matched-controls_UP	NA	203491
bsdb:422/1/2_HIV-infection:Perinatally-HIV-infected-children_vs_uninfected-age-matched-controls_DOWN	NA	186802
bsdb:423/1/1_NA:ALS-patients_vs_Healthy-controls_UP	NA	171551
bsdb:423/1/2_NA:ALS-patients_vs_Healthy-controls_DOWN	NA	31977
bsdb:424/1/1_pancreatic-carcinoma:PC_vs_Healthy-control_UP	NA	31977
bsdb:424/1/2_pancreatic-carcinoma:PC_vs_Healthy-control_DOWN	NA	292632
bsdb:424/3/1_pancreatic-carcinoma:BO-PC_vs_NBO-PC_DOWN	NA	572511
bsdb:424/3/2_pancreatic-carcinoma:BO-PC_vs_NBO-PC_UP	NA	31977
bsdb:424/4/1_pancreatic-carcinoma:NBO-PC_vs_Healthy-control_DOWN	NA	541000
bsdb:424/4/2_pancreatic-carcinoma:NBO-PC_vs_Healthy-control_UP	NA	171549
bsdb:425/1/1_hypertension:Tibetan-Hypertensive-at-High-Altitude-(HTH)_vs_Han-Hypertensive-at-Low-Altitude-(LHH)_DOWN	NA	1239
bsdb:425/1/2_hypertension:Tibetan-Hypertensive-at-High-Altitude-(HTH)_vs_Han-Hypertensive-at-Low-Altitude-(LHH)_UP	NA	74201
bsdb:425/2/1_hypertension:Tibetan-Hypertensive-at-High-Altitude-(HTH)_vs_Han-Hypertensive-at-Middle-Altitude-(MHH)_DOWN	NA	1224
bsdb:425/2/2_hypertension:Tibetan-Hypertensive-at-High-Altitude-(HTH)_vs_Han-Hypertensive-at-Middle-Altitude-(MHH)_UP	NA	976
bsdb:425/3/1_hypertension:Tibetan-Healthy-at-High-Altitude-(HTN)_vs_Han-Healthy-at-Low-Altitude-(LHN)_DOWN	NA	1224
bsdb:425/3/2_hypertension:Tibetan-Healthy-at-High-Altitude-(HTN)_vs_Han-Healthy-at-Low-Altitude-(LHN)_UP	NA	976
bsdb:425/4/1_hypertension:Tibetan-Healthy-at-High-Altitude-(HTN)_vs_Han-Healthy-at-Middle-Altitude-(MHN)_DOWN	NA	95818
bsdb:425/5/1_hypertension:Han-Hypertensive-at-Middle-Altitude-(MHH)_vs_Han-Hypertensive-at-Low-Altitude-(LHH)_DOWN	NA	1239
bsdb:425/5/2_hypertension:Han-Hypertensive-at-Middle-Altitude-(MHH)_vs_Han-Hypertensive-at-Low-Altitude-(LHH)_UP	NA	74201
bsdb:425/6/1_hypertension:Han-Healthy-at-Middle-Altitude-(MHN)_vs_Han-Healthy-at-Low-Altitude-(LHN)_UP	NA	976
bsdb:425/6/2_hypertension:Han-Healthy-at-Middle-Altitude-(MHN)_vs_Han-Healthy-at-Low-Altitude-(LHN)_DOWN	NA	32066
bsdb:426/1/1_NA:autoimmune-hepatits-cases_vs_healthy-controls_UP	NA	29465
bsdb:426/1/2_NA:autoimmune-hepatits-cases_vs_healthy-controls_DOWN	NA	375288
bsdb:427/1/1_diet:omnivores_vs_vegetarians_DOWN	NA	171552
bsdb:427/2/1_diet:omnivores_vs_vegans_DOWN	NA	171552
bsdb:428/1/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	239935
bsdb:428/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	39486
bsdb:428/2/1_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_UP	NA	1512
bsdb:428/2/2_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_DOWN	NA	292632
bsdb:428/3/1_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_UP	NA	29466
bsdb:428/3/2_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_DOWN	NA	39488
bsdb:428/4/1_COVID-19:COVID-19-patients-treated-with-antibiotics_vs_Healthy-controls_DOWN	NA	1896336
bsdb:428/4/2_COVID-19:COVID-19-patients-treated-with-antibiotics_vs_Healthy-controls_UP	NA	1869337
bsdb:430/1/1_COVID-19:Patients-with-high-SARS-CoV-2-infectivity_vs_Patients-with-low-to-none-SARS-CoV-2-infectivity_UP	NA	1898203
bsdb:430/1/2_COVID-19:Patients-with-high-SARS-CoV-2-infectivity_vs_Patients-with-low-to-none-SARS-CoV-2-infectivity_DOWN	NA	626935
bsdb:432/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	2093
bsdb:432/1/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	186826
bsdb:433/1/1_cervical-glandular-intraepithelial-neoplasia:CIN-2+_vs_healthy-controls_UP	NA	2701
bsdb:433/1/2_cervical-glandular-intraepithelial-neoplasia:CIN-2+_vs_healthy-controls_DOWN	NA	186826
bsdb:433/2/1_cervical-cancer:cervical-cancer_vs_healthy-controls_UP	NA	200643
bsdb:433/2/2_cervical-cancer:cervical-cancer_vs_healthy-controls_DOWN	NA	186826
bsdb:434/1/1_human-papilloma-virus-infection:HPV-+_vs_healthy-control_UP	NA	906
bsdb:434/1/2_human-papilloma-virus-infection:HPV-+_vs_healthy-control_DOWN	NA	82135
bsdb:434/2/1_cervical-glandular-intraepithelial-neoplasia:LSIL_vs_healthy-control_UP	NA	419005
bsdb:434/2/2_cervical-glandular-intraepithelial-neoplasia:LSIL_vs_healthy-control_DOWN	NA	82135
bsdb:434/3/1_cervical-glandular-intraepithelial-neoplasia:HSIL_vs_healthy-control_UP	NA	386414
bsdb:434/3/2_cervical-glandular-intraepithelial-neoplasia:HSIL_vs_healthy-control_DOWN	NA	82135
bsdb:434/4/1_cervical-cancer:cervical-cancer_vs_healthy-control_UP	NA	281920
bsdb:434/4/2_cervical-cancer:cervical-cancer_vs_healthy-control_DOWN	NA	82135
bsdb:435/1/1_human-papilloma-virus-infection:HPV+-persistence_vs_HPV-_UP	NA	162289
bsdb:435/1/2_human-papilloma-virus-infection:HPV+-persistence_vs_HPV-_DOWN	NA	1239
bsdb:435/2/1_human-papilloma-virus-infection:HPV+-transient_vs_HPV-_UP	NA	147802
bsdb:435/2/2_human-papilloma-virus-infection:HPV+-transient_vs_HPV-_DOWN	NA	1239
bsdb:436/1/1_cervical-glandular-intraepithelial-neoplasia:CIN2+/cervical-cancer_vs_healthy-control_UP	NA	386414
bsdb:437/1/1_human-papilloma-virus-infection:HPV-16+_vs_healthy-control_UP	NA	2702
bsdb:439/1/1_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	186804
bsdb:439/1/2_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	838
bsdb:440/1/1_NA:Participants-with-papulopustular-rosacea-(PPR)_vs_Healthy-controls_UP	NA	28131
bsdb:440/1/2_NA:Participants-with-papulopustular-rosacea-(PPR)_vs_Healthy-controls_DOWN	NA	38313
bsdb:440/2/1_NA:Participants-with-erythematotelangiectatic-rosacea_vs_Healthy-controls_DOWN	NA	33038
bsdb:441/1/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	1654
bsdb:441/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	1485
bsdb:441/2/1_NA:H1N1-cases_vs_Healthy-controls_DOWN	NA	41978
bsdb:441/2/2_NA:H1N1-cases_vs_Healthy-controls_UP	NA	162289
bsdb:441/3/1_COVID-19:COVID-19-patients_vs_H1N1-patients_UP	NA	1485
bsdb:441/3/2_COVID-19:COVID-19-patients_vs_H1N1-patients_DOWN	NA	836
bsdb:441/4/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	91061
bsdb:442/1/1_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	29918
bsdb:442/1/2_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	5551
bsdb:443/1/1_NA:IBS_vs_Health-Control_UP	NA	287
bsdb:443/1/2_NA:IBS_vs_Health-Control_DOWN	NA	1678
bsdb:443/2/1_NA:IBS-C_vs_Health-Control_UP	NA	29465
bsdb:443/2/2_NA:IBS-C_vs_Health-Control_DOWN	NA	1686
bsdb:443/3/1_NA:IBS-D_vs_Health-Control_UP	NA	287
bsdb:443/3/2_NA:IBS-D_vs_Health-Control_DOWN	NA	1686
bsdb:443/4/1_NA:IBS-U_vs_Health-Control_UP	NA	287
bsdb:443/4/2_NA:IBS-U_vs_Health-Control_DOWN	NA	29465
bsdb:446/1/1_COVID-19:COVID-19-cases_vs_COVID-19-negative-controls_DOWN	NA	38284
bsdb:446/1/2_COVID-19:COVID-19-cases_vs_COVID-19-negative-controls_UP	NA	31957
bsdb:447/1/1_gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_UP	NA	135625
bsdb:447/1/2_gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_DOWN	NA	171550
bsdb:447/2/1_gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_UP	NA	970
bsdb:447/2/2_gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_DOWN	NA	1243
bsdb:449/1/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	55601
bsdb:449/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	221027
bsdb:450/1/1_NA:Day-7_vs_Day-0_DOWN	NA	1239
bsdb:450/1/2_NA:Day-7_vs_Day-0_UP	NA	976
bsdb:450/2/1_NA:Day-7_vs_Day-0_DOWN	NA	1239
bsdb:450/2/2_NA:Day-7_vs_Day-0_UP	NA	976
bsdb:451/1/1_type-II-diabetes-mellitus:Medicated-Type-II-Diabetes-individuals_vs_Healthy-controls_DOWN	NA	649775
bsdb:452/1/1_gestational-diabetes:Pregnant-women-with-Gestational-Diabetes-Mellitus_vs_euglycemic-(control)-singleton-pregnant-women_UP	NA	1263
bsdb:452/1/2_gestational-diabetes:Pregnant-women-with-Gestational-Diabetes-Mellitus_vs_euglycemic-(control)-singleton-pregnant-women_DOWN	NA	29465
bsdb:453/1/1_COVID-19:SARS-CoV-2-infected-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_UP	NA	1392389
bsdb:453/1/2_COVID-19:SARS-CoV-2-infected-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_DOWN	NA	570
bsdb:453/2/1_COVID-19:SARS-CoV-2-recovered-individuals_vs_SARS-CoV-2-infected-patients_DOWN	NA	872
bsdb:453/2/2_COVID-19:SARS-CoV-2-recovered-individuals_vs_SARS-CoV-2-infected-patients_UP	NA	1766253
bsdb:453/3/1_COVID-19:Recovered-COVID-19-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_UP	NA	877428
bsdb:453/3/2_COVID-19:Recovered-COVID-19-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_DOWN	NA	1263
bsdb:453/4/1_COVID-19:Positive-for-COVID-19-viral-RNA-in-feces_vs_Negative-for-COVID-19-viral-RNA-in-feces_UP	NA	1766253
bsdb:453/4/2_COVID-19:Positive-for-COVID-19-viral-RNA-in-feces_vs_Negative-for-COVID-19-viral-RNA-in-feces_DOWN	NA	255204
bsdb:455/1/1_NA:pregnant-women-without-gingivitis_vs_non-pregnant-women-without-gingivitis_UP	NA	95818
bsdb:455/1/2_NA:pregnant-women-without-gingivitis_vs_non-pregnant-women-without-gingivitis_DOWN	NA	217201
bsdb:455/2/1_gingivitis:pregnant-women-with-gingivitis_vs_pregnant-women-without-gingivitis_UP	NA	157
bsdb:455/3/1_gingivitis:pregnant-women-with-gingivitis_vs_pregnant-women-without-gingivitis_UP	NA	2699746
bsdb:455/3/2_gingivitis:pregnant-women-with-gingivitis_vs_pregnant-women-without-gingivitis_DOWN	NA	1382
bsdb:455/4/1_NA:pregnant-women_vs_non-pregnant-women_UP	NA	51123
bsdb:455/4/2_NA:pregnant-women_vs_non-pregnant-women_DOWN	NA	217202
bsdb:456/1/1_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	40544
bsdb:456/1/2_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	46255
bsdb:457/1/1_periodontitis:Individuals-diagnosed-with-Periodontitis_vs_Healthy-controls_UP	NA	58231
bsdb:457/2/1_periodontitis:Individuals-diagnosed-with-Periodontitis-and-Type-2-Diabetes-Mellitus-(DAP)_vs_Healthy-controls_UP	NA	234908
bsdb:457/4/1_periodontitis:Individuals-diagnosed-with-both-Periodontitis-and-Type-2-Diabetes-and-treated-with-metformin-(Met-group)_vs_Healthy-controls_UP	NA	58231
bsdb:457/5/1_periodontitis:Individuals-diagnosed-with-both-Periodontitis-and-Type-2-Diabetes-and-treated-with-metformin-(Met-group)_vs_Individuals-diagnosed-with-Periodontitis-and-Type-2-Diabetes-Mellitus-(DAP)_DOWN	NA	234908
bsdb:457/5/2_periodontitis:Individuals-diagnosed-with-both-Periodontitis-and-Type-2-Diabetes-and-treated-with-metformin-(Met-group)_vs_Individuals-diagnosed-with-Periodontitis-and-Type-2-Diabetes-Mellitus-(DAP)_UP	NA	1309
bsdb:458/1/1_COVID-19:COVID-19-patients_vs_Non-intubated-patients-with-non-incubation-viral-pneumonia-or-non-incubation-non-infectious-diseases_UP	NA	13687
bsdb:458/1/2_COVID-19:COVID-19-patients_vs_Non-intubated-patients-with-non-incubation-viral-pneumonia-or-non-incubation-non-infectious-diseases_DOWN	NA	29465
bsdb:459/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_DOWN	NA	91061
bsdb:459/1/2_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_UP	NA	397456
bsdb:462/1/1_type-I-diabetes-mellitus:Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	4930
bsdb:462/1/2_type-I-diabetes-mellitus:Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	1124675
bsdb:462/2/1_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	148959
bsdb:462/2/2_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	1891946
bsdb:462/3/1_diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_DOWN	NA	42658
bsdb:462/3/2_diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_UP	NA	1500560
bsdb:464/1/1_COVID-19:Confirmed-COVID-19-patients_vs_Healthy-controls_DOWN	NA	836
bsdb:464/1/2_COVID-19:Confirmed-COVID-19-patients_vs_Healthy-controls_UP	NA	195950
bsdb:464/2/1_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_DOWN	NA	836
bsdb:464/2/2_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_UP	NA	970
bsdb:464/3/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	707003
bsdb:464/3/2_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	117563
bsdb:465/1/1_diabetic-neuropathy:Individuals-diagnosed-with-peripheral-neuropathy-associated-with-type-2-diabetes_vs_Healthy-controls_UP	NA	1940338
bsdb:465/1/2_diabetic-neuropathy:Individuals-diagnosed-with-peripheral-neuropathy-associated-with-type-2-diabetes_vs_Healthy-controls_DOWN	NA	216851
bsdb:467/1/1_NA:Her2-positive-tumor_vs_Her2-negative-tumor_UP	NA	904
bsdb:467/1/2_NA:Her2-positive-tumor_vs_Her2-negative-tumor_DOWN	NA	1263
bsdb:467/2/1_NA:later-age-at-menarche-(12)_vs_early-age-at-menarche-(11)_UP	NA	NA
bsdb:467/2/2_NA:later-age-at-menarche-(12)_vs_early-age-at-menarche-(11)_DOWN	NA	1263
bsdb:467/3/1_NA:ER-_vs_ER+_DOWN	NA	29465
bsdb:467/5/1_NA:Grade-High-(III)_vs_Grade-Low-(I/II)_UP	NA	84111
bsdb:467/5/2_NA:Grade-High-(III)_vs_Grade-Low-(I/II)_DOWN	NA	207244
bsdb:467/6/1_NA:Stage-High-(III)_vs_Stage-Low-(I/II)_UP	NA	724
bsdb:467/6/2_NA:Stage-High-(III)_vs_Stage-Low-(I/II)_DOWN	NA	135858
bsdb:467/7/1_age:Age-50_vs_Age-50+_UP	NA	1357
bsdb:467/8/1_NA:Nulliparous_vs_Parous_DOWN	NA	135858
bsdb:467/9/1_body-mass-index:BMI25_vs_BMI<25_UP	NA	239934
bsdb:467/10/1_NA:TBF>46%_vs_TBF46%_UP	NA	31979
bsdb:467/10/2_NA:TBF>46%_vs_TBF46%_DOWN	NA	84107
bsdb:468/1/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	1378
bsdb:468/2/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	168808
bsdb:468/2/2_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_UP	NA	1283313
bsdb:468/3/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	397864
bsdb:468/4/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_UP	NA	1940338
bsdb:468/5/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_UP	NA	1940338
bsdb:468/5/2_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	906
bsdb:469/1/1_COVID-19:COVID-19-patients_vs_Non-COVID-19-controls_DOWN	NA	40324
bsdb:470/1/1_colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	33039
bsdb:470/1/2_colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	292632
bsdb:470/1/3_colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	1904861
bsdb:471/1/1_colorectal-cancer:colorectal-cancer-cases_vs_controls_UP	NA	33039
bsdb:471/1/2_colorectal-cancer:colorectal-cancer-cases_vs_controls_DOWN	NA	1686
bsdb:471/1/3_colorectal-cancer:colorectal-cancer-cases_vs_controls_UP	NA	1077464
bsdb:471/1/4_colorectal-cancer:colorectal-cancer-cases_vs_controls_DOWN	NA	113107
bsdb:472/1/1_gestational-diabetes:Pregnant-individuals-with-gestational-diabetes_vs_Pregnant-individuals-who-are-normal-glucose-tolerance-(NGT)]_UP	NA	36835
bsdb:472/1/2_gestational-diabetes:Pregnant-individuals-with-gestational-diabetes_vs_Pregnant-individuals-who-are-normal-glucose-tolerance-(NGT)]_DOWN	NA	140625
bsdb:473/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_DOWN	NA	724
bsdb:474/1/1_COVID-19:COVID-19-patients_vs_Non-COVID-patients-with-URTI-or-COPD_UP	NA	1117
bsdb:474/1/2_COVID-19:COVID-19-patients_vs_Non-COVID-patients-with-URTI-or-COPD_DOWN	NA	201174
bsdb:476/1/1_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_UP	NA	1268
bsdb:476/1/2_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_DOWN	NA	102106
bsdb:477/1/1_COVID-19:Severe-COVID-19-patients_vs_COVID-19-negative-controls_UP	NA	128827
bsdb:477/2/1_COVID-19:Severe-COVID-19-patients-requiring-ICU_vs_COVID-19-negative-controls_UP	NA	157
bsdb:477/2/2_COVID-19:Severe-COVID-19-patients-requiring-ICU_vs_COVID-19-negative-controls_DOWN	NA	172788
bsdb:477/3/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	838
bsdb:478/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	1750
bsdb:478/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	82688
bsdb:478/2/1_COVID-19:COVID-19-patients_vs_Flu-patients_DOWN	NA	1750
bsdb:478/3/1_COVID-19:Flu-patients_vs_Healthy-controls_UP	NA	419005
bsdb:478/3/2_COVID-19:Flu-patients_vs_Healthy-controls_DOWN	NA	1750
bsdb:478/4/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	2050
bsdb:478/4/2_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	46123
bsdb:478/5/1_COVID-19:Flu-patients_vs_Healthy-controls_DOWN	NA	184869
bsdb:478/5/2_COVID-19:Flu-patients_vs_Healthy-controls_UP	NA	29465
bsdb:479/1/1_COVID-19:ICU-COVID-19-patients_vs_Healthy-controls_DOWN	NA	34072
bsdb:479/1/2_COVID-19:ICU-COVID-19-patients_vs_Healthy-controls_UP	NA	90964
bsdb:479/2/1_COVID-19:Mild-moderate-COVID-19-patients_vs_Healthy-controls_DOWN	NA	34072
bsdb:479/2/2_COVID-19:Mild-moderate-COVID-19-patients_vs_Healthy-controls_UP	NA	90964
bsdb:479/3/1_COVID-19:ICU-COVID-19-patients_vs_Mild-Moderate-COVID-19-patients_DOWN	NA	1737404
bsdb:479/3/2_COVID-19:ICU-COVID-19-patients_vs_Mild-Moderate-COVID-19-patients_UP	NA	32033
bsdb:479/4/1_COVID-19:ICU-COVID-19-patients_vs_Patients-infected-with-other-human-coronaviruses_DOWN	NA	338
bsdb:479/4/2_COVID-19:ICU-COVID-19-patients_vs_Patients-infected-with-other-human-coronaviruses_UP	NA	135621
bsdb:480/1/1_endometriosis:Confirmed-endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-conditions_UP	NA	1301
bsdb:480/1/2_endometriosis:Confirmed-endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-conditions_DOWN	NA	1380
bsdb:480/2/1_endometriosis:Confirmed-endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-conditions_UP	NA	1678
bsdb:480/2/2_endometriosis:Confirmed-endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-conditions_DOWN	NA	2050
bsdb:480/3/1_endometriosis:Confirmed-endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-conditions_UP	NA	1350
bsdb:480/3/2_endometriosis:Confirmed-endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-conditions_DOWN	NA	66831
bsdb:481/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	658655
bsdb:481/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	204516
bsdb:481/2/1_COVID-19:Antibiotic-treated-COVID-19-patients_vs_Antibiotic-naive-COVID-19-patients_UP	NA	1547
bsdb:481/2/2_COVID-19:Antibiotic-treated-COVID-19-patients_vs_Antibiotic-naive-COVID-19-patients_DOWN	NA	821
bsdb:481/3/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	187326
bsdb:481/3/2_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_DOWN	NA	39491
bsdb:482/2/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	375288
bsdb:483/1/1_COVID-19:Antibiotic-naive-COVID-19-patients_vs_Uninfected-controls,-pneumonia-patients,-antibiotics-treated-COVID-19-patients_UP	NA	291645
bsdb:483/1/2_COVID-19:Antibiotic-naive-COVID-19-patients_vs_Uninfected-controls,-pneumonia-patients,-antibiotics-treated-COVID-19-patients_DOWN	NA	39496
bsdb:483/2/1_COVID-19:Antibiotic-treated-COVID-19-patients_vs_Antibiotic-naive-COVID-19-patients,-pneumonia-patients,-uninfected-controls_DOWN	NA	39496
bsdb:483/3/1_COVID-19:Pneumonia-controls_vs_Uninfected-controls,-COVID-19-patients_DOWN	NA	39496
bsdb:484/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-patients-with-fever-and-cough_UP	NA	59823
bsdb:484/4/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-patients-with-fever-and-cough_UP	NA	1311
bsdb:485/1/1_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_UP	NA	1350
bsdb:485/1/2_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_DOWN	NA	84111
bsdb:485/2/1_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_UP	NA	1351
bsdb:485/2/2_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_DOWN	NA	658082
bsdb:486/1/1_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_UP	NA	1587
bsdb:486/1/2_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_DOWN	NA	1531
bsdb:486/2/1_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_UP	NA	358743
bsdb:486/2/2_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_DOWN	NA	186801
bsdb:486/3/1_COVID-19:Severe-COVID-19-patients_vs_Healthy-controls_UP	NA	622
bsdb:486/3/2_COVID-19:Severe-COVID-19-patients_vs_Healthy-controls_DOWN	NA	186801
bsdb:487/1/1_COVID-19:Recovered-COVID-19-samples-(respiratory-negative)_vs_Infected-COVID-19-samples-(respiratory-positive)_UP	NA	171549
bsdb:487/1/2_COVID-19:Recovered-COVID-19-samples-(respiratory-negative)_vs_Infected-COVID-19-samples-(respiratory-positive)_DOWN	NA	2037
bsdb:487/2/1_COVID-19:Recovered-COVID-19-samples-(respiratory-negative)_vs_Healthy-controls_DOWN	NA	33042
bsdb:487/2/2_COVID-19:Recovered-COVID-19-samples-(respiratory-negative)_vs_Healthy-controls_UP	NA	544
bsdb:487/3/1_COVID-19:Infected-COVID-19-samples-(respiratory-positive)_vs_Healthy-controls_DOWN	NA	397864
bsdb:487/3/2_COVID-19:Infected-COVID-19-samples-(respiratory-positive)_vs_Healthy-controls_UP	NA	1505657
bsdb:488/1/1_NA:IBS-D_vs_Healthy-Control_UP	NA	1263
bsdb:488/1/2_NA:IBS-D_vs_Healthy-Control_DOWN	NA	1301
bsdb:489/1/1_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_Pneumonia-control-patients-(COVID-negative)_UP	NA	1720
bsdb:489/1/2_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_Pneumonia-control-patients-(COVID-negative)_DOWN	NA	570
bsdb:489/2/1_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_UP	NA	1282
bsdb:489/2/2_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_DOWN	NA	550
bsdb:489/3/1_COVID-19:COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_vs_Pneumonia-controls-(COVID-negative)_UP	NA	29387
bsdb:489/3/2_COVID-19:COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_vs_Pneumonia-controls-(COVID-negative)_DOWN	NA	818
bsdb:490/1/1_NA:IBS_vs_Healthy-Control_UP	NA	29465
bsdb:491/1/1_NA:IBS_vs_Healthy-Control_UP	NA	213465
bsdb:491/1/2_NA:IBS_vs_Healthy-Control_DOWN	NA	1300
bsdb:492/1/1_type-II-diabetes-mellitus:Individuals-having-Type-2-Diabetes-Mellitus-without-Diabetic-Retinopathy_vs_Healthy-controls_DOWN	NA	191303
bsdb:492/1/2_type-II-diabetes-mellitus:Individuals-having-Type-2-Diabetes-Mellitus-without-Diabetic-Retinopathy_vs_Healthy-controls_UP	NA	46255
bsdb:492/2/1_diabetic-retinopathy:Individuals-diagnosed-with-Type-2-Diabetes-and-clinically-manifest-Diabetic-Retinopathy-(DR)_vs_Healthy-controls_DOWN	NA	95818
bsdb:492/2/2_diabetic-retinopathy:Individuals-diagnosed-with-Type-2-Diabetes-and-clinically-manifest-Diabetic-Retinopathy-(DR)_vs_Healthy-controls_UP	NA	74201
bsdb:492/3/1_diabetic-retinopathy:Individuals-diagnosed-with-Type-2-Diabetes-and-clinically-manifest-Diabetic-Retinopathy-(DR)_vs_Individuals-diagnosed-with-type-2-diabetes-Mellitus_DOWN	NA	46255
bsdb:492/3/2_diabetic-retinopathy:Individuals-diagnosed-with-Type-2-Diabetes-and-clinically-manifest-Diabetic-Retinopathy-(DR)_vs_Individuals-diagnosed-with-type-2-diabetes-Mellitus_UP	NA	74201
bsdb:494/1/1_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	375288
bsdb:494/1/2_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	1301
bsdb:495/1/1_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	838
bsdb:495/1/2_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	577309
bsdb:495/2/1_prediabetes-syndrome:Individuals-with-Prediabetes-(PreDM)_vs_Healthy-controls_UP	NA	1224
bsdb:495/3/1_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Individuals-with-Prediabetes-(PreDM)_DOWN	NA	816
bsdb:496/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	29465
bsdb:496/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	841
bsdb:496/2/1_COVID-19:COVID-19-patients_vs_Seasonal-flu-patients_UP	NA	848
bsdb:496/2/2_COVID-19:COVID-19-patients_vs_Seasonal-flu-patients_DOWN	NA	118747
bsdb:498/1/1_COVID-19:COVID-19-patients_vs_Asymptomatic-uninfected-controls_UP	NA	821
bsdb:498/1/2_COVID-19:COVID-19-patients_vs_Asymptomatic-uninfected-controls_DOWN	NA	28130
bsdb:498/2/1_COVID-19:COVID-19-patients-with-high-viral-load_vs_COVID-19-patients-with-low-viral-load_UP	NA	165179
bsdb:498/2/2_COVID-19:COVID-19-patients-with-high-viral-load_vs_COVID-19-patients-with-low-viral-load_DOWN	NA	1283
bsdb:499/1/1_NA:IBS-A_vs_Healthy-Control_DOWN	NA	195950
bsdb:499/1/2_NA:IBS-A_vs_Healthy-Control_UP	NA	244328
bsdb:499/2/1_NA:IBS-C_vs_Healthy-Control_DOWN	NA	152509
bsdb:499/2/2_NA:IBS-C_vs_Healthy-Control_UP	NA	33038
bsdb:499/3/1_NA:IBS-D_vs_Healthy-Control_DOWN	NA	195950
bsdb:499/3/2_NA:IBS-D_vs_Healthy-Control_UP	NA	46228
bsdb:499/4/1_NA:IBS-(All-patients)_vs_Healthy-Control_DOWN	NA	244328
bsdb:499/4/2_NA:IBS-(All-patients)_vs_Healthy-Control_UP	NA	46228
bsdb:500/1/1_COVID-19:COVID-19-patients_vs_Non-COVID-19-pneumonia-patients_UP	NA	43263
bsdb:500/1/2_COVID-19:COVID-19-patients_vs_Non-COVID-19-pneumonia-patients_DOWN	NA	1301
bsdb:501/1/1_endometriosis:One-(1)-Stage-III-Endometriosis-patient_vs_Women-scheduled-for-laparoscopic-surgery-for-benign-uterine/-ovarian-conditions-as-well-as-women-with-Stage-I-or-Stage-II-endometriosis_UP	NA	191303
bsdb:502/1/1_NA:IBS_vs_Healthy-Control_UP	NA	39491
bsdb:502/1/2_NA:IBS_vs_Healthy-Control_DOWN	NA	29465
bsdb:502/2/1_NA:IBS-C_vs_Healthy-Control_UP	NA	31953
bsdb:502/2/2_NA:IBS-C_vs_Healthy-Control_DOWN	NA	816
bsdb:502/3/1_NA:IBS-D_vs_Healthy-Control_UP	NA	39491
bsdb:502/3/2_NA:IBS-D_vs_Healthy-Control_DOWN	NA	816
bsdb:502/4/1_NA:IBS-M_vs_Healthy-Control_UP	NA	1581
bsdb:504/1/1_NA:BNH-with-TNBC-tumor-tissue_vs_BNH-with-TNBC-normal-tissue_DOWN	NA	201174
bsdb:504/2/1_NA:WNH-with-TNBC-normal-tissue_vs_WNH-with-TNBC-normal-tissue_UP	NA	976
bsdb:504/4/1_NA:TPBC-tumor-tissue_vs_TPBC-normal-tissue_UP	NA	1301
bsdb:504/5/1_race:BNH_vs_WNH_UP	NA	186818
bsdb:504/5/2_race:BNH_vs_WNH_DOWN	NA	20
bsdb:504/6/1_race:BNH_vs_WNH_UP	NA	28100
bsdb:504/6/2_race:BNH_vs_WNH_DOWN	NA	1578
bsdb:505/1/1_NA:IBS_vs_Healthy-Control_UP	NA	216816
bsdb:505/1/2_NA:IBS_vs_Healthy-Control_DOWN	NA	1680
bsdb:505/2/1_NA:IBS-D_vs_Healthy-Control_UP	NA	216816
bsdb:505/2/2_NA:IBS-D_vs_Healthy-Control_DOWN	NA	1681
bsdb:505/3/1_NA:IBS-A_vs_Healthy-Control_UP	NA	1681
bsdb:505/3/2_NA:IBS-A_vs_Healthy-Control_DOWN	NA	216816
bsdb:505/4/1_NA:IBS-C_vs_Healthy-Control_UP	NA	1681
bsdb:505/4/2_NA:IBS-C_vs_Healthy-Control_DOWN	NA	216816
bsdb:506/1/1_NA:IBS-D_vs_Healthy-Control_UP	NA	562
bsdb:507/1/1_antibiotic:Patients-after-Rifaximin-treatment_vs_Patients-before-Rifaximin-treatment_DOWN	NA	29465
bsdb:507/1/2_antibiotic:Patients-after-Rifaximin-treatment_vs_Patients-before-Rifaximin-treatment_UP	NA	NA
bsdb:507/2/1_antibiotic:Patients-1-month-after-Rifaximin-treatment_vs_Patients-before-Rifaximin-treatment_UP	NA	1578
bsdb:507/2/2_antibiotic:Patients-1-month-after-Rifaximin-treatment_vs_Patients-before-Rifaximin-treatment_DOWN	NA	841
bsdb:510/1/1_periodontitis:patients-with-rheumatoid-arthritis_vs_patients-with-no-rheumatoid-arthritis_UP	NA	1872413
bsdb:510/1/2_periodontitis:patients-with-rheumatoid-arthritis_vs_patients-with-no-rheumatoid-arthritis_DOWN	NA	166
bsdb:510/2/1_rheumatoid-arthritis:patients-with-rheumatoid-arthritis_vs_patients-with-no-rheumatoid-arthritis_UP	NA	712711
bsdb:510/2/2_rheumatoid-arthritis:patients-with-rheumatoid-arthritis_vs_patients-with-no-rheumatoid-arthritis_DOWN	NA	325787
bsdb:511/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	44259
bsdb:511/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	59892
bsdb:511/2/1_COVID-19:COVID-19-patients-(severe/critical)_vs_COVID-19-patients-(mild/moderate)_DOWN	NA	2740
bsdb:511/3/1_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_UP	NA	162289
bsdb:511/3/2_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_DOWN	NA	28131
bsdb:511/4/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	117563
bsdb:511/4/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	387090
bsdb:511/5/1_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_UP	NA	1380
bsdb:511/5/2_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_DOWN	NA	482
bsdb:512/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls-and-healthcare-workers_UP	NA	475
bsdb:512/2/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_UP	NA	287
bsdb:512/3/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-healthcare-workers-(controls)_UP	NA	287
bsdb:512/3/2_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-healthcare-workers-(controls)_DOWN	NA	292
bsdb:513/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_UP	NA	29465
bsdb:513/2/1_COVID-19:COVID-19-positive-patients-with-breathing-assistance_vs_COVID-19-positive-patients-without-breathing-assistance_UP	NA	613
bsdb:514/1/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Women-scheduled-for-laparoscopic-surgery-for-benign-uterine/-ovarian-conditions_UP	NA	1301
bsdb:515/1/1_endometriosis:Endometriosis-patients-with-infertility_vs_Non-endometriosis-patients-with-infertility_NA	NA	544448
bsdb:517/1/1_endometriosis:Endometriosis-patients_vs_Fertile-women-being-operated-on-for-other-gynecological-issues_UP	NA	468
bsdb:517/2/1_endometriosis:Endometriosis-patients-treated-with-GnRHa_vs_Endometriosis-patients-not-treated-with-GnRHa_UP	NA	90964
bsdb:517/2/2_endometriosis:Endometriosis-patients-treated-with-GnRHa_vs_Endometriosis-patients-not-treated-with-GnRHa_DOWN	NA	33958
bsdb:517/3/1_endometriosis:Patients-with-ovarian-endometrioma-cysts_vs_Patients-with-non-endometrioma-cysts_UP	NA	90964
bsdb:518/1/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_UP	NA	33958
bsdb:518/1/2_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	171551
bsdb:519/1/1_endometriosis:Endo-mice_vs_Non-endo-mice_UP	NA	816
bsdb:520/1/1_endometriosis:Stage-3/4-Endometriosis-patients_vs_Stage-1/2-Endometriosis-patients_UP	NA	165779
bsdb:521/1/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Surgical-controls_DOWN	NA	1654
bsdb:521/1/2_endometriosis:Stage-3/4-endometriosis-patients_vs_Surgical-controls_UP	NA	212791
bsdb:522/1/1_endometriosis:Endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-tumors_UP	NA	NA
bsdb:522/2/1_endometriosis:Endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-tumors_DOWN	NA	147802
bsdb:522/2/2_endometriosis:Endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-tumors_UP	NA	NA
bsdb:522/3/1_endometriosis:Endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-tumors_UP	NA	33069
bsdb:522/3/2_endometriosis:Endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-tumors_DOWN	NA	33069
bsdb:522/4/1_endometriosis:Endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-tumors_UP	NA	1485
bsdb:522/4/2_endometriosis:Endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-tumors_DOWN	NA	128780
bsdb:522/5/1_endometriosis:Endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-tumors_UP	NA	28454
bsdb:522/5/2_endometriosis:Endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-tumors_DOWN	NA	296
bsdb:523/1/1_endometriosis:Endo-mice_vs_Non-endo-mice_DOWN	NA	207244
bsdb:523/1/2_endometriosis:Endo-mice_vs_Non-endo-mice_UP	NA	375288
bsdb:524/1/1_NA:Individuals-diagnosed-with--Nonalcoholic-steatohepatitis-(without-cirrhosis)_vs_Healthy-controls_UP	NA	41295
bsdb:524/1/2_NA:Individuals-diagnosed-with--Nonalcoholic-steatohepatitis-(without-cirrhosis)_vs_Healthy-controls_DOWN	NA	1505652
bsdb:524/2/1_NA:Individuals-diagnosed-with-Nonalcoholic-steatohepatitis-(NASH)-with-cirrhosis_vs_Healthy-controls_UP	NA	1506553
bsdb:524/2/2_NA:Individuals-diagnosed-with-Nonalcoholic-steatohepatitis-(NASH)-with-cirrhosis_vs_Healthy-controls_DOWN	NA	171551
bsdb:525/1/1_endometriosis:Women-with-EM-associated-CPPS_vs_Women-without-CPPS-presenting-for-routine-examinations_DOWN	NA	1578
bsdb:525/1/2_endometriosis:Women-with-EM-associated-CPPS_vs_Women-without-CPPS-presenting-for-routine-examinations_UP	NA	180282
bsdb:525/2/1_endometriosis:Women-with-EM-associated-CPPS_vs_Women-without-CPPS-presenting-for-routine-examinations_UP	NA	187328
bsdb:525/2/2_endometriosis:Women-with-EM-associated-CPPS_vs_Women-without-CPPS-presenting-for-routine-examinations_DOWN	NA	109790
bsdb:526/1/1_endometriosis:Endometriosis/-adenomyosis-patients_vs_Endometriosis-patients_UP	NA	84107
bsdb:526/2/1_endometriosis:Endometriosis/-adenomyosis-patients_vs_Patients-without-endometriosis_UP	NA	84107
bsdb:527/1/1_endometriosis:Endometriosis-patients_vs_Healthy-controls-taken-from-a-larger-cohort-study_DOWN	NA	191303
bsdb:527/1/2_endometriosis:Endometriosis-patients_vs_Healthy-controls-taken-from-a-larger-cohort-study_UP	NA	375288
bsdb:527/2/1_endometriosis:Endometriosis-patients_vs_Healthy-controls-taken-from-a-larger-cohort-study_DOWN	NA	171549
bsdb:527/2/2_endometriosis:Endometriosis-patients_vs_Healthy-controls-taken-from-a-larger-cohort-study_UP	NA	119852
bsdb:529/2/1_arthritis:rheumatoid-arthritis_vs_Osteoarthritis_UP	NA	482
bsdb:529/2/2_arthritis:rheumatoid-arthritis_vs_Osteoarthritis_DOWN	NA	46123
bsdb:535/1/1_NA:Antibiotic-treated_vs_Antibiotic-untreated_DOWN	NA	41200
bsdb:535/1/2_NA:Antibiotic-treated_vs_Antibiotic-untreated_UP	NA	1591
bsdb:535/2/1_NA:Antibiotic-treated_vs_Antibiotic-untreated_DOWN	NA	1224
bsdb:535/2/2_NA:Antibiotic-treated_vs_Antibiotic-untreated_UP	NA	75787
bsdb:535/3/1_antibiotic-exposure:Antibiotic-treated_vs_Antibiotic-untreated_DOWN	NA	28050
bsdb:535/3/2_antibiotic-exposure:Antibiotic-treated_vs_Antibiotic-untreated_UP	NA	583
bsdb:535/4/1_antibiotic-exposure:Antibiotic-treated_vs_Antibiotic-untreated_DOWN	NA	543
bsdb:535/4/2_antibiotic-exposure:Antibiotic-treated_vs_Antibiotic-untreated_UP	NA	1578
bsdb:536/1/1_antibiotic-therapy:The-group-given-an-azithromycin-oral-solution_vs_The-group-given-a-placebo_DOWN	NA	165187
bsdb:536/1/2_antibiotic-therapy:The-group-given-an-azithromycin-oral-solution_vs_The-group-given-a-placebo_UP	NA	946234
bsdb:537/1/1_parkinson's-disease:patients-with-idiopathic-parkinson's-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	239934
bsdb:537/1/2_parkinson's-disease:patients-with-idiopathic-parkinson's-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	1263
bsdb:537/2/1_parkinson's-disease:the-trend-over-Parkinson's-disease-progression_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	203557
bsdb:537/2/2_parkinson's-disease:the-trend-over-Parkinson's-disease-progression_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	186803
bsdb:537/3/1_parkinson's-disease:patients-with-MSA(multiple-system-atrophy)-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	203557
bsdb:537/3/2_parkinson's-disease:patients-with-MSA(multiple-system-atrophy)-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	171552
bsdb:537/4/1_parkinson's-disease:patients-with-PSP(progressive-supranuclear-palsy)-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	203557
bsdb:537/4/2_parkinson's-disease:patients-with-PSP(progressive-supranuclear-palsy)-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	1301
bsdb:537/5/1_parkinson's-disease:patients-with-De-novo-Parkinson's-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	186803
bsdb:537/6/1_parkinson's-disease:patients-with-early-Parkinson's-disease_vs_healthy-controls-without-any-form-of-Parkinson's-disease_UP	NA	203557
bsdb:537/6/2_parkinson's-disease:patients-with-early-Parkinson's-disease_vs_healthy-controls-without-any-form-of-Parkinson's-disease_DOWN	NA	186803
bsdb:537/7/1_parkinson's-disease:patients-with-mid-stage-Parkinson's_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	203557
bsdb:537/7/2_parkinson's-disease:patients-with-mid-stage-Parkinson's_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	186803
bsdb:537/8/1_parkinson's-disease:patients-with-advanced-stage-Parkinson's_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	203557
bsdb:537/8/2_parkinson's-disease:patients-with-advanced-stage-Parkinson's_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	186803
bsdb:541/1/1_schizophrenia:Schizophrenic-patients-(ARSCZ,-FESCZ)_vs_Healthy-controls_UP	NA	1613
bsdb:541/1/2_schizophrenia:Schizophrenic-patients-(ARSCZ,-FESCZ)_vs_Healthy-controls_UP	NA	1632
bsdb:541/2/1_schizophrenia:Schizophrenic-patients-(ARSCZ,-FESCZ)_vs_Healthy-controls_UP	NA	310297
bsdb:541/2/2_schizophrenia:Schizophrenic-patients-(ARSCZ,-FESCZ)_vs_Healthy-controls_DOWN	NA	1244
bsdb:541/2/3_schizophrenia:Schizophrenic-patients-(ARSCZ,-FESCZ)_vs_Healthy-controls_UP	NA	1613
bsdb:541/3/1_schizophrenia:Schizophrenic-patients_vs_Healthy-controls_UP	NA	310297
bsdb:541/3/2_schizophrenia:Schizophrenic-patients_vs_Healthy-controls_DOWN	NA	357276
bsdb:541/4/1_schizophrenia:Baseline-schizophrenic-patients_vs_Healthy-controls_NA	NA	310297
bsdb:541/5/1_schizophrenia:Baseline-schizophrenic-patients_vs_Healthy-controls_NA	NA	310297
bsdb:545/1/1_antibiotic-therapy:7-week-old-(young)-mice-10-days-after-antibiotic-treatments_vs_7-week-old-(young)-mice-before-antibiotic-treatment_UP	NA	1350
bsdb:545/1/2_antibiotic-therapy:7-week-old-(young)-mice-10-days-after-antibiotic-treatments_vs_7-week-old-(young)-mice-before-antibiotic-treatment_DOWN	NA	1898207
bsdb:545/2/1_antibiotic-therapy:7-week-old-(young)-mice-6-months-after-antibiotic-treatments_vs_7-week-old-(young)-mice-before-antibiotic-treatment_UP	NA	1937008
bsdb:545/2/2_antibiotic-therapy:7-week-old-(young)-mice-6-months-after-antibiotic-treatments_vs_7-week-old-(young)-mice-before-antibiotic-treatment_DOWN	NA	1470349
bsdb:545/3/1_antibiotic-therapy:40-week-old-(old)-mice-10-days-after-antibiotic-treatments_vs_40-week-old-(old)-mice-before-antibiotic-treatment_UP	NA	171549
bsdb:545/3/2_antibiotic-therapy:40-week-old-(old)-mice-10-days-after-antibiotic-treatments_vs_40-week-old-(old)-mice-before-antibiotic-treatment_DOWN	NA	526525
bsdb:545/4/1_antibiotic-therapy:40-week-old-(old)-mice-6-months-after-antibiotic-treatments_vs_40-week-old-(old)-mice-before-antibiotic-treatment_DOWN	NA	1898207
bsdb:545/4/2_antibiotic-therapy:40-week-old-(old)-mice-6-months-after-antibiotic-treatments_vs_40-week-old-(old)-mice-before-antibiotic-treatment_UP	NA	526525
bsdb:546/1/1_COVID-19:COVID-19-cases_vs_Non-infected-controls_UP	NA	1224
bsdb:546/1/2_COVID-19:COVID-19-cases_vs_Non-infected-controls_DOWN	NA	1301
bsdb:547/1/1_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_UP	NA	208479
bsdb:547/1/2_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_DOWN	NA	1150298
bsdb:548/1/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	1239
bsdb:548/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	724
bsdb:549/1/1_HIV-infection:HIV-Postive-patients_vs_Control_UP	NA	194924
bsdb:550/1/1_NA:JIA-patients_vs_healthy-controls_UP	NA	712365
bsdb:550/1/2_NA:JIA-patients_vs_healthy-controls_DOWN	NA	712464;712187
bsdb:550/2/1_NA:JIA-patients-with-TMJ_vs_JIA-patients-without-TMJ_DOWN	NA	724
bsdb:550/2/2_NA:JIA-patients-with-TMJ_vs_JIA-patients-without-TMJ_UP	NA	729
